Archive for January, 2011
			
 	  	
			
			
			
				
				
				
TORONTO, ONTARIO — (Marketwire) — 01/31/11 — Denison Mines Corp. (TSX:  DML) (NYSE Amex: DNN) (“Denison” or the “Company”) announces that its 2011  operating plan forecasts production of 1.2 million pounds U3O8 and 2.2 million  pounds V2O5 from its operations in the United States. “The 2011 plan and budget  is focused on the growth of the Company with the largest exploration program  ever undertaken on our Wheeler River project, the recommencement of drilling on  our Zambian project and the development of our second mine on the Arizona Strip”  said Ron Hochstein, President and CEO of Denison. Unless otherwise stated all  figures are in U.S. dollars.
2011 Operating Plans
Production
Denison’s uranium production is expected to total 1.2 million pounds of U3O8  from ore in stockpile and from the Beaver, Pandora and Arizona 1 mines and  production from the alternate feed circuit at the White Mesa Mill in the United  States. Vanadium production is projected to total approximately 2.2 million  pounds of V2O5. The White Mesa mill is anticipated to continue processing  conventional ore during most of 2011, except for scheduled maintenance  shutdowns. Production of alternate feed material will continue throughout 2011.  The cash cost of production is expected to average approximately $43.50 per  pound of U3O8 net of vanadium credits, excluding sales royalties. The cash cost  per pound reflects the impact of an increase of over 200% of the cost of  sulphuric acid as compared to 2010. Capital expenditures on the mines and mill  facilities are estimated at $9.7 million.
Sales
Uranium sales are forecast to be approximately 1.3 million pounds of U3O8 of  which just over 500,000 pounds will be sold into long term contracts and the  remainder will be sold on the spot market. Vanadium sales are projected to be  2.8 million pounds V2O5 in 2011.
Business Development
Denison’s business development activities include advancement of its existing  development stage projects and exploration projects and the search for new  potential acquisitions. These activities, as part of its Five Year Business  Development Plan, are aimed at increasing Denison’s sustainable uranium  production to at least 10 million pounds per year by 2020.
In 2011, Denison will participate in exploration programs in Canada and the  United States. The total budget for these programs will be $15.0 million of  which Denison’s share will be $8.8 million. The Wheeler River program at a total  cost of $10.0 million (Denison’s share $6.0 million) represents the most  significant of these programs. A 35,000 metre drilling program has begun to test  additional areas with known uranium mineralization along the same mineralized  trend hosting the Phoenix deposit.
Exploration work in Canada will also be carried out on the Moore Lake,  Hatchet Lake, Murphy Lake, Bell Lake, McClean Lake and Wolly projects at a total  cost of $3.8 million (Denison’s share $1.6 million). In the United States,  drilling is planned on the Beaver mine trend and at the Sunday Complex to  outline potential resources which could extend the life of existing operations  on these properties. In Arizona, an exploration program on the Company’s DB1  breccia pipe is planned. The total cost of the U.S. exploration program is $1.3  million.
The Company is pleased to announce that exploration and development  activities will be restarted at its Mutanga project in Zambia. A 17,000 metre  exploration drill program will follow up on positive drilling results obtained  in 2009 and metallurgical test work will be undertaken to further define process  design criteria and operating costs. The Zambian program will total an estimated  $6.2 million.
In Mongolia, a $7.4 million exploration and development program is projected.  A $3.0 million, 38,000 metre exploration program is anticipated to be undertaken  on license areas that currently do not have defined resources in order to  confirm resources and support future work on these license areas. Development  activities on license areas which are more advanced will include drilling of  initial test patterns and pilot plant design. The implementation of the  Mongolian program is contingent upon resolution of outstanding issues with the  Mongolian Government regarding the Nuclear Energy Law and the structure of the  Gurvan Saihan Joint Venture. The Company remains hopeful that these issues will  be resolved early in 2011 such that the planned programs can be completed.
In Canada and the U.S., a total of $6.4 million will be spent by Denison on  development stage projects in 2011. In the United States, development of the  Pinenut mine is moving forward with initial production anticipated in early  2012, and permitting will be advanced for the EZ1/EZ2 and Canyon deposits. The  cost of these programs is estimated at $5.6 million. In Canada, the McClean  North underground development feasibility study will be advanced along with  continued evaluation of the Midwest development project under the operatorship  of majority owner AREVA Resources Canada Inc.
2010 PRODUCTION AND SALES
Denison’s uranium production in 2010 was 1.4 million pounds U3O8 from its  U.S. operations and its 22.5% share of production from the McClean Lake  operation in the Athabasca basin in Canada. Vanadium production totalled 2.3  million pounds V2O5 from its White Mesa mill in Utah.
Uranium sales in 2010 totalled 1.8 million pounds U3O8 at an average realized  price of $47.67 per pound U3O8. Vanadium sales in 2010 sales were 2.4 million  pounds V2O5 equivalent, at an average realized price of $6.33 per pound V2O5.
About Denison
Denison Mines Corp. is a mid-sized uranium producer in North America, with  mining assets in the Athabasca Basin region of Saskatchewan, Canada and the  southwest United States including Colorado, Utah, and Arizona. The Company has  ownership interests in two conventional uranium mills in North America. Denison  also has a strong exploration and development portfolio including the Phoenix  discovery in the Athabasca Basin as well as large land positions in the United  States, Canada, Mongolia and Zambia.
Cautionary Statements Regarding Forward Looking Information
Certain information contained in this press release constitutes  “forward-looking information”, within the meaning of the United States Private  Securities Litigation Reform Act of 1995 and similar Canadian legislation  concerning the business, operations and financial performance and condition of  Denison.
Generally, these forward-looking statements can be identified by the use of  forward-looking terminology such as “plans”, “expects” or “does not expect”, “is  expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”,  “anticipates” or “does not anticipate”, or “believes”, or variations of such  words and phrases or state that certain actions, events or results “may”,  “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” and “has  the potential to”.
Forward looking statements are based on the assumptions noted in this press  release and on the opinions and estimates of management as of the date such  statements are made, and they are subject to known and unknown risks,  uncertainties and other factors that may cause the actual results, level of  activity, performance or achievements of Denison to be materially different from  those expressed or implied by such forward-looking statements. Denison believes  that the expectations reflected in this forward-looking information is  reasonable, but no assurance can be given that these expectations will prove to  be correct and such forward-looking information included in this press release  should not be unduly relied upon. This information speaks only as of the date of  this press release. In particular, this press release may contain  forward-looking information pertaining to the following: the estimates of  Denison’s mineral reserves and mineral resources; uranium and vanadium  production and sales volumes; capital expenditure programs, estimated production  costs, exploration and development expenditures and reclamation costs;  expectations of market prices and costs; supply and demand for uranium and  vanadium; possible impacts of litigation on Denison; exploration, development,  production and expansion plans and objectives; Denison’s expectations regarding  raising capital and adding to its mineral reserves through acquisitions and  development; and receipt of regulatory approvals and permits and treatment under  governmental regulatory regimes.
There can be no assurance that such statements will prove to be accurate, as  Denison’s actual results and future events could differ materially from those  anticipated in this forward-looking information as a result of those factors  discussed in or referred to under the heading “Risk Factors” in Denison’s Annual  Information Form dated March 19, 2010, available at http://www.sedar.com and its  Form 40-F for the financial year ended December 31, 2009, available at  http://www.sec.gov, as well as the following: global financial conditions;  volatility in market prices for uranium and vanadium; changes in foreign  currency exchange rates and interest rates; the market price of Denison’s  securities; the ability to access capital; the ability of Denison to meet its  obligations to its creditors; liabilities inherent in mining operations;  uncertainties associated with estimating mineral reserves and resources; failure  to obtain industry partner and other third party consents and approvals, when  required; delays in obtaining permits and licenses for development properties;  competition for, among other things, capital, acquisitions of mineral reserves,  undeveloped lands and skilled personnel; incorrect assessments of the value of  acquisitions; geological, technical and processing problems; and, the potential  influence of, or reliance upon, a business partner.
Accordingly, readers should not place undue reliance on forward-looking  statements. These factors are not, and should not be construed as being,  exhaustive. Statements relating to “mineral reserves” or “mineral resources” are  deemed to be forward-looking information, as they involve the implied  assessment, based on certain estimates and assumptions that the mineral reserves  and mineral resources described can be profitably produced in the future. The  forward-looking information contained in this press release is expressly  qualified by this cautionary statement. Denison does not undertake any  obligation to publicly update or revise any forward-looking information after  the date of this press release to conform such information to actual results or  to changes in Denison’s expectations, except as otherwise required by applicable  legislation.
Contacts:
Denison Mines Corp.
Ron Hochstein
President and Chief  Executive Officer
(416) 979-1991 Extension 232
Denison Mines  Corp.
Jim Anderson
Executive Vice President and CFO
(416) 979-1991  Extension 372
 
				
								
								
				
			
			 
		
			
			
			
				
				
				
JUNAN COUNTY, China, Jan. 31, 2011 /PRNewswire-Asia-FirstCall/ — American  Lorain Corporation (NYSE Amex: ALN) (“American Lorain” or the “Company”), an  international processed snack foods, convenience foods, and frozen foods company  based in the Shandong Province, China, today announced that on January 28th,  2011, DEG has disbursed the second tranche of its loan to American Lorain in the  amount of $10 million.
American Lorain signed the loan agreement with DEG on May 31, 2010. The total  amount of the loan with DEG is $15 million, the first tranche of $5 million has  been disbursed on December 13, 2010. The loan has a term of 5 years and  commencing from the full disbursement, the interest rate will be fixed at 5.51%  per annum.
Mr. Si Chen, Chairman and CEO of American Lorain commented: “We are  very pleased to see the loan with DEG finally approved and disbursed. DEG is a  German financial institution dedicated to providing debt and equity financing  for quality enterprises in developing counties. The final approval of the loan  reflected the trust and support this rigorous German institution has in American  Lorain. The loan also comes in very attractive rate, which we believe will well  serve to support American Lorain’s business and thus maximize shareholder  value.”
About DEG
DEG (Deutsche Investitions- und Entwicklungsgesellschaft) translates into  German Investment Corporation. Founded in 1962, DEG is headquartered in Cologne,  Germany and is a member of KfW Bank Group (KfW Bankengruppe), a German  government-owned development bank based in Frankfurt. It finances investments of  private companies in developing and emerging economies. As one of Europe’s  largest development finance institutions, it promotes private business  structures to contribute to sustainable economic growth and improved living  conditions in these countries. For more information, please visit  http://www.deginvest.de/EN_Home/index.jsp or www.kfw.de.
About American Lorain Corporation
American Lorain Corporation products include chestnut products, convenience  food products and frozen food products. The Company currently sells over 234  products to 26 provinces and administrative regions in China as well as to 42  foreign countries. The Company operates through its five direct and indirect  subsidiaries and one leased factory located in China. For further information  about American Lorain Corporation, please visit the Company’s website at  http://www.americanlorain.com.
| For more information, please contact: |  | 
|  |  | 
| At the company: |  | 
| American Lorain Corporation |  | 
| Mr. David She, CFO |  | 
| Tel:   +86-10 8411 3393 |  | 
| Email: david.she@americanlorain.com |  | 
| Web:   http://www.americanlorain.com |  | 
|  | 
 
SOURCE American Lorain Corporation
 
 
				
								
								
				
			
			 
		
			
			
			
				
				
				HANGZHOU, China, Jan. 31, 2011 (GLOBE NEWSWIRE) — Sky-mobi Limited  (Nasdaq:MOBI) (“Sky-mobi” or the “Company”), the leading mobile application  store in China, today announced that the Company and Tencent, one of China’s  most popular Internet portals, have formed a strategic partnership. This  strategic partnership is to promote Tencent’s QQ Mobile Browser on Sky-mobi’s  Maopao application store and make Sky-mobi a preferred partner for a series of  Tencent’s mobile software, including mobile security software and Tencent  miniblog.
Under the terms of the collaboration agreement between the two companies,  Tencent will pay Sky-mobi a commission for each of its users that become an  active Tencent QQ Mobile Browser user. Sky-mobi estimates that this partnership  will make a meaningful contribution to its top- and bottom-line results in the  quarters ahead, driven by Sky-mobi’s large user base and access to the Maopao  application store.
“The collaboration we have announced today represents another step in  establishing Maopao as the leading application store in China,” commented  Michael Song, Chairman and CEO of Sky-Mobi. “Our large user base will have  access to Tencent’s QQ browser, which adds to the range of fun and useful  Tencent services available on Maopao. In return, Tencent will have the  opportunity to introduce its services to mobile phone users across China. We  look forward to a successful collaboration for both parties.”
Sky-mobi’s Maopao store is accessed by hundreds of millions of Chinese mobile  phone users and includes a variety of utilities, games and entertainment  options. Sky-mobi collaborates with mobile service providers and handset vendors  who pre-install the Sky-mobi’s Maopao platform on their mobile phones. The  Maopao store offers a large number of applications and content titles that  extends the usability of low-to-mid range mobile phones, or feature phones, by  giving them many of the capabilities of more expensive smart phones, with such  features as leading-edge user interfaces and Internet access. The partnership  with Tencent is another important step in extending the range of applications  available to Maopao users to make their phones smarter.
About Tencent:
Tencent Holdings Limited (SEHK 700) was founded in November, 1998, and has  since grown into one of China’s largest and most widely used Internet portal.   Presently, Tencent is providing value-added Internet, mobile and telecom  services as well as online advertising with the goal of providing users with  “one-stop online lifestyle services”. Tencent’s leading Internet platforms in  China — QQ (QQ Instant Messenger), QQ.com, QQ Games, Qzone, 3g.QQ.com, SoSo,  PaiPai and Tenpay — have brought together China’s largest Internet community,  to meet the various needs of Internet users including communication,  information, entertainment, e-commerce and others. As of September 30, 2010,  active QQ user accounts for QQ IM totaled 636.6 million while peak concurrent  users reached 118.7 million.
About Sky-mobi Limited: 
Sky-mobi Limited (Nasdaq:MOBI) operates the leading mobile application store  in China.  Sky-mobi works with handset companies to pre-install its Maopao  mobile application store on handsets and with content developers to provide  users with high quality applications and content titles.  Users of the Maopao  store can browse, download and purchase a wide range of applications and content  such as single-player games, mobile music and books. In addition, Sky-mobi has  established a leading mobile social network community in China, the Maopao  Community, where it offers popular localized mobile social games as well as  applications and content with social network functions to its registered  members. The Maopao store enables mobile applications and content to be  downloaded and run on a variety of mobile handsets with different hardware and  operating system configurations.
The Sky-mobi Limited logo is available at  http://www.globenewswire.com/newsroom/prs/?pkgid=8458
Safe Harbor Statement
This press release contains forward-looking statements that reflect the  Company’s current expectations and views of future events that involve known and  unknown risks, uncertainties and other factors that may cause its actual  results, performance or achievements to be materially different from any future  results, performance or achievements expressed or implied by the forward-looking  statements. The Company has based these forward-looking statements largely on  its current expectations and projections about future events and financial  trends that it believes may affect its financial condition, results of  operations, business strategy and financial needs.  You should understand that  the Company’s actual future results may be materially different from and worse  than what  the Company expects. Information regarding these risks, uncertainties  and other factors is included in the Company’s registration statement on Form  F-1 and other filings with the SEC.
CONTACT: Sky-mobi Limited
         Mr. Carl Yeung, CFO
         Phone: +(86) 571-87770978 (Hangzhou)
         Email: ir@sky-mobi.com
         CCG Investor Relations
         Mr. Ed Job, Account Manager
         Phone: +(86) 21-3133-5075 (Shanghai)
         Email: ed.job@ccgir.com
         Ms. Kristin Knies, Sr. MI Executive (New York)
         Phone: + (1) 646-833-3401

				
								
								
				
			
			 
		
			
			
			
				
				
				Jan. 31, 2011 (Business Wire) — NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a  specialty pharmaceutical company developing innovative therapeutics for rare  gastrointestinal and endocrine disorders, today announced that its Phase 3  pivotal study of GATTEX® (teduglutide) met the primary efficacy  endpoint of reducing parenteral nutrition (PN) dependence in patients with adult  short bowel syndrome (SBS). The 24-week randomized, double-blind study, known as  STEPS, was designed to compare the efficacy, safety and tolerability of GATTEX  to placebo.
The study reached statistical significance for the primary efficacy endpoint,  defined as the percentage of patients who achieved a 20 percent or greater  reduction in weekly PN volume at Weeks 20 and 24, compared to baseline. In an  intent-to-treat analysis, 63 percent (27/43) of GATTEX-treated patients  responded versus 30 percent (13/43) of placebo-treated patients (p=0.002).  Patients treated with GATTEX for 24 weeks also achieved significantly greater  reductions in weekly PN volume versus placebo. On average, patients who received  GATTEX experienced a 4.4 liter reduction in weekly PN volume from a  pre-treatment baseline of 12.9 liters; patients who received placebo experienced  a 2.3 liter reduction from a pre-treatment baseline of 13.2 liters (p less than  or equal to 0.001).
“SBS patients who receive their nutrients and fluids intravenously due to  malabsorption and diarrhea are prone to a number of serious complications  including life-threatening infections, blood clots and liver and kidney damage.  The STEPS results suggest teduglutide helps restore normal intestinal function  in patients with short bowel syndrome, thereby reducing dependence on parenteral  nutrition and potentially improving their quality of life,” said Palle Bekker  Jeppesen, M.D., associate professor, department of medical gastroenterology,  Rigshospitalet, University Hospital of Copenhagen, Denmark. “These findings  bring us closer to an important new therapeutic option for patients with this  debilitating condition.”
The STEPS study showed that GATTEX was well tolerated. Four of the 86  randomized patients discontinued the study due to adverse events, of which one  was GATTEX-treated and three were placebo-treated. Adverse events appear to be  consistent with the pharmacological effects of the drug.
“We are very pleased with these findings as they confirm our belief that  GATTEX provides meaningful clinical benefits to adult patients with short bowel  syndrome,” said Francois Nader, MD, president and chief executive officer of NPS  Pharmaceuticals. “Based on these results, we expect to file for FDA approval of  GATTEX in the second half of this year as a first-in-class treatment for SBS. We  thank the patients, clinical investigators, and study coordinators who  participated in this landmark study, as well as our ex-North American partner  Nycomed who co-managed and co-funded the study. We look forward to reporting  additional results from the STEPS study at upcoming medical meetings.”
More than 97 percent of eligible patients who participated in STEPS elected  to roll into STEPS 2, an open-label continuation study in which all participants  receive up to an additional 24 months of GATTEX therapy.
STEPS study design
STEPS was an international, double-blind, placebo-controlled Phase 3 pivotal  study designed to provide additional evidence of safety and efficacy of GATTEX  in reducing PN dependence in adult SBS patients.
Twenty-nine centers in North America and Europe enrolled patients in the  STEPS study. Eighty-six patients were randomized and analyzed for efficacy and  safety. The trial included an initial PN optimization and stabilization period,  after which patients were randomized 1:1 to compare daily subcutaneous dosing of  0.05 mg/kg of GATTEX to placebo over a 24-week treatment period. A total of 78  patients completed the study.
The primary efficacy endpoint was the percentage of patients who achieved a  20 percent or greater reduction in weekly PN volume at Week 20 and maintained  that response at Week 24, compared to baseline. The study’s secondary endpoints  included reductions in PN volume and the direct effects of improved intestinal  absorption of fluid.
NPS conducted STEPS with the support of its partner, Nycomed, a global  pharmaceutical company, headquartered in Switzerland, which holds the rights to  develop and commercialize teduglutide outside of North America. Nycomed expects  to submit a Marketing Authorization Application (MAA) to the European Medicines  Agency (EMA) for teduglutide in the first half of 2011. The two companies share  certain external costs for the teduglutide development program.
Conference Call Information
NPS will host a conference call today at 9:00 a.m. Eastern Time to discuss  these findings. To participate in the conference call, dial (888) 396-2356 and  use pass code 22757353. International callers may dial (617) 847-8709, using the  same pass code. In addition, a live audio of the conference call will be  available over the Internet. Interested parties can access the event through the  NPS website, http://www.npsp.com.
For those unable to participate in the live call, a replay will be available  at (888) 286-8010, with pass code 24296023, until midnight Eastern Time,  February 14, 2011. International callers may access the replay by dialing (617)  801-6888, using the same pass code. The webcast will also be available through  the NPS website for the same period.
About Short Bowel Syndrome
Short bowel syndrome, or SBS, is a highly disabling condition that can impair  a patient’s quality-of-life and lead to serious life-threatening complications.  SBS typically arises after extensive resection of the bowel due to Crohn’s  disease, ischemia or other conditions. SBS patients often suffer from  malnutrition, severe diarrhea, dehydration, fatigue, osteopenia, and weight loss  due to the reduced intestinal capacity to absorb nutrients, water, and  electrolytes. The usual treatment for short bowel syndrome is nutritional  support, including parenteral nutrition (PN) or intravenous feeding to  supplement and stabilize nutritional needs.
Although PN can provide nutritional support for short bowel syndrome  patients, it does not improve the body’s own ability to absorb nutrients. PN is  also associated with serious complications, such as infections, blood clots or  liver damage, and the risks increase the longer patients are on PN. Patients on  PN often experience a poor quality-of-life with difficulty sleeping, frequent  urination and loss of independence.
There are an estimated 10,000 to 15,000 SBS patients in the U.S. who are  dependent on PN, the direct cost of which can exceed $100,000 annually per  patient.
About GATTEX® (teduglutide)
GATTEX (teduglutide) is a novel, recombinant analog of human glucagon-like  peptide 2, a protein involved in the rehabilitation of the intestinal lining.  GATTEX is in Phase 3 development to reduce dependence on parenteral nutrition  (PN) in adult patients with short bowel syndrome (SBS). NPS has reported  findings from completed studies in which GATTEX demonstrated a favorable safety  profile and reductions in mean PN volume from pretreatment baseline were  observed. NPS is also advancing preclinical studies to evaluate teduglutide in  additional intestinal failure related conditions.
Teduglutide has received orphan drug designation for the treatment of SBS  from the U.S. Food and Drug Administration and the European Medicines Agency.
In 2007, NPS granted Nycomed the rights to develop and commercialize  teduglutide outside the United States, Canada and Mexico. NPS retains all rights  to teduglutide in North America.
About NPS Pharmaceuticals
NPS Pharmaceuticals is developing new treatment options for patients with  rare gastrointestinal and endocrine disorders. The company is currently  advancing two Phase 3 registration programs. Teduglutide, a proprietary analog  of GLP-2, is in Phase 3 development for parenteral nutrition dependent adult  short bowel syndrome and is in preclinical development for additional intestinal  failure related conditions. NPSP558 (parathyroid hormone 1-84 [rDNA origin]  injection) is in Phase 3 development as a hormone replacement therapy for  hypoparathyroidism. NPS complements its proprietary programs with a  royalty-based portfolio of products and product candidates that includes  agreements with Amgen, Kyowa Hakko Kirin, Nycomed, and Ortho-McNeil  Pharmaceutical.
“NPS”, “NPS Pharmaceuticals”, and “GATTEX” are the company’s registered  trademarks. All other trademarks, trade names or service marks appearing in this  press release are the property of their respective owners.
Statements made in this press release, which are not historical in nature,  constitute forward-looking statements for purposes of the safe harbor provided  by the Private Securities Litigation Reform Act of 1995. These statements are  based on the company’s current expectations and beliefs and are subject to a  number of factors and uncertainties that could cause actual results to differ  materially from those described in the forward-looking statements. Risks  associated to the company’s business include, but are not limited to, the risks  associated with any failure by the company to successfully complete its  preclinical and clinical studies within the projected time frames or not at all,  the risk of not gaining marketing approvals for GATTEX and NPSP558, the risks  associated with the company’s strategy, as well as other risk factors described  in the company’s periodic filings with the U.S. Securities and Exchange  Commission, including its Annual Report on Form 10-K and Form 10-Qs. All  information in this press release is as of the date of this release and NPS  undertakes no duty to update this information.

NPS:
Susan M. Mesco
NPS Investor  Relations
908-450-5516
smesco@npsp.com
or
Tony Plohoros
6  Degrees PR
908-591-2839
tplohoros@6degreespr.com
or
Nycomed:
Beatrix  Benz
Nycomed Media Relations
+41 44 555 1508
beatrix.benz@nycomed.com
				
								
								
				
			
			 
		
			
			
			
				
				
				
ELK GROVE VILLAGE, Ill., Jan. 28, 2011 /PRNewswire/ — Material Sciences  Corporation (Nasdaq: MASC), a leading provider of material-based solutions for  acoustical and coated applications, today announced that the company’s board of  directors has authorized the repurchase of up to one million shares of common  stock.  These one million shares are in addition to the 114,081 shares remaining  available for repurchase under the Board’s January 7, 2008 authorization.  The  share repurchases will be made from time to time at MSC’s discretion, subject to  market conditions and other factors, and will be funded with internally  generated cash.  As of January 27, 2011, MSC had 12,909,133 shares  outstanding.
About Material Sciences
Material Sciences Corporation is a leading provider of material-based  solutions for acoustical and coated applications. MSC uses its expertise in  materials, which it leverages through relationships and a network of partners,  to solve customer-specific problems. The company’s stock is traded on the NASDAQ  Capital Market under the symbol MASC.
SOURCE Material Sciences Corporation
 
				
								
								
				
			
			 
		
			
			
			
				
				
				PHILADELPHIA, Jan. 27, 2011 /PRNewswire/ — Destination Maternity Corporation  (Nasdaq: DEST), the world’s leading maternity apparel retailer, today announced  operating results for the first quarter of fiscal 2011, which ended December 31,  2010, with its first quarter diluted earnings per share significantly exceeding  both its prior earnings guidance and its prior year first quarter earnings  results.  The Company also increased its earnings guidance for the full year  fiscal 2011.  In addition, yesterday the Company announced that its Board of  Directors has initiated a regular quarterly cash dividend and approved a  two-for-one split of its common stock in the form of a stock dividend.
First Quarter Fiscal 2011 Financial Results
- GAAP net income for the first quarter of fiscal 2011 was $5.2 million, or  $0.81 per share (diluted), a significant improvement compared to GAAP net income  of $1.3 million, or $0.20 per share (diluted) for the first quarter of fiscal  2010.  This first quarter fiscal 2011 GAAP earnings performance was better than  the Company’s guidance, provided in its November 18, 2010 press release, of GAAP  diluted earnings per share of between $0.51 and $0.66.
- Non-GAAP adjusted net income (before restructuring and other charges, stock  compensation expense, and loss on extinguishment of debt) for the first quarter  of fiscal 2011 was $5.7 million, or $0.88 per share (diluted), an increase of  49% over the comparably adjusted non-GAAP net income for the first quarter of  fiscal 2010 of $3.8 million, or $0.62 per share (diluted).  This first quarter  fiscal 2011 non-GAAP adjusted earnings performance was better than the Company’s  guidance, provided in its November 18, 2010 press release, of non-GAAP adjusted  diluted earnings per share of between $0.56 and $0.71.
- Adjusted EBITDA was $13.3 million for the first quarter of fiscal 2011, an  increase of 69% over the $7.9 million of Adjusted EBITDA for the first quarter  of fiscal 2010.
- Adjusted EBITDA before restructuring and other charges was $13.3 million for  the first quarter of fiscal 2011, an increase of 14% over the $11.6 million of  Adjusted EBITDA before restructuring and other charges for the first quarter of  fiscal 2010.
- Net sales for the first quarter of fiscal 2011 increased 1.2% to $135.4  million from $133.8 million for the first quarter of fiscal 2010 and were at the  top end of the Company’s guidance range of $132.5 to $135.5 million provided in  November.  The increase in sales for the first quarter of fiscal 2011 compared  to fiscal 2010 resulted primarily from an increase in comparable store sales,  increased sales due to the opening of an additional 217 Sears® and Kmart® leased  department locations in September and October 2010, and increased Internet  sales, partially offset by decreased sales related to the Company’s continued  efforts to close underperforming stores and decreased sales from the Company’s  licensed relationship.
- Comparable retail sales (which consists of comparable store sales and  Internet sales) for the first quarter of fiscal 2011 increased 2.1% versus a  comparable retail sales decrease of 4.4% for the first quarter of fiscal 2010.   During the first quarter of fiscal 2011, comparable store sales increased 1.2%,  and Internet sales increased 17.9%.  The comparable store sales increase of 1.2%  during the first quarter of fiscal 2011 exceeded the top end of the Company’s  guidance range of down 1.5% to up 0.5% provided in November.
Cash Dividend and Stock Split 
- Yesterday the Company announced that its Board of Directors has initiated a  regular quarterly cash dividend and approved a two-for-one split of the  Company’s common stock in the form of a stock dividend.  The first quarterly  cash dividend of $0.35 per share pre-split (equivalent to $0.175 per share  post-split) is payable March 11, 2011 to stockholders of record at the close of  business on February 16, 2011.  As a result of the stock split, on March 1, 2011  stockholders of record at the close of business on February 16, 2011 will  receive one additional common share for every share held.  Upon completion of  the split, the number of common shares outstanding will be approximately 12.7  million.  All share and per share amounts included in this first quarter fiscal  2011 earnings release are presented on a pre-split basis unless otherwise  specifically stated.
Restructuring and Other Charges
- Beginning in late fiscal 2008, the Company implemented a significant  restructuring and cost reduction program, with the objectives of simplifying its  merchandise brand and store nameplate structure, improving and simplifying  critical processes, and reducing its expense structure.  The Company has  substantially completed the planned activities of the initiative and incurred  $3.9 million of pretax expense related to this initiative in fiscal 2010, of  which $2.5 million was incurred in the first quarter of fiscal 2010.  This  initiative resulted in pretax savings of approximately $12 million in fiscal  2009, with incremental pretax savings of approximately $11 million in fiscal  2010.  The Company projects total annualized pretax savings of approximately $27  to $30 million in fiscal 2011 as a result of this initiative, which includes the  savings realized in fiscal 2009 and fiscal 2010.
- In addition, the Company recorded pretax charges of $1.3 million in the  first quarter of fiscal 2010 associated with the retirement of the Company’s  President and Chief Creative Officer in September 2010 and the retirement of the  Company’s non-executive Chairman of the Board in January 2010.
Retail Locations 
The table below summarizes store opening and closing activity for the first  quarter of fiscal 2011 and 2010, as well as the Company’s store, total retail  location and total international franchised location count at the end of each  fiscal period.  The increase in leased department locations at December 31, 2010  versus December 31, 2009 predominantly reflects the opening of an additional 217  Sears and Kmart leased department locations in September and October 2010.
|  | First Quarter Ended |  | 
|  | 12/31/10 |  | 12/31/09 |  | 
|  |  |  |  | 
| Store Openings (1) |  |  |  |  |  |  |  | 
| Total |  | 1 |  |  | 2 |  |  | 
| Multi-Brand Store Openings |  | 1 |  |  | 1 |  |  | 
|  |  |  |  |  |  |  |  | 
| Store Closings (1) |  |  |  |  |  |  |  | 
| Total |  | 9 |  |  | 5 |  |  | 
| Closings Related to Multi-Brand Store Openings |  | 1 |  |  | 2 |  |  | 
|  |  |  |  |  |  |  |  | 
| Period End Retail Location Count (1) |  |  |  |  |  |  |  | 
| Stores |  | 690 |  |  | 721 |  |  | 
| Leased Department Locations |  | 1,192 |  |  | 980 |  |  | 
| Total Retail Locations (1) |  | 1,882 |  |  | 1,701 |  |  | 
|  |  | 
| (1)  Excludes international franchised  locations. |  | 
|  |  |  |  |  |  |  |  |  | 
 
|  | First Quarter Ended |  | 
|  | 12/31/10 |  | 12/31/09 |  | 
|  |  |  |  | 
| International Franchised Location  Openings |  |  |  |  |  |  |  | 
| Stores |  | — |  |  | 1 |  |  | 
| Shop-in-Shop Locations |  | 13 |  |  | — |  |  | 
| Total International Franchised Location Openings |  | 13 |  |  | 1 |  |  | 
|  |  |  |  |  |  |  |  | 
| Period End International Franchised Location  Count |  |  |  |  |  |  |  | 
| Stores |  | 8 |  |  | 2 |  |  | 
| Shop-in-Shop Locations |  | 36 |  |  | 7 |  |  | 
| Total International Franchised Locations |  | 44 |  |  | 9 |  |  | 
|  |  |  |  |  |  |  |  |  | 
 
Commentary
Ed Krell, Chief Executive Officer and President of Destination Maternity  Corporation, noted, “We are pleased with the continued increase in the  profitability of our business, as well as the improvement of our sales  performance for the first quarter of fiscal 2011.  Our GAAP diluted earnings per  share of $0.81 for the first quarter exceeded the top end of our prior earnings  guidance range of $0.51 to $0.66 per share that we provided in our November 18,  2010 press release, and was significantly higher than last year’s first quarter  GAAP diluted earnings of $0.20 per share.  Our sales performance for the first  quarter was at the high end of our sales guidance, with our comparable retail  sales increasing 2.1% and our comparable store sales increasing 1.2% for the  quarter.
“As we have indicated previously, we are keenly focused on initiatives to  drive profitable sales growth, including increasing our comparable store sales,  and we are pleased that our comparable store sales and comparable retail sales  were positive for the first quarter.  Among our other initiatives, the  significant expansion of our maternity apparel leased department relationship  with Macy’s® will occur in February 2011, through which we will expand from our  current 115 Macy’s locations to over 615 Macy’s locations throughout the United  States, offering a mix of Motherhood Maternity® and A Pea in the Pod® branded  merchandise.  This expansion with Macy’s will deepen our position as the leading  maternity apparel retailer in the world.  In addition, we are focused on  continuing to enhance our merchandise assortments, merchandise presentation and  customer experience.”
Cash Dividend and Stock Split
“Yesterday we announced that our Board of Directors has initiated a regular  quarterly cash dividend and approved a two-for-one split of our common stock.   Initiating a regular quarterly cash dividend demonstrates the Board’s  confidence in our Company’s financial strength and our prospects for the future,  and highlights our strong earnings and cash flow generation and our commitment  to continue to drive shareholder value.  In addition, we believe that the stock  split, combined with the regular quarterly cash dividend, will make our stock  even more attractive to a broader range of investors and may increase the  trading liquidity of our stock.
“Over the past several years, we have used our free cash flow predominantly  to pre-pay debt and, as a result, we have significantly reduced our financial  leverage and our interest expense, as reflected by our total debt decreasing  from $128.9 million at the end of fiscal 2005 to $45.2 million at the end of  fiscal 2010, and our interest expense decreasing from $15.3 million in fiscal  2005 to $3.3 million in fiscal 2010.  With this significant reduction in our  financial leverage and interest expense, we believe it is now appropriate for us  to use a portion of our earnings and cash flow to return cash to our  stockholders through a regular quarterly cash dividend which can enhance the  total return to our stockholders, while also potentially broadening our investor  base.”
Guidance for Fiscal 2011
“Looking forward, we are confident that we can continue to drive significant  growth in earnings, while also growing our sales and positioning our company for  continued future growth, by continuing to improve our product and customer  experience, and continuing to focus on our strategic plan as summarized in our  five key goals and strategic objectives discussed later under “Company  Strategy.”  For fiscal 2011, we look forward to:  the expansion into over 500  additional Macy’s locations in February 2011; the continued growth of our  Internet and international sales; the continued rollout of our multi-brand  Destination Maternity stores; and the continued enhancement of our merchandise  assortments, merchandise presentation and customer experience.  Given the  continued uncertainty as to the timing and extent of a recovery in consumer  spending, we continue to plan our sales and inventory conservatively.
“Our financial guidance for the full year fiscal 2011 is as follows:
- Net sales in the $560 to $570 million range, representing a projected sales  increase of between 5.4% and 7.3% versus fiscal 2010 net sales of $531.2  million.  The planned increase in net sales for fiscal 2011 versus fiscal 2010  is driven primarily from the expansion into over 500 additional Macy’s locations  in February 2011; the expansion of the Sears and K-Mart relationships, with 217  additional Sears and K-Mart maternity locations added in September and October  2010; and the continued planned growth of our Internet and international sales.
- We are planning continued improvement in our comparable store sales  performance, especially in the second half of fiscal 2011.  However, it is  important to note that our comparable store sales and comparable retail sales  will be negatively impacted by our significant Macy’s leased department  expansion in February 2011.  The following table provides guidance for our  projected full year fiscal 2011 comparable store sales and comparable retail  sales, both before and after the projected impact of this leased department  expansion.  Included in the guidance range for comparable retail sales (which  consists of comparable store sales and Internet sales) is a projected increase  in Internet sales of between 15% and 20% for fiscal 2011.
|  | Comparable Store  Sales | Comparable Retail  Sales |  | 
| Including projected cannibalization impact of leased department expansion | Down 1.5% to Up 0.5% | Down 0.5% to Up 1.5% |  | 
|  |  |  |  | 
| Excluding projected cannibalization impact of leased department expansion | Up 0.5% to Up 2.5% | Up 1.5% to Up 3.5% |  | 
|  |  |  | 
 
- Gross margin for fiscal 2011 is expected to increase modestly versus fiscal  2010, primarily driven by leveraging product overhead expenses over a larger  planned sales volume, with product cost reductions expected to be recognized for  much of the year being partially offset by the expected impact of upward product  cost pressures for Summer 2011 and Fall 2011 merchandise to be recognized later  in fiscal 2011.
- Total selling, general and administrative (SG&A) expenses are planned to  be higher than fiscal 2010 in dollar terms and comparable to fiscal 2010 as a  percentage of net sales.  The projected SG&A expense increase for the full  year primarily results from additional operating expenses resulting from the  Macy’s leased department expansion in February 2011 and certain other projected  expense increases, including increased marketing expenses, partially offset by  expense savings from the Company’s restructuring and cost reduction initiatives.
- Operating income in the $40.9 to $44.9 million range, a projected increase  of between 30% and 43% compared to fiscal 2010 operating income of $31.4  million.  Operating income before restructuring and other charges is projected  in the $41.2 to $45.2 million range, a projected increase of between 11% and 22%  compared to fiscal 2010 operating income, before restructuring and other  charges, of $37.1 million.
- GAAP diluted earnings per share of between $3.62 and $3.98 per share for  fiscal 2011, a projected increase of between 37% and 50% compared to earnings of  $2.65 per share (diluted) for fiscal 2010.  This guidance range for fiscal 2011  GAAP diluted earnings per share of $3.62 to $3.98 is higher than the prior  guidance range of $3.52 to $3.87 provided by the Company in its November 18,  2010 press release.
- Non-GAAP adjusted diluted earnings per common share (before restructuring  and other charges, stock compensation expense, and loss on extinguishment of  debt) is projected to be between $3.89 and $4.24 per share for fiscal 2011, a  projected increase of between 14% and 25% versus non-GAAP adjusted diluted  earnings per share of $3.40 per share for fiscal 2010, and higher than the  Company’s prior guidance range of $3.76 to $4.10.
- Adjusted EBITDA in the $58.0 to $62.0 million range, a projected increase of  between 20% and 28% compared to the fiscal 2010 Adjusted EBITDA of $48.3  million.  Adjusted EBITDA before restructuring and other charges is projected in  the $58.3 to $62.3 million range, a projected increase of between 8% and 15%  versus the fiscal 2010 figure of $54.0 million.
- Open approximately 12 to 19 new stores during the year, including  approximately 6 to 12 new multi-brand Destination Maternity stores, and close  approximately 45 to 62 stores, with approximately 12 to 24 of these planned  store closings related to openings of new Destination Maternity stores.
- Capital expenditures planned at between $15 and $18 million compared to  fiscal 2010 capital expenditures of $10.4 million.  After deducting projected  tenant construction allowance payments to us from store landlords, the Company  expects net cash outlay for capital projects to be between $10 million and $12  million, compared to $7.4 million in fiscal 2010.
- Inventory at fiscal 2011 year end planned to be approximately 4-8% higher  (approximately $3 to $6 million higher) than fiscal 2010 year end, primarily due  to inventory increases related to the Macy’s expansion.
- Given these assumptions, the Company plans to generate free cash flow  (defined as net cash provided by operating activities minus capital  expenditures) of approximately $13 to $19 million for the full year fiscal  2011.
“We expect our comparable store sales for the full month of January to  decrease between 0.5% and 3.0% on a reported basis, and to be between a decrease  of 2.0% and an increase of 0.5% after adjusting for the “days adjustment  calendar shift,” reflecting one less Friday in January 2011 compared to January  2010.  We expect our comparable retail sales for the full month of January to be  between a decrease of 1.0% and an increase of 2.0% after adjusting for the “days  adjustment calendar shift.”
“Our financial guidance for the second quarter of fiscal 2011 is as  follows:
- Net sales in the $134 to $137 million range.
- Comparable store sales decrease of between 0.5% and 2.5% on a reported basis  (including the projected cannibalization impact of the Macy’s leased department  expansion) and an increase in Internet sales of between 15% and 20%.  Excluding  the projected cannibalization impact of the Macy’s leased department expansion,  comparable store sales are projected to be between a decrease of 1.0% and an  increase of 1.0%, with comparable retail sales projected to be between flat and  an increase of 2.0%.
- GAAP diluted earnings per common share of between $0.60 and $0.71 per share,  a significant projected improvement versus GAAP diluted earnings per share of  $0.42 for the second quarter of fiscal 2010.
- Non-GAAP adjusted diluted earnings per common share (before restructuring  and other charges, stock compensation expense, and loss on extinguishment of  debt) of between $0.64 and $0.75 per share, versus comparably adjusted non-GAAP  diluted earnings per share of $0.61 for the second quarter of fiscal  2010.
Company Strategy
Mr. Krell added, “As we plan and execute our business for both the coming  year and beyond, we continue to be guided by our five key goals and strategic  objectives:
- Be a profitable global leader in the maternity apparel business, treating  all our partners and stakeholders with respect and fairness.
- Increase the profitability of our U.S. business, focusing on the following:
- Increase comparable store sales, through continued improvement of  merchandise assortments, merchandise presentation and customer experience,  providing a more shoppable store environment for our customers, and through  enhanced marketing and advertising.
- Reduce our expenditures and continue to be more efficient in operating our  business—streamline, simplify and focus.
- Continue to expand our multi-brand Destination Maternity store chain where  ROI hurdles are met, with the goal of operating fewer but larger stores over  time.
- Continue to close underperforming stores.
 
- In addition to achieving increased comparable store sales, we aim to grow  our sales where we can do so profitably, including the following areas of focus:
- International expansion
- Potential growth of our leased department and licensed relationships
- Increased utilization of the Internet to drive sales, targeting both  increased direct Internet sales and enhanced web marketing initiatives to drive  store sales
- Selective new store openings and relocations in the U.S. and Canada
- Continued focus on enhancing our overall customer relationship, including  our marketing partnership programs.
 
- Focus on generating free cash flow to drive increased shareholder value.
- Maintain and intensify our primary focus on delivering great maternity  apparel product and service in each of our brands and store formats, to serve  the maternity apparel customer like no one else can.”
Mr. Krell concluded, “We feel very good about our Company’s position and the  actions we have taken to improve the profitability of our business and generate  increased shareholder value, even in the face of a challenging sales  environment, while also making investments and pursuing targeted initiatives for  profitable future sales growth.  We are proud of what we have accomplished in  the past two years to significantly improve our operating results, our financial  position, and our outlook.  At the same time, we have not been satisfied with  our sales performance, although we recognize that over the past two to three  years we have faced the dual challenges of a deep recession and a 6.0% decrease  in births in the United States.  We are focused on turning around our sales  performance through initiatives to continue to enhance our merchandise  assortments, merchandise presentation and customer experience, and we are  cautiously optimistic that we may be starting to see some initial signs of this  turnaround, as evidenced by our positive comparable store sales for the first  quarter.  We are confident in our ability to continue to manage our business  through this uncertain consumer environment and to continue to drive near term  improvements while also making progress towards our longer term goals.”
Conference Call Information
As announced previously, the Company will hold a conference call today at  9:00 a.m. Eastern Time, regarding the Company’s first quarter fiscal 2011  earnings and future financial guidance.  You can participate in this conference  call by calling (800) 901-5231.  Please call ten minutes prior to 9:00 a.m.  Eastern Time.  The conference call (listen only) will also be available on the  investor section of our website at http://investor.destinationmaternity.com.   The passcode for the conference call is “79373208.”  In the event that you are  unable to participate in the call, a replay will be available through Thursday,  February 10, 2011 by calling (888) 286-8010.  The passcode for the replay is  “94896169.”
Destination Maternity Corporation is the world’s largest designer and  retailer of maternity apparel.   In the United States and Canada, as of December  31, 2010, Destination Maternity operates 1,882 retail locations, including 690  stores, predominantly under the tradenames Motherhood Maternity®, A Pea in the  Pod®, and Destination Maternity®, and sells on the web through its  DestinationMaternity.com and brand-specific websites.  Destination Maternity  also distributes its Oh Baby by Motherhood™ collection through a licensed  arrangement at Kohl’s® stores throughout the United States and on Kohls.com.  In  addition, Destination Maternity is expanding internationally and has exclusive  store franchise and product supply relationships in India and the Middle East.
The Company cautions that any forward-looking statements (as such term is  defined in the Private Securities Litigation Reform Act of 1995) contained in  this press release or made from time to time by management of the Company,  including those regarding the continuation of the regular quarterly cash  dividend, the trading liquidity of our common stock, earnings, net sales,  comparable retail sales, comparable store sales, Internet sales, other results  of operations, liquidity and financial condition, and various business  initiatives, involve risks and uncertainties, and are subject to change based on  various important factors.  The following factors, among others, in some cases  have affected and in the future could affect the Company’s financial performance  and actual results and could cause actual results to differ materially from  those expressed or implied in any such forward-looking statements: the  continuation of the economic recovery of the retail industry in general and on  apparel purchases in particular, our ability to successfully manage our various  business initiatives, our ability to successfully implement our merchandise  brand and retail nameplate restructuring, the success of our international  expansion, our ability to successfully manage and retain our leased department  and licensed relationships and marketing partnerships, future sales trends in  our existing store base, unusual weather patterns, changes in consumer  preferences, raw material price increases, overall economic conditions  and other factors affecting consumer confidence, demographics and other  macroeconomic factors that may impact the level of spending for maternity  apparel, expense savings initiatives, our ability to anticipate and respond to  fashion trends and consumer preferences, anticipated fluctuations in our  operating results, the impact of competition and fluctuations in the price,  availability and quality of raw materials and contracted products, availability  of suitable store locations, continued availability of capital and financing,  our ability to hire and develop senior management and sales associates, our  ability to develop and source merchandise, our ability to receive production  from foreign sources on a timely basis, potential stock repurchases, potential  debt prepayments, changes in market interest rates, war or acts of terrorism and  other factors set forth in the Company’s periodic filings with the Securities  and Exchange Commission, or in materials incorporated therein by  reference.
| DESTINATION MATERNITY CORPORATION  AND SUBSIDIARIES Consolidated Statements of  Income (in thousands, except per share  data) (unaudited) |  | 
|  | First Quarter Ended |  |  | 
|  | 12/31/10 |  | 12/31/09 |  |  | 
|  |  |  |  |  |  |  |  | 
| Net sales | $ | 135,435 |  | $ | 133,771 |  |  | 
| Cost of goods sold |  | 62,502 |  |  | 62,077 |  |  | 
|  |  |  |  |  |  |  |  | 
| Gross profit |  | 72,933 |  |  | 71,694 |  |  | 
| Gross margin |  | 53.9 | % |  | 53.6 | % |  | 
| Selling, general and administrative expenses  (SG&A) |  | 63,504 |  |  | 63,933 |  |  | 
| SG&A expenses as a percentage of net  sales |  | 46.9 | % |  | 47.8 | % |  | 
| Store closing, asset impairment and asset disposal  expenses |  | 243 |  |  | 688 |  |  | 
| Restructuring and other charges |  | — |  |  | 3,777 |  |  | 
|  |  |  |  |  |  |  |  |  | 
| Operating income |  | 9,186 |  |  | 3,296 |  |  | 
| Interest expense, net |  | 644 |  |  | 955 |  |  | 
| Loss on extinguishment of debt |  | 9 |  |  | 30 |  |  | 
|  |  |  |  |  |  |  |  | 
| Income before income taxes |  | 8,533 |  |  | 2,311 |  |  | 
| Income tax provision |  | 3,285 |  |  | 1,055 |  |  | 
|  |  |  |  |  |  |  |  | 
| Net income | $ | 5,248 |  | $ | 1,256 |  |  | 
|  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  | 
| Net income per share – basic (1) | $ | 0.84 |  | $ | 0.21 |  |  | 
| Average shares outstanding – basic (1) |  | 6,254 |  |  | 6,048 |  |  | 
|  |  |  |  |  |  |  |  | 
| Net income per share – diluted (1) | $ | 0.81 |  | $ | 0.20 |  |  | 
| Average shares outstanding – diluted (1) |  | 6,497 |  |  | 6,223 |  |  | 
|  |  |  |  |  |  |  |  | 
| Supplemental information: |  |  |  |  |  |  |  | 
| Net income, as reported | $ | 5,248 |  | $ | 1,256 |  |  | 
| Add: restructuring and other charges, net of tax |  | — |  |  | 2,304 |  |  | 
| Add: stock compensation expense, net of tax |  | 465 |  |  | 269 |  |  | 
| Add: loss on extinguishment of debt, net of tax |  | 6 |  |  | 18 |  |  | 
| Adjusted net income, before restructuring and other charges, stock compensation expense, and loss on extinguishment of debt | $ | 5,719 |  | $ | 3,847 |  |  | 
|  |  |  |  |  |  |  |  | 
| Adjusted net income per share – diluted, before restructuring and other charges, stock  compensation expense, and loss on extinguishment of debt  (1) | $ | 0.88 |  | $ | 0.62 |  |  | 
|  |  | 
| (1)  Does not reflect the effect of the two-for-one stock  split payable March 1, 2011. |  | 
|  |  |  |  |  |  |  |  | 
 
| DESTINATION MATERNITY CORPORATION  AND SUBSIDIARIES Selected Consolidated Balance  Sheet Data (in thousands) (unaudited) |  | 
|  | December 31,2010
 |  | September 30,2010
 |  | December 31,2009
 |  |  | 
|  |  |  |  |  |  |  |  | 
| Cash and cash equivalents | $              35,976 |  | $              24,633 |  | $              14,273 |  |  | 
| Inventories | 72,287 |  | 80,735 |  | 74,161 |  |  | 
| Property, plant and equipment, net | 58,255 |  | 58,702 |  | 62,642 |  |  | 
| Line of credit borrowings | — |  | — |  | — |  |  | 
| Total debt | 42,266 |  | 45,161 |  | 51,138 |  |  | 
| Net debt (1) | 6,290 |  | 20,528 |  | 36,865 |  |  | 
| Stockholders’ equity | 77,717 |  | 71,598 |  | 51,988 |  |  | 
|  |  | 
| (1)  Net debt represents total debt minus cash and cash  equivalents and short-term investments. |  | 
|  |  |  |  |  |  |  | 
 
| DESTINATION MATERNITY CORPORATION  AND SUBSIDIARIES Supplemental Financial  Information Reconciliation of Operating Income  to Adjusted EBITDA(1)and Adjusted EBITDA Before Restructuring and  Other Charges,
 and Operating Income Margin to Adjusted EBITDA  Margin
 and Adjusted EBITDA Margin Before Restructuring and Other  Charges
 (in thousands, except percentages)
 (unaudited) |  | 
|  |  | First Quarter Ended |  |  | 
|  |  | 12/31/10 |  | 12/31/09 |  |  | 
|  |  |  |  |  |  |  |  |  | 
| Operating income |  | $ | 9,186 |  | $ | 3,296 |  |  | 
| Add: depreciation and amortization expense |  |  | 3,144 |  |  | 3,441 |  |  | 
| Add: loss on impairment of long-lived assets |  |  | 129 |  |  | 675 |  |  | 
| Add: loss on disposal of assets |  |  | 70 |  |  | 3 |  |  | 
| Add: stock compensation expense |  |  | 745 |  |  | 441 |  |  | 
| Adjusted EBITDA (1) |  |  | 13,274 |  |  | 7,856 |  |  | 
| Add: restructuring and other charges |  |  | — |  |  | 3,777 |  |  | 
| Adjusted EBITDA before restructuring and other  charges |  | $ | 13,274 |  | $ | 11,633 |  |  | 
|  |  |  |  |  |  |  |  |  | 
| Net sales |  | $ | 135,435 |  | $ | 133,771 |  |  | 
|  |  |  |  |  |  |  |  |  | 
| Operating income margin (operating income as a percentage of net sales) |  |  | 6.8% |  |  | 2.5% |  |  | 
| Adjusted EBITDA margin (Adjusted EBITDA as a percentage of net sales) |  |  | 9.8% |  |  | 5.9% |  |  | 
| Adjusted EBITDA margin before restructuring and other charges (Adjusted EBITDA before restructuring and  other charges as a percentage of net sales) |  |  | 9.8% |  |  | 8.7% |  |  | 
|  |  | 
| (1)  Adjusted EBITDA represents operating income before  deduction for the following non-cash charges: (i) depreciation and amortization  expense; (ii) loss on impairment of tangible and intangible assets; (iii) loss  on disposal of assets; and (iv) stock compensation expense. |  | 
|  |  |  |  |  |  |  |  | 
 
| Consolidated Statement of  Income For the Twelve Months Ended  December 31, 2010 (in thousands, except percentages and  per share data) (unaudited) |  | 
|  |  | 
| Net sales | $ | 532,856 |  |  | 
| Cost of goods sold |  | 240,591 |  |  | 
|  |  |  |  |  | 
| Gross profit |  | 292,265 |  |  | 
| Gross margin |  | 54.8 | % |  | 
| Selling, general and administrative |  |  |  |  | 
| expenses (SG&A) |  | 251,224 |  |  | 
| SG&A expenses as a percentage of net  sales |  | 47.1 | % |  | 
| Store closing, asset impairment and asset |  |  |  |  | 
| disposal expenses |  | 1,837 |  |  | 
| Restructuring and other charges |  | 1,881 |  |  | 
|  |  |  |  |  | 
| Operating income |  | 37,323 |  |  | 
| Interest expense, net |  | 2,989 |  |  | 
| Loss on extinguishment of debt |  | 30 |  |  | 
|  |  |  |  |  | 
| Income before income taxes |  | 34,304 |  |  | 
| Income tax provision |  | 13,483 |  |  | 
|  |  |  |  |  | 
| Net income | $ | 20,821 |  |  | 
|  |  |  |  |  | 
|  |  |  |  |  | 
| Net income per share – basic (1) | $ | 3.36 |  |  | 
| Average shares outstanding – basic (1) |  | 6,204 |  |  | 
|  |  |  |  |  | 
| Net income per share – diluted (1) | $ | 3.25 |  |  | 
| Average shares outstanding – diluted (1) |  | 6,415 |  |  | 
|  |  |  |  |  | 
| Supplemental information: |  |  |  |  | 
| Net income, as reported | $ | 20,821 |  |  | 
| Add: restructuring and other charges, net of tax |  | 1,168 |  |  | 
| Add: stock compensation expense, net of tax |  | 1,400 |  |  | 
| Add: loss on extinguishment of debt, net of tax |  | 19 |  |  | 
| Adjusted net income, before restructuring and other charges, stock compensation expense,  and loss on extinguishment of debt | $ | 23,408 |  |  | 
|  |  |  |  |  | 
| Adjusted net income per share – diluted, before restructuring and other charges, stock  compensation expense, and loss on extinguishment of  debt (1) | $ | 3.65 |  |  | 
|  |  | 
| (1)  Does not reflect the effect of the two-for-one stock  split payable March 1, 2011. |  | 
|  |  |  |  | 
 
| Reconciliation of Operating Income  to Adjusted EBITDA and Adjusted EBITDA Before  Restructuring and Other Charges, and Operating Income Margin to  Adjusted EBITDA Margin and Adjusted EBITDA Margin Before  Restructuring and Other Charges For the Twelve Months Ended  December 31, 2010 (in thousands, except  percentages) (unaudited) |  | 
| Operating income | $ | 37,323 |  |  | 
| Add: depreciation and amortization expense |  | 12,619 |  |  | 
| Add: loss on impairment of long-lived assets |  | 1,319 |  |  | 
| Add: loss on disposal of assets |  | 263 |  |  | 
| Add: stock compensation expense |  | 2,240 |  |  | 
| Adjusted EBITDA |  | 53,764 |  |  | 
| Add: restructuring and other charges |  | 1,881 |  |  | 
| Adjusted EBITDA before restructuring and other  charges | $ | 55,645 |  |  | 
|  |  |  |  |  | 
| Net sales | $ | 532,856 |  |  | 
|  |  |  |  |  | 
| Operating income margin |  | 7.0 | % |  | 
| Adjusted EBITDA margin |  | 10.1 | % |  | 
| Adjusted EBITDA margin before restructuring and other charges |  | 10.4 | % |  | 
|  |  |  |  | 
 
| Reconciliation of Net Income Per  Share – Diluted to Adjusted Net Income Per Share –  Diluted, Before Restructuring and Other  Charges, Stock Compensation Expense, and Loss on  Extinguishment of Debt (unaudited) |  | 
|  | Projected for the Year Ending | Actual for the Year Ended |  | 
|  |  | 9/30/11 (1) (2) |  |  | 9/30/10 (2) |  |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Net income per share – diluted (3) |  | $ | 3.62 to 3.98 |  |  | $ | 2.65 |  |  | 
| Add: per share effect of restructuring and other  charges |  |  | 0.03 |  |  |  | 0.55 |  |  | 
| Add: per share effect of stock compensation  expense |  |  | 0.23 |  |  |  | 0.19 |  |  | 
| Add: per share effect of loss on extinguishment of  debt |  |  | 0.01 |  |  |  | 0.01 |  |  | 
| Adjusted net income per share – diluted, before  restructuring and other charges, stock compensation  expense, and loss on extinguishment of debt (3) |  | $ | 3.89 to 4.24 |  |  | $ | 3.40 |  |  | 
|  |  | 
| (1)  Components do not add to total due to  rounding. (2)  Does not reflect the effect of the two-for-one stock  split payable March 1, 2011. (3)   Projected net income and projected adjusted net  income per share – diluted for the year ending September 30, 2011 are based on  approximately 6,535,000 to 6,571,000 projected average diluted shares  outstanding. |  | 
|  |  |  |  |  |  |  |  |  | 
 
| Reconciliation of Net Income Per  Share – Diluted to Adjusted Net Income Per Share –  Diluted, Before Restructuring and Other  Charges, Stock Compensation Expense, and Loss on  Extinguishment of Debt (unaudited) |  | 
|  | Projected for the Second Quarter Ending | Actual for the Second Quarter Ended |  | 
|  |  | 3/31/11 (1) |  |  | 3/31/10 (1) |  |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Net income per share – diluted (2) |  | $ | 0.60 to 0.71 |  |  | $ | 0.42 |  |  | 
| Add: per share effect of restructuring and other  charges |  |  | — |  |  |  | 0.14 |  |  | 
| Add: per share effect of stock compensation  expense |  |  | 0.04 |  |  |  | 0.05 |  |  | 
| Adjusted net income per share – diluted, before  restructuring and other charges, stock compensation expense, and loss on extinguishment of debt (2) |  | $ | 0.64 to 0.75 |  |  | $ | 0.61 |  |  | 
|  |  | 
| (1)  Does not reflect the effect of the two-for-one stock  split payable March 1, 2011. (2)   Projected net income and projected adjusted net  income per share – diluted for the second quarter ending March 31, 2011 are  based on approximately 6,497,000 to 6,546,000 projected average diluted shares  outstanding. |  | 
|  |  |  |  |  |  |  |  |  | 
 
| Reconciliation of Operating Income  to Adjusted EBITDA and Adjusted EBITDA Before  Restructuring and Other Charges (in millions, unaudited) |  | 
|  | Projected for the Year Ending | Actual for the Year Ended |  | 
|  |  | 9/30/11 |  |  | 9/30/10 |  |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Operating income |  | $ | 40.9 to 44.9 |  |  | $ | 31.4 |  |  | 
| Add: depreciation and amortization expense |  |  | 12.9 |  |  |  | 12.9 |  |  | 
| Add: loss on impairment of long-lived assets and loss on disposal of assets |  |  | 1.7 |  |  |  | 2.1 |  |  | 
| Add: stock compensation expense |  |  | 2.5 |  |  |  | 1.9 |  |  | 
| Adjusted EBITDA |  |  | 58.0 to 62.0 |  |  |  | 48.3 |  |  | 
| Add: restructuring and other charges |  |  | 0.3 |  |  |  | 5.7 |  |  | 
| Adjusted EBITDA before restructuring and other  charges |  | $ | 58.3 to 62.3 |  |  | $ | 54.0 |  | 
 
				
								
								
				
			
			 
		
			
			
			
				
				
				Jan. 27, 2011 (Business Wire) — Cirrus Logic, Inc. (Nasdaq: CRUS), a  leader in high-precision analog and digital signal processing components, today  announced financial results for the third quarter of fiscal year 2011, which  ended Dec. 25, 2010.
Revenue for the quarter was $95.6 million, up 47 percent compared to the same  quarter a year ago, and down five percent sequentially from the previous  quarter. Gross margin for the quarter was 55 percent, up slightly from 54  percent in the third quarter a year ago, and down slightly from 56 percent for  the previous quarter.
Total GAAP operating expenses for the quarter were approximately $29.4  million, compared to $27.7 million in the previous quarter. Non-GAAP operating  expenses for the quarter were approximately $28.0 million compared to $27.6  million in the previous quarter.
Income from operations on a GAAP basis was approximately $23.1 million,  representing an operating margin of 24 percent. Income from operations on a  non-GAAP basis was $24.5 million, representing a non-GAAP operating margin of 26  percent
GAAP net income for the quarter was approximately $24.6 million, or $0.34 per  share, based on 71.7 million average diluted shares outstanding. Non-GAAP net  income was $24.2 million, or $0.34 per diluted share.
A reconciliation of the non-GAAP charges is included in a table below.
“Revenue from portable audio products exceeded our expectations, helping to  drive overall Q3 revenue growth of 47 percent year over year,” said Jason Rhode,  president and chief executive officer, Cirrus Logic. “Looking at both the fourth  quarter and the next fiscal year, we believe we will continue to grow revenue at  a faster rate than the semiconductor industry as a whole. With the production  ramps continuing this next year in portable audio, new design wins in other  audio markets, and ongoing design activity with our strategic energy  initiatives, we are very excited about the opportunities ahead.”
Outlook for Fourth Quarter FY 2011 (ending Mar. 26, 2011):
- Revenue is expected to range between $88 million and  $94 million;
- Gross margin is expected to be between 54 percent and  56 percent; and
- Combined R&D and SG&A expenses are expected to  range between $31 million and $33 million, which include approximately $2.5  million in share-based compensation and amortization of acquisition-related  intangibles expenses.
Other Highlights and Company News
- The company repurchased and retired approximately 1.76  million shares during the quarter, at an average price of $12.94, while cash and  cash equivalents grew by approximately $8 million during the quarter.
- Total employee headcount during the quarter increased  to 549 employees, a net increase of 15 employees.
- In January, the company began construction on its new  headquarters facility at 800 W. Sixth Street in downtown Austin that is expected  to be completed in the summer of 2012.
- Thurman Case, chief financial officer, will be  presenting at the Stifel Nicolaus Technology Conference in San Francisco on  February 11, at 11:00 a.m. ET. A live webcast will be available in the investor  relations section of cirrus website.
Conference Call
Cirrus Logic management will hold a conference call to discuss the company’s  results for the third quarter fiscal year 2011, on January 27, at 10:30 a.m. ET.  The conference call will be simulcast over the internet in the investor  relations section of the company website at http://investor.cirrus.com. A replay  of the conference call will be available on the website listed above beginning  one hour following the completion of the call, or by calling (303) 590-3030, or  toll-free at (800) 406-7325 (Access Code: 4398706).
Shareholders who would like to submit a question to be addressed during the  call are requested to email investor.relations@cirrus.com.
Cirrus Logic, Inc.
Cirrus Logic develops high-precision, analog and mixed-signal integrated  circuits for a broad range of innovative customers. Building on its diverse  analog and signal-processing patent portfolio, Cirrus Logic delivers highly  optimized products for a variety of audio and energy-related applications. The  company operates from headquarters in Austin, Texas, with offices in Tucson,  Ariz., Europe, Japan and Asia. More information about Cirrus Logic is available  at www.cirrus.com.
Use of non-GAAP Financial Information
To supplement Cirrus Logic’s financial statements presented on a GAAP  basis, Cirrus has provided non-GAAP financial information, including non-GAAP  operating expenses, non-GAAP net income, non-GAAP income from operations,  non-GAAP operating margin and non-GAAP diluted earnings per share. A  reconciliation of the adjustments to GAAP results is included in the tables  below. Non-GAAP financial information is not meant as a substitute for GAAP  results, but is included because management believes such information is useful  to our investors for informational and comparative purposes. In addition,  certain non-GAAP financial information is used internally by management to  evaluate and manage the company. As a note, the non-GAAP financial information  used by Cirrus Logic may differ from that used by other companies. These  non-GAAP measures should be considered in addition to, and not as a substitute  for, the results prepared in accordance with GAAP.
Safe Harbor Statement
Except for historical information contained herein, the matters set forth  in this news release contain forward-looking statements, including our estimates  of fourth quarter fiscal year 2011 revenue, our future growth rate, gross  margin, combined research and development and selling, general and  administrative expense levels, share-based compensation expense, and  amortization of acquired intangible expenses. In some cases, forward-looking  statements are identified by words such as “expect,” “anticipate,” “target,”  “project,” “believe,” “goals,” “opportunity,” “estimates,” “intend,” and  variations of these types of words and similar expressions. In addition,  any statements that refer to our plans, expectations, strategies or other  characterizations of future events or circumstances are forward-looking  statements. These forward-looking statements are based on our current  expectations, estimates and assumptions and are subject to certain risks and  uncertainties that could cause actual results to differ materially. These risks  and uncertainties include, but are not limited to, the following: the level of  orders and shipments during the fourth quarter of fiscal year 2011, as well as  customer cancellations of orders, or the failure to place orders consistent with  forecasts; the loss of a key customer; and the risk factors listed in our Form  10-K for the year ended March 27, 2010, and in our other filings with the  Securities and Exchange Commission, which are available at www.sec.gov. The foregoing information concerning our  business outlook represents our outlook as of the date of this news release, and  we undertake no obligation to update or revise any forward-looking statements,  whether as a result of new developments or otherwise.
Cirrus Logic and Cirrus are trademarks of Cirrus Logic Inc.
CRUS-F
Summary financial data follows:
|  | 
| CIRRUS LOGIC, INC. | 
| CONSOLIDATED CONDENSED  STATEMENT OF OPERATIONS | 
| (unaudited) | 
| (in thousands, except  per share data) | 
|  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Three  Months Ended |  | Nine  Months Ended | 
|  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Dec. 25, |  | Sep. 25, |  | Dec. 26, |  | Dec. 25, |  | Dec. 26, | 
|  |  | 2010 |  | 2010 |  | 2009 |  | 2010 |  | 2009 | 
|  |  | Q3’11 |  | Q2’11 |  | Q3’10 |  | Q3’11 |  | Q3’10 | 
| Audio products |  | $ | 72,716 |  |  | $ | 71,171 |  |  | $ | 47,063 |  |  | $ | 197,875 |  |  | $ | 113,121 |  | 
| Energy products |  |  | 22,909 |  |  |  | 29,427 |  |  |  | 18,099 |  |  |  | 80,263 |  |  |  | 45,229 |  | 
| Net revenue |  |  | 95,625 |  |  |  | 100,598 |  |  |  | 65,162 |  |  |  | 278,138 |  |  |  | 158,350 |  | 
| Cost of sales |  |  | 43,163 |  |  |  | 43,818 |  |  |  | 30,276 |  |  |  | 122,161 |  |  |  | 74,903 |  | 
| Gross Profit |  |  | 52,462 |  |  |  | 56,780 |  |  |  | 34,886 |  |  |  | 155,977 |  |  |  | 83,447 |  | 
|  |  |  |  |  |  |  |  |  |  |  | 
| Operating expenses: |  |  |  |  |  |  |  |  |  |  | 
| Research and development |  |  | 16,348 |  |  |  | 15,450 |  |  |  | 12,834 |  |  |  | 46,890 |  |  |  | 37,697 |  | 
| Selling, general and administrative |  |  | 13,431 |  |  |  | 15,372 |  |  |  | 11,428 |  |  |  | 42,814 |  |  |  | 33,245 |  | 
| Restructuring and other costs, net |  |  | (395 | ) |  |  | 401 |  |  |  | 86 |  |  |  | 6 |  |  |  | (79 | ) | 
| Charge (proceeds) from non-marketable  securities |  |  | – |  |  |  | 500 |  |  |  | (500 | ) |  |  | 500 |  |  |  | (500 | ) | 
| Provision for (proceeds from)  litigation expenses and settlements |  |  | (30 | ) |  |  | – |  |  |  | 135 |  |  |  | 105 |  |  |  | (2,610 | ) | 
| Patent purchase agreement, net |  |  | – |  |  |  | (4,000 | ) |  |  | – |  |  |  | (4,000 | ) |  |  | (1,400 | ) | 
| Total operating expenses |  |  | 29,354 |  |  |  | 27,723 |  |  |  | 23,983 |  |  |  | 86,315 |  |  |  | 66,353 |  | 
|  |  |  |  |  |  |  |  |  |  |  | 
| Operating income |  |  | 23,108 |  |  |  | 29,057 |  |  |  | 10,903 |  |  |  | 69,662 |  |  |  | 17,094 |  | 
|  |  |  |  |  |  |  |  |  |  |  | 
| Interest income, net |  |  | 212 |  |  |  | 233 |  |  |  | 269 |  |  |  | 673 |  |  |  | 1,108 |  | 
| Other expense, net |  |  | (31 | ) |  |  | (14 | ) |  |  | (7 | ) |  |  | (13 | ) |  |  | (46 | ) | 
| Income before income taxes |  |  | 23,289 |  |  |  | 29,276 |  |  |  | 11,165 |  |  |  | 70,322 |  |  |  | 18,156 |  | 
| Provision (benefit) for income  taxes |  |  | (1,332 | ) |  |  | (1,598 | ) |  |  | 110 |  |  |  | (2,775 | ) |  |  | 116 |  | 
| Net income |  | $ | 24,621 |  |  | $ | 30,874 |  |  | $ | 11,055 |  |  | $ | 73,097 |  |  | $ | 18,040 |  | 
|  |  |  |  |  |  |  |  |  |  |  | 
| Basic income per share: |  | $ | 0.36 |  |  | $ | 0.45 |  |  | $ | 0.17 |  |  | $ | 1.08 |  |  | $ | 0.28 |  | 
| Diluted income per share: |  | $ | 0.34 |  |  | $ | 0.42 |  |  | $ | 0.17 |  |  | $ | 1.02 |  |  | $ | 0.28 |  | 
|  |  |  |  |  |  |  |  |  |  |  | 
| Weighted average number of shares: |  |  |  |  |  |  |  |  |  |  | 
| Basic |  |  | 68,074 |  |  |  | 68,513 |  |  |  | 65,302 |  |  |  | 67,731 |  |  |  | 65,279 |  | 
| Diluted |  |  | 71,695 |  |  |  | 72,878 |  |  |  | 65,632 |  |  |  | 71,868 |  |  |  | 65,452 |  | 
|  |  |  |  |  |  |  |  |  |  |  | 
| Prepared in accordance  with Generally Accepted Accounting Principles |  |  |  |  |  |  |  |  | 
|  | 
| CIRRUS LOGIC, INC. | 
| CONSOLIDATED CONDENSED  BALANCE SHEET | 
| (in thousands) | 
|  | 
|  |  | Dec. 25, |  | Mar. 27, |  | Dec. 26, | 
|  |  | 2010 |  | 2010 |  | 2009 | 
|  |  | (unaudited) |  |  |  | (unaudited) | 
| ASSETS |  |  |  |  |  |  | 
| Current assets |  |  |  |  |  |  | 
| Cash and cash equivalents |  | $ | 28,491 |  |  | $ | 16,109 |  |  | $ | 24,831 |  | 
| Restricted investments |  |  | 5,755 |  |  |  | 5,855 |  |  |  | 5,755 |  | 
| Marketable securities |  |  | 156,052 |  |  |  | 85,384 |  |  |  | 77,636 |  | 
| Accounts receivable, net |  |  | 37,266 |  |  |  | 23,963 |  |  |  | 25,131 |  | 
| Inventories |  |  | 40,196 |  |  |  | 35,396 |  |  |  | 30,408 |  | 
| Other current assets |  |  | 22,612 |  |  |  | 18,148 |  |  |  | 6,318 |  | 
| Total Current Assets |  |  | 290,372 |  |  |  | 184,855 |  |  |  | 170,079 |  | 
|  |  |  |  |  |  |  | 
| Long-term marketable securities |  |  | – |  |  |  | 34,278 |  |  |  | 25,235 |  | 
| Property and equipment, net |  |  | 32,919 |  |  |  | 18,674 |  |  |  | 18,499 |  | 
| Intangibles, net |  |  | 20,688 |  |  |  | 21,896 |  |  |  | 22,654 |  | 
| Goodwill |  |  | 6,027 |  |  |  | 6,027 |  |  |  | 6,027 |  | 
| Other assets |  |  | 1,978 |  |  |  | 1,880 |  |  |  | 1,906 |  | 
| Total Assets |  | $ | 351,984 |  |  | $ | 267,610 |  |  | $ | 244,400 |  | 
|  |  |  |  |  |  |  | 
| LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  | 
| Current liabilities |  |  |  |  |  |  | 
| Accounts payable |  | $ | 25,371 |  |  | $ | 20,340 |  |  | $ | 25,172 |  | 
| Accrued salaries and benefits |  |  | 9,509 |  |  |  | 9,962 |  |  |  | 7,609 |  | 
| Other accrued liabilities |  |  | 5,034 |  |  |  | 5,100 |  |  |  | 5,047 |  | 
| Deferred income on shipments  to distributors |  |  | 7,108 |  |  |  | 6,488 |  |  |  | 4,033 |  | 
| Total Current Liabilities |  |  | 47,022 |  |  |  | 41,890 |  |  |  | 41,861 |  | 
|  |  |  |  |  |  |  | 
| Long-term restructuring accrual |  |  | 179 |  |  |  | 596 |  |  |  | 492 |  | 
| Other long-term obligations |  |  | 6,113 |  |  |  | 6,523 |  |  |  | 6,555 |  | 
|  |  |  |  |  |  |  | 
| Stockholders’ equity: |  |  |  |  |  |  | 
| Capital stock |  |  | 982,610 |  |  |  | 952,803 |  |  |  | 950,023 |  | 
| Accumulated deficit |  |  | (683,220 | ) |  |  | (733,553 | ) |  |  | (753,911 | ) | 
| Accumulated other  comprehensive loss |  |  | (720 | ) |  |  | (649 | ) |  |  | (620 | ) | 
| Total Stockholders’ Equity |  |  | 298,670 |  |  |  | 218,601 |  |  |  | 195,492 |  | 
| Total Liabilities and  Stockholders’ Equity |  | $ | 351,984 |  |  | $ | 267,610 |  |  | $ | 244,400 |  | 
|  |  |  |  |  |  |  | 
| Prepared in accordance  with Generally Accepted Accounting Principles | 
|  | 
| CIRRUS LOGIC, INC. | 
| RECONCILIATION BETWEEN GAAP AND  NON-GAAP FINANCIAL INFORMATION | 
| (unaudited, in thousands, except  per share data) | 
| (not prepared in accordance with  GAAP) | 
Non-GAAP financial information is not meant as a substitute for GAAP  results, but is included because management believes such information is useful  to our investors for informational and comparative purposes. In addition,  certain non-GAAP financial information is used internally by management to  evaluate and manage the company. As a note, the non-GAAP financial information  used by Cirrus Logic may differ from that used by other companies. These  non-GAAP measures should be considered in addition to, and not as a substitute  for, the results prepared in accordance with GAAP.
|  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Three Months Ended |  | Nine Months Ended | 
|  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Dec. 25, |  | Sep. 25, |  | Dec. 26, |  | Dec. 25, |  | Dec. 26, | 
|  |  | 2010 |  | 2010 |  | 2009 |  | 2010 |  | 2009 | 
| Net Income  Reconciliation |  | Q3’11 |  | Q2’11 |  | Q3’10 |  | Q3’11 |  | Q3’10 | 
| GAAP Net Income |  | $ | 24,621 |  |  | $ | 30,874 |  |  | $ | 11,055 |  |  | $ | 73,097 |  |  | $ | 18,040 |  | 
| Amortization of acquisition  intangibles |  |  | 353 |  |  |  | 353 |  |  |  | 404 |  |  |  | 1,076 |  |  |  | 1,212 |  | 
| Stock based compensation expense |  |  | 1,467 |  |  |  | 3,025 |  |  |  | 1,397 |  |  |  | 5,848 |  |  |  | 4,133 |  | 
| Facility Related adjustments |  |  | – |  |  |  | (100 | ) |  |  | (375 | ) |  |  | (96 | ) |  |  | (397 | ) | 
| International sales reorganization  charges |  |  | – |  |  |  | – |  |  |  | – |  |  |  | 790 |  |  |  | – |  | 
| Provision for  (proceeds from) litigation expenses and settlements |  |  | (30 | ) |  |  | – |  |  |  | 135 |  |  |  | 105 |  |  |  | (2,610 | ) | 
| Restructuring and other costs, net |  |  | (395 | ) |  |  | 401 |  |  |  | 86 |  |  |  | 6 |  |  |  | (79 | ) | 
| Charge (proceeds) from non-marketable  securities |  |  | – |  |  |  | 500 |  |  |  | (500 | ) |  |  | 500 |  |  |  | (500 | ) | 
| Patent purchase agreement, net |  |  | – |  |  |  | (4,000 | ) |  |  | – |  |  |  | (4,000 | ) |  |  | (1,400 | ) | 
| Provision (benefit) for income  taxes |  |  | (1,847 | ) |  |  | (2,229 | ) |  |  | – |  |  |  | (4,076 | ) |  |  | – |  | 
| Non-GAAP Net Income |  | $ | 24,169 |  |  | $ | 28,824 |  |  | $ | 12,202 |  |  | $ | 73,250 |  |  | $ | 18,399 |  | 
|  |  |  |  |  |  |  |  |  |  |  | 
| Earnings Per Share  Reconciliation |  |  |  |  |  |  |  |  |  |  | 
| GAAP Diluted income per share |  | $ | 0.34 |  |  | $ | 0.42 |  |  | $ | 0.17 |  |  | $ | 1.02 |  |  | $ | 0.28 |  | 
| Effect of Amortization of acquisition  intangibles |  |  | – |  |  |  | – |  |  |  | 0.01 |  |  |  | 0.02 |  |  |  | 0.02 |  | 
| Effect of Stock based compensation  expense |  |  | 0.02 |  |  |  | 0.04 |  |  |  | 0.02 |  |  |  | 0.08 |  |  |  | 0.06 |  | 
| Effect of Facility Related adjustments |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | (0.01 | ) | 
| Effect of International sales  reorganization charges |  |  | – |  |  |  | – |  |  |  | – |  |  |  | 0.01 |  |  |  | – |  | 
| Effect of Provision  for (proceeds from) litigation expenses and settlements |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | (0.04 | ) | 
| Effect of Restructuring and other  costs, net |  |  | – |  |  |  | 0.01 |  |  |  | – |  |  |  | – |  |  |  | – |  | 
| Effect of Charge (proceeds) from  non-marketable securities |  |  | – |  |  |  | 0.01 |  |  |  | (0.01 | ) |  |  | 0.01 |  |  |  | (0.01 | ) | 
| Effect of Patent purchase agreement,  net |  |  | – |  |  |  | (0.05 | ) |  |  | – |  |  |  | (0.06 | ) |  |  | (0.02 | ) | 
| Effect of Provision (benefit) for  income taxes |  |  | (0.02 | ) |  |  | (0.03 | ) |  |  | – |  |  |  | (0.06 | ) |  |  | – |  | 
|  |  |  |  |  |  |  |  |  |  |  | 
| Non-GAAP Diluted income per  share |  | $ | 0.34 |  |  | $ | 0.40 |  |  | $ | 0.19 |  |  | $ | 1.02 |  |  | $ | 0.28 |  | 
|  |  |  |  |  |  |  |  |  |  |  | 
| Operating Income Reconciliation |  |  |  |  |  |  |  |  |  |  | 
| GAAP Operating Income (Loss) |  | $ | 23,108 |  |  | $ | 29,057 |  |  | $ | 10,903 |  |  | $ | 69,662 |  |  | $ | 17,094 |  | 
| GAAP Operating Margin |  |  | 24 | % |  |  | 29 | % |  |  | 17 | % |  |  | 25 | % |  |  | 11 | % | 
| Amortization of acquisition  intangibles |  |  | 353 |  |  |  | 353 |  |  |  | 404 |  |  |  | 1,076 |  |  |  | 1,212 |  | 
| Stock compensation expense – COGS |  |  | 46 |  |  |  | 64 |  |  |  | 55 |  |  |  | 165 |  |  |  | 150 |  | 
| Stock compensation expense – R&D |  |  | 579 |  |  |  | 617 |  |  |  | 438 |  |  |  | 1,717 |  |  |  | 1,380 |  | 
| Stock compensation expense – SG&A |  |  | 842 |  |  |  | 2,344 |  |  |  | 904 |  |  |  | 3,966 |  |  |  | 2,603 |  | 
| Facility Related adjustments |  |  | – |  |  |  | (100 | ) |  |  | (375 | ) |  |  | (96 | ) |  |  | (397 | ) | 
| International sales reorganization  charges |  |  | – |  |  |  | – |  |  |  | – |  |  |  | 790 |  |  |  | – |  | 
| Provision for (proceeds from)  litigation expenses and settlements |  |  | (30 | ) |  |  | – |  |  |  | 135 |  |  |  | 105 |  |  |  | (2,610 | ) | 
| Restructuring and other costs, net |  |  | (395 | ) |  |  | 401 |  |  |  | 86 |  |  |  | 6 |  |  |  | (79 | ) | 
| Charge (proceeds) from non-marketable  securities |  |  | – |  |  |  | 500 |  |  |  | (500 | ) |  |  | 500 |  |  |  | (500 | ) | 
| Patent purchase agreement, net |  |  | – |  |  |  | (4,000 | ) |  |  | – |  |  |  | (4,000 | ) |  |  | (1,400 | ) | 
| Non-GAAP Operating Income  (Loss) |  | $ | 24,503 |  |  | $ | 29,236 |  |  | $ | 12,050 |  |  | $ | 73,891 |  |  | $ | 17,453 |  | 
| Non-GAAP Operating Margin |  |  | 26 | % |  |  | 29 | % |  |  | 18 | % |  |  | 27 | % |  |  | 11 | % | 
|  |  |  |  |  |  |  |  |  |  |  | 
| Operating Expense  Reconciliation |  |  |  |  |  |  |  |  |  |  | 
| GAAP Operating Expenses |  | $ | 29,354 |  |  | $ | 27,723 |  |  | $ | 23,983 |  |  | $ | 86,315 |  |  | $ | 66,353 |  | 
| Amortization of acquisition  intangibles |  |  | (353 | ) |  |  | (353 | ) |  |  | (404 | ) |  |  | (1,076 | ) |  |  | (1,212 | ) | 
| Stock compensation expense – R&D |  |  | (579 | ) |  |  | (617 | ) |  |  | (438 | ) |  |  | (1,717 | ) |  |  | (1,380 | ) | 
| Stock compensation expense – SG&A |  |  | (842 | ) |  |  | (2,344 | ) |  |  | (904 | ) |  |  | (3,966 | ) |  |  | (2,603 | ) | 
| Facility Related adjustments |  |  | – |  |  |  | 100 |  |  |  | 375 |  |  |  | 96 |  |  |  | 397 |  | 
| International sales reorganization  charges |  |  | – |  |  |  | – |  |  |  | – |  |  |  | (790 | ) |  |  | – |  | 
| Provision for (proceeds from)  litigation expenses and settlements |  |  | 30 |  |  |  | – |  |  |  | (135 | ) |  |  | (105 | ) |  |  | 2,610 |  | 
| Restructuring and other costs, net |  |  | 395 |  |  |  | (401 | ) |  |  | (86 | ) |  |  | (6 | ) |  |  | 79 |  | 
| Charge (proceeds) from non-marketable  securities |  |  | – |  |  |  | (500 | ) |  |  | 500 |  |  |  | (500 | ) |  |  | 500 |  | 
| Patent purchase agreement, net |  |  | – |  |  |  | 4,000 |  |  |  | – |  |  |  | 4,000 |  |  |  | 1,400 |  | 
| Non-GAAP Operating  Expenses |  | $ | 28,005 |  |  | $ | 27,608 |  |  | $ | 22,891 |  |  | $ | 82,251 |  |  | $ | 66,144 |  | 

Cirrus Logic, Inc.
Thurman K. Case, 512-851-4125
Chief  Financial Officer
Investor.Relations@cirrus.com
				
								
								
				
			
			 
		
			
			
			
				
				
				Jan. 27, 2011 (Business Wire) — Arctic Cat Inc. (NASDAQ:ACAT) today reported  net earnings of $9.3 million, or $0.50 per diluted share, on net sales of $152.0  million for the fiscal 2011 third quarter ended December 31, 2010. Arctic Cat  reported net earnings in the prior-year third quarter of $2.6 million, or $0.14  per diluted share, on net sales of $131.0 million.
For the nine months ended December 31, 2010, Arctic Cat’s net earnings were  $22.6 million, or $1.22 per diluted share, on net sales of $391.2 million. In  the first nine months of last fiscal year, the company reported net earnings of  $11.4 million, or $0.63 per diluted share, on net sales of $366.7 million.
Commented Arctic Cat’s president and chief executive officer Claude Jordan:  “We are very pleased with the company’s strong third-quarter and year-to-date  performance. Our results were fueled by higher sales across all product lines,  including double-digit gains in our snowmobile business. The combination of  increased volume, product mix, product cost-reduction efforts, higher selling  prices and a continued focus on efficiency led to another quarter of  significantly improved gross margins and profitability.”
Among the highlights of Arctic Cat’s 2011 third quarter and year-to-date  financial results versus the same periods last year:
- Gross margins improved 430 basis points in the quarter  and 370 basis points year to date;
- Operating profit for the quarter rose to $12.2 million  from $0.6 million, and year to date increased to $32.7 million from $13.9  million;
- Factory inventory declined 27 percent to $77.2 million  from $106.3 million;
- Total cash and short-term investments rose to $107.1  million from $50.4 million; and
- The company has no short- or long-term debt.
“We are excited by the traction and momentum we’ve achieved year to date,”  said Jordan. “We continued to successfully execute against our objectives to  reduce dealer and factory inventory, improve gross margins and keep operating  expenses flat as a percent of sales.”
Business Line Results
Snowmobile sales grew 33 percent to $77.8 million in the third quarter  compared to $58.7 million in the prior-year quarter, led by increases in both  North American dealer sales and international sales to distributors.  Year-to-date snowmobile sales increased 15 percent to $186.5 million versus  $162.3 million in the same period last year, led by higher international sales  to distributors.
All-terrain vehicle (ATV) sales rose 1 percent to $48.6 million in the third  quarter versus $48.2 million in the prior-year quarter, chiefly driven by sales  of the company’s new Prowler HDX heavy duty utility vehicle. During the quarter,  Arctic Cat announced the launch of three all-new 2011 ATV models: the  full-featured, value-priced 350 4X4 automatic; the valued-priced 425 EFI 4X4  automatic; and the XC450i 4X4, a crossover model for consumers seeking  four-wheel-drive capabilities in a sport ATV. Arctic Cat’s year-to-date ATV  sales were up 1 percent to $133.0 million compared to $132.1 million in the  first nine months of fiscal 2010.
Sales of parts, garments and accessories (PG&A) in the third quarter grew  6 percent to $25.6 million versus $24.2 million in the prior-year quarter,  primarily driven by stronger garments sales including the new Drift garment  line. Year-to-date PG&A sales totaled $71.7 million, down 1 percent from  $72.3 million in the year-ago period.
Outlook
“We remain confident that the company is on track to deliver improved  operating results, increased profitability and enhanced shareholder value again  this fiscal year,” Jordan said.
Arctic Cat is focused on improving its profitability in a continued  low-demand recreational vehicle market, which remains well below pre-recession  industry sales levels. The company’s fiscal 2011 outlook includes the following  assumptions: ATV industry retail sales declining approximately 15 to 20 percent;  snowmobile industry retail sales increasing 5 to 10 percent; Arctic Cat dealer  inventories declining 20 to 30 percent; improving gross margins between 200 to  300 basis points; achieving flat to slightly down operating expense levels as a  percent of sales; increasing cash flow from operations; and ending the year with  more cash on the balance sheet.
Based on its year-to-date results and expectations of future performance,  Arctic Cat is raising and narrowing its estimated full-year earnings for the  current fiscal year ending March 31, 2011. The company now anticipates that  fiscal 2011 earnings will be in the range of $0.57 to $0.65 per diluted share,  driven by increased international revenue, as well as higher gross margins  resulting from higher volume, product mix and cost reduction efforts. The  company’s previous guidance anticipated fiscal 2011 earnings of $0.40 to $0.55  per diluted share. The company continues to estimate fiscal 2011 net sales of  $453 million to $463 million.
Conference Call
A conference call is scheduled for 11:00 a.m. CT (12:00 p.m. ET) today. To  listen to the live webcast or replay of this call via the Internet, go to the  corporate portion of the company’s website at www.arcticcat.com. To listen to a  telephone replay of the conference call, dial 800-406-7325 and enter conference  call passcode 4403970. The telephone replay will be available through Thursday,  February 3, 2011.
About Arctic Cat
Arctic Cat Inc. designs, engineers, manufactures and markets all-terrain  vehicles (ATVs) and snowmobiles under the Arctic Cat® brand name, as well as  related parts, garments and accessories. Its common stock is traded on the  Nasdaq Global Select Market under the ticker symbol “ACAT.” More information  about Arctic Cat and its products is available at www.arcticcat.com.
Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides  a safe harbor for certain forward-looking statements. The Company’s Annual  Report, as well as the Report on Form 10-K and future filings with the  Securities and Exchange Commission, the Company’s press releases and oral  statements made with the approval of an authorized executive officer, contain  forward-looking statements that reflect the Company’s current views with respect  to future events and financial performance. These forward-looking statements are  subject to certain risks and uncertainties that could cause actual results to  differ materially from historical results or those anticipated. The words “aim,”  “believe,” “expect,” “anticipate,” “intend,” “estimate” and other expressions  that indicate future events and trends identify forward-looking statements.  Actual future results and trends may differ materially from historical results  or those anticipated depending on a variety of factors, including, but not  limited to: product mix and volume; competitive pressure on sales and pricing;  cost and availability of financing for the Company, our dealers and our  suppliers; increase in material or production cost which cannot be recouped in  product pricing; changes in the sourcing of snowmobile engines from Suzuki;  warranty expenses; foreign currency exchange rate fluctuations; product  liability claims and other legal proceedings in excess of insured amounts;  environmental and product safety regulatory activity; effects of the weather;  overall economic conditions; and consumer demand and confidence. The Company  does not undertake any obligation to publicly update or revise any  forward-looking statement, whether as a result of new information, future events  or otherwise.
|  | 
| ARCTIC CAT INC. Financial Highlights (000s omitted, except per share amounts) (Unaudited) | 
|  |  |  |  |  | 
|  |  | Three  Months Ended |  | Nine Months  Ended | 
|  |  | December 31, |  | December 31, | 
|  |  | 2010 |  | 2009 |  | 2010 |  | 2009 | 
| Net Sales |  |  |  |  |  |  |  |  | 
| Snowmobile & ATV Units |  | $ | 126,381 |  |  | $ | 106,879 |  |  | $ | 319,485 |  |  | $ | 294,433 |  | 
| Parts Garments &  Accessories |  |  | 25,595 |  |  |  | 24,161 |  |  |  | 71,709 |  |  |  | 72,277 |  | 
| Total Net Sales |  |  | 151,976 |  |  |  | 131,040 |  |  |  | 391,194 |  |  |  | 366,710 |  | 
| Cost of Goods Sold |  |  |  |  |  |  |  |  | 
| Snowmobile & ATV Units |  |  | 104,723 |  |  |  | 95,025 |  |  |  | 254,252 |  |  |  | 249,115 |  | 
| Parts Garments &  Accessories |  |  | 14,521 |  |  |  | 13,434 |  |  |  | 42,193 |  |  |  | 42,255 |  | 
| Cost of Goods Sold |  |  | 119,244 |  |  |  | 108,459 |  |  |  | 296,445 |  |  |  | 291,370 |  | 
| Gross Profit |  |  | 32,732 |  |  |  | 22,581 |  |  |  | 94,749 |  |  |  | 75,340 |  | 
| Operating Expenses |  |  |  |  |  |  |  |  | 
| Selling & Marketing |  |  | 8,502 |  |  |  | 8,941 |  |  |  | 24,973 |  |  |  | 24,982 |  | 
| Research & Development |  |  | 3,418 |  |  |  | 2,979 |  |  |  | 9,828 |  |  |  | 9,177 |  | 
| General & Administrative |  |  | 8,595 |  |  |  | 10,037 |  |  |  | 27,255 |  |  |  | 27,323 |  | 
| Total Operating Expenses |  |  | 20,515 |  |  |  | 21,957 |  |  |  | 62,056 |  |  |  | 61,482 |  | 
| Operating Profit |  |  | 12,217 |  |  |  | 624 |  |  |  | 32,693 |  |  |  | 13,858 |  | 
| Other Income (Expense) |  |  |  |  |  |  |  |  | 
| Interest Income |  |  | 28 |  |  |  | — |  |  |  | 72 |  |  |  | 4 |  | 
| Interest Expense |  |  | (1 | ) |  |  | (2 | ) |  |  | (11 | ) |  |  | (249 | ) | 
| Total Other Income (Expense) |  |  | 27 |  |  |  | (2 | ) |  |  | 61 |  |  |  | (245 | ) | 
| Earnings Before Income Taxes |  |  | 12,244 |  |  |  | 622 |  |  |  | 32,754 |  |  |  | 13,613 |  | 
| Income Tax Expense (Benefit) |  |  | 2,982 |  |  |  | (1,980 | ) |  |  | 10,161 |  |  |  | 2,178 |  | 
| Net Earnings |  | $ | 9,262 |  |  | $ | 2,602 |  |  | $ | 22,593 |  |  | $ | 11,435 |  | 
| Net Earnings Per Share |  |  |  |  |  |  |  |  | 
| Basic |  | $ | 0.51 |  |  | $ | 0.14 |  |  | $ | 1.24 |  |  | $ | 0.63 |  | 
| Diluted |  | $ | 0.50 |  |  | $ | 0.14 |  |  | $ | 1.22 |  |  | $ | 0.63 |  | 
| Weighted Average Shares |  |  |  |  |  |  |  |  | 
| Outstanding: |  |  |  |  |  |  |  |  | 
| Basic |  |  | 18,236 |  |  |  | 18,228 |  |  |  | 18,214 |  |  |  | 18,217 |  | 
| Diluted |  |  | 18,644 |  |  |  | 18,297 |  |  |  | 18,484 |  |  |  | 18,249 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  | 
|  |  |  | December 31, | 
| Selected Balance  Sheet Data: |  |  | 2010 |  |  | 2009 | 
| Cash and Short-term Investments |  |  | $ | 107,070 |  |  | $ | 50,356 | 
| Accounts Receivable, net |  |  |  | 50,301 |  |  |  | 43,008 | 
| Inventories |  |  |  | 77,150 |  |  |  | 106,264 | 
| Total Assets |  |  |  | 296,505 |  |  |  | 267,077 | 
| Short-term Bank Borrowings |  |  |  | 0 |  |  |  | 0 | 
| Total Current Liabilities |  |  |  | 102,984 |  |  |  | 82,788 | 
| Long-term Debt |  |  |  | 0 |  |  |  | 0 | 
| Shareholders’ Equity |  |  |  | 190,953 |  |  |  | 179,710 | 
|  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  | 
|  |  | Three Months Ended |  | Nine Months Ended | 
|  |  | December 31 |  | December 31 | 
| Product Line Data: |  |  | 2010 |  |  | 2009 |  | Change |  |  | 2010 |  |  | 2009 |  | Change | 
| Snowmobiles |  | $ | 77,822 |  | $ | 58,665 |  | 33% |  | $ | 186,452 |  | $ | 162,321 |  | 15% | 
| All-terrain Vehicles |  |  | 48,559 |  |  | 48,214 |  | 1% |  |  | 133,033 |  |  | 132,112 |  | 1% | 
| Parts, Garments &  Accessories |  |  | 25,595 |  |  | 24,161 |  | 6% |  |  | 71,709 |  |  | 72,277 |  | -1% | 
| Total Sales |  | $ | 151,976 |  | $ | 131,040 |  | 16% |  | $ | 391,194 |  | $ | 366,710 |  | 7% | 

Arctic Cat Inc.
Timothy C. Delmore, 763-354-1800
Chief  Financial Officer
or
Padilla Speer Beardsley Inc.
Shawn  Brumbaugh, 612-455-1754
				
								
								
				
			
			 
		
			
			
			
				
				
				LOS ANGELES, Jan. 27, 2011 (GLOBE NEWSWIRE) — Hanmi Financial Corporation  (Nasdaq:HAFC), the holding company for Hanmi Bank, today reported a fourth  quarter profit of $5.3 million or $0.04 per diluted share, with substantial  improvement in credit metrics. In the fourth quarter of 2009, Hanmi’s net loss  totaled $35.9 million, or $0.70 per share. For the full year in 2010, the net  loss improved to $88.0 million, or $0.93 per share, compared to $122.3 million,  or $2.57 per share in 2009.
“We believe that our continuing efforts to shed problem assets through credit  workouts and asset sales has improved credit quality metrics and allowed us to  return to profitability,” said Jay S. Yoo, President and Chief Executive  Officer. “Our successful capital raise earlier in July 2010 was an additional  factor in strengthening our capital position. Hanmi Bank continued to be  categorized as ‘well-capitalized’ for regulatory purposes at December 31,  2010.”
2010 Highlights
- Hanmi’s fourth quarter results mark the first time in over two years that  Hanmi Financial has earned a quarterly profit of $5.3 million.
- Credit metrics, which began to improve at the beginning of 2010, continued  improving as the year progressed. Non-performing assets (NPA), which is  non-performing loans (NPLs) and other real estate owned (OREO) assets, decreased  by 20% to $173.1 million, or 5.95% of total assets, from $215.3 million or 7.25%  of total assets in the third quarter and $245.4 million, or 7.76% a year ago.  The coverage ratio of the allowance to non-performing loans increased to 86.4%  at December 31, 2010 compared to 66.2% a year ago while slightly decreased  compared to 90.4% in the prior quarter.
- During 2010, the successful deleveraging of the balance sheet reduced total  assets by 8% or $256 million to $2.91 billion, with gross loans down 20%.
- Net interest margin (NIM) was stable at 3.48% in the fourth quarter of 2010,  down one basis point from 3.49% in the third quarter of 2010 and up 2 basis  points from the fourth quarter a year ago. For the full year, NIM increased 71  basis points to 3.55% from 2.84% at December 31, 2009.
Capital Management
“The successful rights offering and best efforts stock offerings in July 2010  have provided the necessary capital to return our balance sheet to ‘well  capitalized’ regulatory status and provided us with the capital resources to  assist us in achieving profitability in this most recently completed quarter,”  Mr. Yoo stated. “We understand that Woori Finance continues to work closely with  regulators to achieve approval for the previously announced transaction. While  this transaction is no longer exclusive, we believe it is still quite viable. In  addition, we are also considering alternative capital sources to further enhance  our capital position and fund balance sheet growth.”
With the profit generated from operations along with the decrease in our  total assets, the Bank’s Total Risk-Based Capital Ratio at year-end increased to  12.23% compared with 11.61% in the immediate prior quarter-end and 9.07% a year  ago. At December 31, 2010, Tier 1 Risk-Based Capital Ratio was 10.91% compared  to 10.28% at September 30, 2010, and 7.77% a year ago. Fourth quarter Tier 1  Leverage Ratio was 8.55% compared to 8.26% in the third quarter and 6.69% in the  fourth quarter of 2009. The Bank’s Tangible Common Equity to Tangible Assets at  year-end increased to 8.60% compared with 8.37% in the linked quarter and 7.13%  a year ago.
Asset Quality
At December 31, 2010, the allowance for loan losses was $146.1 million, or  6.44% of gross loans, compared to $176.1 million, or 7.35% of gross loans, at  September 30, 2010, and $145.0 million, or 5.14% of gross loans a year ago. The  ratio of Hanmi’s loan loss allowance to non-performing loans at December 31,  2010, increased to 86.41%, up from 66.19% a year ago. Fourth quarter  charge-offs, net of recoveries, were $35.2 million compared to $21.3 million in  the third quarter and $57.3 million in the fourth quarter of 2009. For the full  year in 2010, net charge-offs were $121.9 million compared to $122.6 million in  2009.
NPLs declined 13% to $169.0 million at December 31, 2010, from $194.7 million  at September 30, 2010, and are down 23% from $219.1 million at December 31,  2009. Of the total $169.0 million NPLs, $43.0 million, or 25%, were current on  payments. In addition, $69.4 million, or 41%, were marked to current market  value with partial charge-offs. Out of the $69.4 million, $26.6 million were  categorized as available for sale. We sold 29 NPLs with carrying value of $28.6  million in the fourth quarter, which contributed to the decline of NPLs in the  quarter. Year-to-date, we sold 87 loans with carrying value of $156.8  million.
Sale of OREOs, real estate acquired through foreclosures, continued during  the fourth quarter, with 5 properties sold for net proceeds of $17.1 million,  resulting in a $115,000 net loss. In 2010, OREO sales generated $25.9 million in  net proceeds on the sale of 18 properties, resulting in a $196,000 net  loss. OREOs totaled $4.1 million at December 31, 2010, down from $20.6 million  at September 30, 2010 and also down from $26.3 million a year ago. Hanmi  actively manages its loan portfolio and regularly sells assets prior to  foreclosure, which partially accounts for the reduction of OREO. The following  table shows non-performing loans by loan category:
| Total Non-Performing  Loans | 
| (‘000) | 12/31/2010 | % of Total NPL | 9/30/2010 | % of Total NPL | 12/31/2009 | % of Total NPL | 
| Real Estate Loans: |  |  |  |  |  |  | 
| Commercial Property | 21,129 | 12.5% | 31,103 | 16.0% | 60,159 | 27.5% | 
| Construction | 19,097 | 11.3% | 9,338 | 4.8% | 15,166 | 6.9% | 
| Land Loans | 26,808 | 15.2% | 29,701 | 15.2% | 19 | 0.0% | 
| Residential Property | 2,674 | 1.6% | 2,264 | 1.2% | 3,662 | 1.7% | 
| Commercial & Industrial Loans: |  |  |  |  |  |  | 
| Owner Occupied Property | 68,441 | 40.5% | 90,777 | 46.6% | 96,966 | 44.3% | 
| Other C&I | 30,581 | 18.1% | 31,216 | 16.0% | 42,405 | 19.4% | 
| Consumer Loans | 298 | 0.2% | 330 | 0.2% | 690 | 0.3% | 
| TOTAL NPL | 169,028 | 100.0% | 194,729 | 100.0% | 219,067 | 100.0% | 
The proactive approach to resolving problematic credits in 2010 helped reduce  delinquent loans on accrual status, which are not included in the NPL total.  Delinquent loans on accrual status decreased to $21.5 million, or 0.95% of gross  loans at December 31, 2010, from $41.2 million, or 1.46% of gross loans at  December 31, 2009. On a sequential quarter basis, the amount of delinquent loans  on accrual status decreased from $23.9 million at September 30, 2010 due to a  decrease in delinquent construction loans on accrual status. This decrease was  partially offset by a minor increase in Commercial & Industrial delinquent  loans on an accrual status. The following table shows delinquent loans on  accrual status by loan category:
| Delinquent loans on accrual  status | 
| (‘000) | 12/31/2010 | % of Total | 9/30/2010 | % of Total | 12/31/2009 | % of Total | 
| Real Estate Loans: |  |  |  |  |  |  | 
| Commercial Property |  |  | 382 | 1.6% | 3,500 | 8.5% | 
| Construction | 4,894 | 22.8% | 8,714 | 36.5% |  |  | 
| Land Loans |  |  |  |  | 150 | 0.4% | 
| Residential Property | 951 | 4.4% | 801 | 3.4% | 1,190 | 2.9% | 
| Commercial & Industrial Loans: |  |  |  |  |  |  | 
| Owner Occupied Property | 10,408 | 48.5% | 9,261 | 38.7% | 23,833 | 57.8% | 
| Other C&I | 5,004 | 23.3% | 4,543 | 19.0% | 11,951 | 29.0% | 
| Consumer Loans | 200 | 0.9% | 195 | 0.8% | 594 | 1.4% | 
| TOTAL | 21,457 | 100.0% | 23,896 | 100.0% | 41,218 | 100.0% | 
Balance Sheet 
We believe that our deleveraging strategy in the last two years has been  successful in reducing portfolio risk and preserving capital. With our enhanced  capital levels, we have begun to implement plans to grow our customer base,  albeit at moderate levels. With loan demand still soft, we anticipate that any  growth will come from attracting new customers and capitalizing on continuing  disruption in the regional banking market.
Total assets decreased slightly at the end of the fourth quarter to $2.91  billion, from $2.97 billion at September 30, 2010, and down 8% from $3.16  billion at December 31, 2009. Gross loans, net of deferred loan fees, were $2.27  billion at December 31, 2010, down 5% from $2.39 billion at September 30, 2010,  and down 20% from $2.82 billion at December 31, 2009.
Average gross loans decreased 20% to $2.35 billion for the fourth quarter of  2010 from $2.92 billion for the like quarter a year ago and declined 4% during  the fourth quarter from $2.46 billion for the third quarter of 2010. Hanmi’s  average investment securities portfolio increased 92% to $351.0 million for the  fourth quarter of 2010 from $182.6 million for the fourth quarter of 2009 and  increased 57% for the fourth quarter of 2010 from $223.7 million from the  quarter ended September 30. 2010. The decreases in average gross loans over the  past year were the direct result of the balance sheet deleveraging strategy. The  Bank increased investment securities to enforce liquidity preservation  strategy.
Consistent with the deleveraging strategy, average deposits also decreased  14% to $2.51 billion for the fourth quarter of 2010 from $2.91 billion for the  like quarter in 2009 and declined 2% from $2.56 billion for the third quarter of  2010.
The deposit mix at year-end continues to reflect efforts to build core  deposits and improve the Bank’s cost of funds. There are no brokered deposits in  the deposit mix at year-end. Total deposits decreased 10% year-over-year and  declined 2% from the prior quarter. The 10% year-over-year decrease in total  deposits was primarily due to a $203 million decrease in brokered  deposits. Total deposits were $2.47 billion at December 31, 2010, compared to  $2.53 billion at September 30, 2010, and $2.75 billion at December 31, 2009.
Results of Operations
Net interest income, before the provision for credit losses, totaled $26.0  million for the fourth quarter of 2010 which was down 1% from $26.3 million in  the linked quarter and down 9% from $28.4 million in the fourth quarter a year  ago. Increased liquidity from the capital raise earlier in the year was deployed  to cash and cash equivalent balances and investment securities which are  generally lower yielding assets. The cost of funds also declined in the quarter  reflecting reductions in high-cost time deposits and an increase in low-cost  deposits. For the full year in 2010, net interest income before provision for  credit losses increased 5% to $105.9 million compared to $101.2 million in  2009.
Loan yields increased and deposit costs decreased which benefited our net  interest margin. These benefits were offset by higher balances of investment  securities, which generate lower yields but allowing a strong liquidity  position. The average yield on the loan portfolio increased 4 basis points to  5.48% from 5.44% from the prior quarter and decreased 6 basis points from the  fourth quarter in 2009. For the full year 2010, the average yield on the loan  portfolio decreased 9 basis points to 5.40% from 5.49% in 2009. In 2010, the  reversal of previously recorded interest income due to the additional  non-accrual loans was $3.2 million ($0.3 million in the fourth quarter),  resulting in a negative impact on NIM by 11 basis points. The cost of average  interest-bearing deposits in the fourth quarter was 1.55%, down 10 basis points  from the prior quarter and 71 basis points from the fourth quarter of 2009. For  the full year 2010, the cost of average interest bearing deposits was 1.70%,  down 127 basis points from a year ago. As a result, Hanmi’s net interest margin  was down just one basis point at 3.48% in the fourth quarter of 2010 from 3.49%  in the third quarter and up 2 basis points compared to 3.46% in the fourth  quarter of 2009. NIM improved 71 basis points to 3.55% for 2010 from 2.84% for  2009.
Despite the quarterly increase in net charge-offs, the provision for credit  losses in the fourth quarter of 2010 decreased to $5.0 million, compared to  $22.0 million in the prior quarter and $77.0 million in the fourth quarter a  year ago, due to the decrease in classified assets, non-performing loans, and  overall loan balance. For the full year, the provision for credit losses totaled  $122.5 million, down from $196.4 million in 2009. The provision for loan losses  has decreased steadily now for four consecutive quarters.
Total non-interest income in the fourth quarter of 2010 was $6.1 million, up  7% from $5.7 million in the third quarter of 2010 and down 23% from $7.8 million  in the fourth quarter of 2009.  The year-over-year decrease in non-interest  income is primarily attributable to decreases in service charges on deposit  accounts and a decrease in net gain on sale of loans and securities.  Service  charges on deposit accounts decreased to $3.3 million for the fourth quarter of  2010 from $3.4 million in the linked quarter and $4.0 million for the same  quarter of 2009. The decrease in service charges on deposit accounts was  associated with the reduction of the deposit portfolio reflecting the  deleveraging strategy. The net gain on the sale of loans decreased 69% from the  prior quarter and 80% from the fourth quarter a year ago. In the fourth quarter  of 2009, the Bank sold accumulated inventory of SBA loans upon the recovery of  the SBA secondary market.  For the year, non-interest income decreased 21%, or  $6.7 million, to $25.4 million, compared to $32.1 million in 2009, primarily due  to a $1.7 million decrease in net gain on sales of investment securities in  addition to the aforementioned factors.
Total non-interest expense decreased 10% in the quarter and 4% year-over-year  to $21.7 million for the fourth quarter, down from $24.1 million in the third  quarter of 2010 and $22.7 million for the fourth quarter a year ago. The overall  improvement of non-interest expense in general was across the board. For the  year, non-interest expense increased 7.1%, or $6.5 million, to $96.8 million,  compared to $90.4 million in 2009, primarily due to expenses related to managing  and provisioning for OREO properties and the absence of reversal of a $2.5  million previously accrued liability on a post-retirement death benefit that was  recognized in 2009.
Conference Call Information
Management will host a conference today at 1:30 p.m. PST (4.30 p.m. EST) to  discuss these financial results. This call will also be broadcast live via the  internet. Investment professionals and all others are invited to access the live  call by dialing (866) 383-8108 or (617) 597-5343 for international callers at  1:30 p.m. (PST), using access code HANMI. To listen to the call online, either  live or archived, visit the Investor Relations page of Hanmi Financial  Corporation website at www.hanmi.com. Shortly after the call concludes, the  replay will also be available at (888) 286-8010 or (617) 801-6888 for  international callers, using access code #12399068 where it will be archived  until February 14, 2011.
About Hanmi Financial Corporation
Headquartered in Los Angeles, Hanmi Bank, a wholly-owned subsidiary of Hanmi  Financial Corporation, provides services to the multi-ethnic communities of  California, with 27 full-service offices in Los Angeles, Orange, San Bernardino,  San Francisco, Santa Clara and San Diego counties, and a loan production office  in Washington State. Hanmi Bank specializes in commercial, SBA and trade finance  lending, and is a recognized community leader. Hanmi Bank’s mission is to  provide a full range of quality products and premier services to its customers  and to maximize shareholder value. Additional information is available at  www.hanmi.com.
Forward-Looking Statements
This press release contains forward-looking statements, which are included in  accordance with the “safe harbor” provisions of the Private Securities  Litigation Reform Act of 1995. In some cases, you can identify forward-looking  statements by terminology such as “may,” “will,” “should,” “could,” “expects,”  “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,”  “potential,” or “continue,” or the negative of such terms and other comparable  terminology. Although we believe that the expectations reflected in the  forward-looking statements are reasonable, we cannot guarantee future results,  levels of activity, performance or achievements. All statements other than  statements of historical fact are “forward –looking statements” for purposes of  federal and state securities laws, including, but not limited to, statements  about anticipated future operating and financial performance, financial position  and liquidity, business strategies, regulatory and competitive outlook,  investment and expenditure plans, capital and financing needs and availability,  plans and objectives of management for future operations, developments regarding  our securities purchase agreement with Woori Finance Holdings, and other similar  forecasts and statements of expectation and statements of assumption underlying  any of the foregoing. These statements involve known and unknown risks,  uncertainties and other factors that may cause our actual results, levels of  activity, performance or achievements to differ from those expressed or implied  by the forward-looking statement. These factors include the following: inability  to consummate the proposed transaction with Woori Finance Holdings on the terms  contemplated in the Securities Purchase Agreement entered into with Woori on  May 25, 2010, as amended (the “transaction”); failure to receive  regulatory approval for the Transaction; inability to continue as a going  concern; inability to raise additional capital on acceptable terms or at all;  failure to maintain adequate levels of capital and liquidity to support our  operations; the effect of regulatory orders we have entered into and potential  future supervisory action against us or Hanmi Bank; general economic and  business conditions internationally, nationally and in those areas in which we  operate; volatility and deterioration in the credit and equity markets; changes  in consumer spending, borrowing and savings habits; availability of capital from  private and government sources; demographic changes; competition for loans and  deposits and failure to attract or retain loans and deposits; fluctuations in  interest rates and a decline in the level of our interest rate spread; risks of  natural disasters related to our real estate portfolio; risks associated with  Small Business Administration loans; failure to attract or retain key employees;  changes in governmental regulation, including, but not limited to, any increase  in FDIC insurance premiums; ability to receive regulatory approval for Hanmi  Bank to declare dividends to the Company; adequacy of our allowance for loan  losses, credit quality and the effect of credit quality on our provision for  credit losses and allowance for loan losses; changes in the financial  performance and/or condition of our borrowers and the ability of our borrowers  to perform under the terms of their loans and other terms of credit agreements;  our ability to successfully integrate acquisitions we may make; our ability to  control expenses; and changes in securities markets. In addition, we set forth  certain risks in our reports filed with the U.S. Securities and Exchange  Commission (“SEC”), including attached as an Exhibit to a Current Report on Form  8-K filed with the SEC on June 18, 2010, and our most recent Quarterly Report on  Form 10-Q, as well as current and periodic reports filed with the U.S.  Securities and Exchange Commission hereafter, which could cause actual results  to differ from those projected. We undertake no obligation to update such  forward-looking statements except as required by law.
Cautionary Statements
Future issuance of any securities relating to the Woori transaction has not  been and will not be registered under the Securities Act of 1933, as amended, or  any state securities laws, and may not be offered or sold in the United States  absent registration or an applicable exemption from the registration  requirements of the Securities Act and applicable state securities laws. This  press release shall not constitute an offer to sell or the solicitation of an  offer to buy any securities, nor shall there be any sale of securities in any  jurisdiction or state in which such offer, solicitation or sale would be  unlawful prior to registration or qualification under the securities laws of any  such jurisdiction or state.
|  | 
| HANMI FINANCIAL CORPORATION AND  SUBSIDIARIES | 
| CONDENSED CONSOLIDATED BALANCE  SHEETS (UNAUDITED) | 
| (Dollars in Thousands) | 
|  |  |  |  |  |  | 
|  | December 31, | September 30, | % | December 31, | % | 
|  | 2010 | 2010 | Change | 2009 | Change | 
| ASSETS |  |  |  |  |  | 
|  |  |  |  |  |  | 
| Cash and Due from Banks | $ 60,983 | $ 63,455 | (3.9)% | $ 55,263 | 10.4 % | 
| Interest-Bearing Deposits in Other Banks | 158,737 | 218,843 | (27.5)% | 98,847 | 60.6 % | 
| Federal Funds Sold | 30,000 | — | — | — | — | 
|  |  |  |  |  |  | 
| Cash and Cash Equivalents | 249,720 | 282,298 | (11.5)% | 154,110 | 62.0 % | 
|  |  |  |  |  |  | 
| Investment Securities | 413,963 | 325,428 | 27.2 % | 133,289 | 210.6 % | 
|  |  |  |  |  |  | 
| Loans: |  |  |  |  |  | 
| Gross Loans, Net of Deferred Loan Fees | 2,267,126 | 2,394,291 | (5.3)% | 2,819,060 | (19.6)% | 
| Allowance for Loan Losses | (146,059) | (176,063) | (17.0)% | (144,996) | 0.7 % | 
|  |  |  |  |  |  | 
| Loans Receivable, Net | 2,121,067 | 2,218,228 | (4.4)% | 2,674,064 | (20.7)% | 
|  |  |  |  |  |  | 
| Due from Customers on Acceptances | 711 | 1,375 | (48.3)% | 994 | (28.5)% | 
| Premises and Equipment, Net | 17,599 | 17,639 | (0.2)% | 18,657 | (5.7)% | 
| Accrued Interest Receivable | 8,048 | 8,442 | (4.7)% | 9,492 | (15.2)% | 
| Other Real Estate Owned, Net | 4,089 | 20,577 | (80.1)% | 26,306 | (84.5)% | 
| Deferred Income Taxes, Net | — | — | — | 3,608 | — | 
| Investment in FHLB and FRB Stock, at Cost | 34,731 | 35,201 | (1.3)% | 30,697 | 13.1 % | 
| Bank-Owned Life Insurance | 27,350 | 27,111 | 0.9 % | 34,286 | (20.2)% | 
| Income Taxes Receivable | 9,188 | 9,188 | — | 56,554 | (83.8)% | 
| Other Assets | 20,682 | 23,018 | (10.1)% | 20,649 | 0.2 % | 
|  |  |  |  |  |  | 
| TOTAL ASSETS | $ 2,907,148 | $ 2,968,505 | (2.1)% | $ 3,162,706 | (8.1)% | 
|  |  |  |  |  |  | 
| LIABILITIES AND STOCKHOLDERS’  EQUITY |  |  |  |  |  | 
|  |  |  |  |  |  | 
| Liabilities: |  |  |  |  |  | 
| Deposits: |  |  |  |  |  | 
| Noninterest-Bearing | $ 546,815 | $ 559,764 | (2.3)% | $ 556,306 | (1.7)% | 
| Interest-Bearing | 1,919,906 | 1,967,622 | (2.4)% | 2,193,021 | (12.5)% | 
|  |  |  |  |  |  | 
| Total Deposits | 2,466,721 | 2,527,386 | (2.4)% | 2,749,327 | (10.3)% | 
|  |  |  |  |  |  | 
| Accrued Interest Payable | 15,966 | 13,727 | 16.3 % | 12,606 | 26.7 % | 
| Bank Acceptances Outstanding | 711 | 1,375 | (48.3)% | 994 | (28.5)% | 
| FHLB Advances and Other Borrowings | 155,220 | 156,292 | (0.7)% | 155,725 | (0.3)% | 
| Junior Subordinated Debentures | 82,406 | 82,406 | — | 82,406 | — | 
| Accrued Expenses and Other Liabilities | 12,868 | 14,687 | (12.4)% | 11,904 | 8.1 % | 
|  |  |  |  |  |  | 
| Total Liabilities | 2,733,892 | 2,795,873 | (2.2)% | 3,012,962 | (9.3)% | 
|  |  |  |  |  |  | 
| Stockholders’ Equity | 173,256 | 172,632 | 0.4 % | 149,744 | 15.7 % | 
|  |  |  |  |  |  | 
| TOTAL LIABILITIES AND STOCKHOLDERS’  EQUITY | $ 2,907,148 | $ 2,968,505 | (2.1)% | $ 3,162,706 | (8.1)% | 
|  | 
|  | 
| HANMI FINANCIAL CORPORATION AND  SUBSIDIARIES | 
| CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) | 
| (Dollars in Thousands, Except Per Share  Data) | 
|  |  |  |  |  |  | 
|  | Three Months  Ended | 
|  | December 31, | September 30, | % | December 31, | % | 
|  | 2010 | 2010 | Change | 2009 | Change | 
| INTEREST AND DIVIDEND INCOME: |  |  |  |  |  | 
| Interest and Fees on Loans | $ 32,466 | $ 33,681 | (3.6)% | $ 40,810 | (20.4)% | 
| Taxable Interest on Investment Securities | 1,839 | 1,592 | 15.5 % | 1,414 | 30.1 % | 
| Tax-Exempt Interest on Investment Securities | 9 | 62 | (85.5)% | 432 | (97.9)% | 
| Interest on Interest-Bearing Deposits in Other  Banks | 149 | 165 | (9.7)% | 70 | 112.9 % | 
| Dividends on FHLB and FRB Stock | 135 | 135 | — | 136 | (0.7)% | 
| Interest on Federal Funds Sold | 15 | 40 | (62.5)% | 95 | (84.2)% | 
| Total Interest and Dividend Income | 34,613 | 35,675 | (3.0)% | 42,957 | (19.4)% | 
| INTEREST EXPENSE: |  |  |  |  |  | 
| Interest on Deposits | 7,592 | 8,299 | (8.5)% | 13,410 | (43.4)% | 
| Interest on Junior Subordinated Debentures | 711 | 739 | (3.8)% | 690 | 3.0 % | 
| Interest on FHLB Advances and Other Borrowings | 339 | 364 | (6.9)% | 412 | (17.7)% | 
| Total Interest Expense | 8,642 | 9,402 | (8.1)% | 14,512 | (40.4)% | 
| NET INTEREST INCOME BEFORE PROVISION FOR CREDIT LOSSES | 25,971 | 26,273 | (1.1)% | 28,445 | (8.7)% | 
| Provision for Credit Losses | 5,000 | 22,000 | (77.3)% | 77,000 | (93.5)% | 
| NET INTEREST INCOME (LOSS) AFTER PROVISION FOR CREDIT  LOSSES | 20,971 | 4,273 | 390.8 % | (48,555) | (143.2)% | 
| NON-INTEREST INCOME: |  |  |  |  |  | 
| Service Charges on Deposit Accounts | 3,279 | 3,442 | (4.7)% | 4,022 | (18.5)% | 
| Insurance Commissions | 1,122 | 1,089 | 3.0 % | 1,062 | 5.6 % | 
| Remittance Fees | 499 | 484 | 3.1 % | 530 | (5.8)% | 
| Trade Finance Fees | 379 | 381 | (0.5)% | 439 | (13.7)% | 
| Other Service Charges and Fees | 323 | 409 | (21.0)% | 371 | (12.9)% | 
| Bank-Owned Life Insurance Income | 239 | 237 | 0.8 % | 237 | 0.8 % | 
| Net Gain on Sales of Loans | 71 | 229 | (69.0)% | 354 | (79.9)% | 
| Net Gain on Sales of Investment Securities | 5 | 4 | 25.0 % | 665 | (99.2)% | 
| Impairment Loss on Investment Securities | — | (790) | (100.0)% | — | — | 
| Other Operating Income | 136 | 186 | (26.9)% | 159 | (14.5)% | 
| Total Non-Interest Income | 6,053 | 5,671 | 6.7 % | 7,839 | (22.8)% | 
| NON-INTEREST EXPENSE: |  |  |  |  |  | 
| Salaries and Employee Benefits | 9,381 | 9,552 | (1.8)% | 8,442 | 11.1 % | 
| Occupancy and Equipment | 2,672 | 2,702 | (1.1)% | 2,733 | (2.2)% | 
| Deposit Insurance Premiums and Regulatory  Assessments | 2,204 | 2,253 | (2.2)% | 2,998 | (26.5)% | 
| Data Processing | 1,499 | 1,446 | 3.7 % | 1,606 | (6.7)% | 
| Other Real Estate Owned Expense | 681 | 2,580 | (73.6)% | 873 | (22.0)% | 
| Professional Fees | 680 | 753 | (9.7)% | 1,354 | (49.8)% | 
| Directors and Officers Liability Insurance | 716 | 716 | — | 293 | 144.4 % | 
| Other Operating Expenses | 3,902 | 4,077 | (4.3)% | 4,411 | (11.5)% | 
| Total Non-Interest Expense | 21,735 | 24,079 | (9.7)% | 22,710 | (4.3)% | 
| INCOME (LOSS) BEFORE PROVISION (BENEFIT) FOR INCOME  TAXES | 5,289 | (14,135) | (137.4)% | (63,426) | (108.3)% | 
| Provision (Benefit) for Income Taxes | (23) | 442 | (105.2)% | (27,545) | (99.9)% | 
| NET INCOME (LOSS) | $ 5,312 | $ (14,577) | (136.4)% | $ (35,881) | (114.8)% | 
|  |  |  |  |  |  | 
| EARNINGS (LOSS) PER SHARE: |  |  |  |  |  | 
| Basic | $ 0.04 | $ (0.12) | (133.3)% | $ (0.70) | (105.7)% | 
| Diluted | $ 0.04 | $ (0.12) | (133.3)% | $ (0.70) | (105.7)% | 
| WEIGHTED-AVERAGE SHARES OUTSTANDING: |  |  |  |  |  | 
| Basic | 151,051,903 | 122,789,120 |  | 50,998,103 |  | 
| Diluted | 151,197,503 | 122,789,120 |  | 50,998,103 |  | 
| SHARES OUTSTANDING AT PERIOD-END | 151,198,390 | 151,198,390 |  | 51,182,390 |  | 
|  | 
|  | 
| HANMI FINANCIAL CORPORATION AND  SUBSIDIARIES | 
| CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) | 
| (Dollars in Thousands, Except Per Share  Data) | 
|  |  |  |  | 
|  | Year Ended | 
|  | December 31, | December 31, | % | 
|  | 2010 | 2009 | Change | 
| INTEREST AND DIVIDEND INCOME: |  |  |  | 
| Interest and Fees on Loans | $ 137,328 | $ 173,318 | (20.8)% | 
| Taxable Interest on Investment Securities | 5,874 | 5,675 | 3.5 % | 
| Tax-Exempt Interest on Investment Securities | 225 | 2,303 | (90.2)% | 
| Interest on Interest-Bearing Deposits in Other  Banks | 468 | 151 | 209.9 % | 
| Dividends on FHLB and FRB Stock | 532 | 656 | (18.9)% | 
| Interest on Federal Funds Sold | 85 | 2,044 | (95.8)% | 
| Total Interest and Dividend Income | 144,512 | 184,147 | (21.5)% | 
| INTEREST EXPENSE: |  |  |  | 
| Interest on Deposits | 34,408 | 76,246 | (54.9)% | 
| Interest on Junior Subordinated Debentures | 2,811 | 3,271 | (14.1)% | 
| Interest on FHLB Advances and Other Borrowings | 1,419 | 3,401 | (58.3)% | 
| Total Interest Expense | 38,638 | 82,918 | (53.4)% | 
| NET INTEREST INCOME BEFORE PROVISION FOR CREDIT LOSSES | 105,874 | 101,229 | 4.6 % | 
| Provision for Credit Losses | 122,496 | 196,387 | (37.6)% | 
| NET INTEREST INCOME (LOSS) AFTER PROVISION FOR CREDIT  LOSSES | (16,622) | (95,158) | (82.5)% | 
| NON-INTEREST INCOME: |  |  |  | 
| Service Charges on Deposit Accounts | 14,049 | 17,054 | (17.6)% | 
| Insurance Commissions | 4,695 | 4,492 | 4.5 % | 
| Remittance Fees | 1,968 | 2,109 | (6.7)% | 
| Trade Finance Fees | 1,523 | 1,956 | (22.1)% | 
| Other Service Charges and Fees | 1,516 | 1,810 | (16.2)% | 
| Bank-Owned Life Insurance Income | 942 | 932 | 1.1 % | 
| Net Gain on Sales of Loans | 514 | 1,220 | (57.9)% | 
| Net Gain on Sales of Investment Securities | 122 | 1,833 | (93.3)% | 
| Impairment Loss on Investment Securities | (790) | — | — | 
| Other Operating Income | 867 | 704 | 23.2 % | 
| Total Non-Interest Income | 25,406 | 32,110 | (20.9)% | 
| NON-INTEREST EXPENSE: |  |  |  | 
| Salaries and Employee Benefits | 36,730 | 33,101 | 11.0 % | 
| Occupancy and Equipment | 10,773 | 11,239 | (4.1)% | 
| Deposit Insurance Premiums and Regulatory  Assessments | 10,756 | 10,418 | 3.2 % | 
| Data Processing | 5,931 | 6,297 | (5.8)% | 
| Other Real Estate Owned Expense | 10,679 | 5,890 | 81.3 % | 
| Professional Fees | 3,521 | 4,099 | (14.1)% | 
| Directors and Officers Liability Insurance | 2,865 | 1,175 | 143.8 % | 
| Other Operating Expenses | 15,550 | 18,135 | (14.3)% | 
| Total Non-Interest Expense | 96,805 | 90,354 | 7.1 % | 
| LOSS BEFORE BENEFIT FOR INCOME TAXES | (88,021) | (153,402) | (42.6)% | 
| Benefit for Income Taxes | (12) | (31,125) | (100.0)% | 
| NET LOSS | $ (88,009) | $ (122,277) | (28.0)% | 
|  |  |  |  | 
| LOSS PER SHARE: |  |  |  | 
| Basic | $ (0.93) | $ (2.57) | (63.8)% | 
| Diluted | $ (0.93) | $ (2.57) | (63.8)% | 
| WEIGHTED-AVERAGE SHARES OUTSTANDING: |  |  |  | 
| Basic | 94,322,222 | 47,570,361 |  | 
| Diluted | 94,322,222 | 47,570,361 |  | 
| SHARES OUTSTANDING AT PERIOD-END | 151,198,390 | 51,182,390 |  | 
|  | 
|  | 
| HANMI FINANCIAL CORPORATION AND  SUBSIDIARIES | 
| SELECTED FINANCIAL DATA (UNAUDITED) | 
| (Dollars in Thousands) | 
|  | Three Months Ended | Year Ended | 
|  | December 31, | September 30, | December 31, | December 31, | December 31, | 
|  | 2010 | 2010 | 2009 | 2010 | 2009 | 
|  |  |  |  |  |  | 
| AVERAGE BALANCES: |  |  |  |  |  | 
| Average Gross Loans, Net of Deferred Loan Fees | $ 2,349,660 | $ 2,456,883 | $ 2,924,722 | $ 2,544,472 | $ 3,157,133 | 
| Average Investment Securities | 350,954 | 223,709 | 182,635 | 215,280 | 188,325 | 
| Average Interest-Earning Assets | 2,961,297 | 2,989,762 | 3,291,042 | 2,981,878 | 3,611,009 | 
| Average Total Assets | 2,949,647 | 2,983,632 | 3,356,383 | 2,998,507 | 3,717,179 | 
| Average Deposits | 2,512,893 | 2,559,116 | 2,914,794 | 2,587,686 | 3,109,322 | 
| Average Borrowings | 237,702 | 239,992 | 244,704 | 243,690 | 341,514 | 
| Average Interest-Bearing Liabilities | 2,186,920 | 2,238,036 | 2,598,520 | 2,268,954 | 2,909,014 | 
| Average Stockholders’ Equity | 166,753 | 155,056 | 164,767 | 137,968 | 225,708 | 
| Average Tangible Equity | 164,381 | 152,417 | 161,169 | 135,171 | 221,537 | 
|  |  |  |  |  |  | 
| PERFORMANCE RATIOS  (Annualized): |  |  |  |  |  | 
| Return on Average Assets | 0.71% | (1.94)% | (4.24)% | (2.94)% | (3.29)% | 
| Return on Average Stockholders’ Equity | 12.64% | (37.30)% | (86.40)% | (63.79)% | (54.17)% | 
| Return on Average Tangible Equity | 12.82% | (37.94)% | (88.33)% | (65.11)% | (55.19)% | 
| Efficiency Ratio | 67.87% | 75.38% | 62.59% | 73.74% | 67.76% | 
| Net Interest Spread (1) | 3.07% | 3.07% | 2.99% | 3.15% | 2.28% | 
| Net Interest Margin (1) | 3.48% | 3.49% | 3.46% | 3.55% | 2.84% | 
|  |  |  |  |  |  | 
| ALLOWANCE FOR LOAN LOSSES: |  |  |  |  |  | 
| Balance at Beginning of Period | $ 176,063 | $ 176,667 | $ 124,768 | $ 144,996 | $ 70,986 | 
| Provision Charged to Operating Expense | 5,245 | 20,700 | 77,540 | 122,955 | 196,607 | 
| Charge-Offs, Net of Recoveries | (35,249) | (21,304) | (57,312) | (121,892) | (122,597) | 
| Balance at End of Period | $ 146,059 | $ 176,063 | $ 144,996 | $ 146,059 | $ 144,996 | 
|  |  |  |  |  |  | 
| Allowance for Loan Losses to Total Gross  Loans | 6.44% | 7.35% | 5.14% | 6.44% | 5.14% | 
| Allowance for Loan Losses to Total Non-Performing  Loans | 86.41% | 90.41% | 66.19% | 86.41% | 66.19% | 
|  |  |  |  |  |  | 
| ALLOWANCE FOR OFF-BALANCE SHEET  ITEMS: |  |  |  |  | 
| Balance at Beginning of Period | $ 3,662 | $ 2,362 | $ 4,416 | $ 3,876 | $ 4,096 | 
| Provision Charged to Operating Expense | (245) | 1,300 | (540) | (459) | (220) | 
| Balance at End of Period | $ 3,417 | $ 3,662 | $ 3,876 | $ 3,417 | $ 3,876 | 
|  |  |  |  |  |  | 
| (1) Amounts calculated on a fully  taxable equivalent basis using the current statutory federal tax  rate. | 
|  |  |  |  |  |  | 
|  | 
| HANMI FINANCIAL CORPORATION AND  SUBSIDIARIES | 
| SELECTED FINANCIAL DATA (UNAUDITED) (Continued) | 
| (Dollars in Thousands) | 
|  |  |  |  |  |  | 
|  | December 31, | September 30, | December 31, |  |  | 
|  | 2010 | 2010 | 2009 |  |  | 
| NON-PERFORMING ASSETS: |  |  |  |  |  | 
| Non-Accrual Loans | $ 169,028 | $ 194,729 | $ 219,000 |  |  | 
| Loans 90 Days or More Past Due and Still Accruing | — | — | 67 |  |  | 
| Total Non-Performing Loans | 169,028 | 194,729 | 219,067 |  |  | 
| Other Real Estate Owned, Net | 4,089 | 20,577 | 26,306 |  |  | 
| Total Non-Performing Assets | $ 173,117 | $ 215,306 | $ 245,373 |  |  | 
|  |  |  |  |  |  | 
| Total Non-Performing Loans/Total Gross  Loans | 7.45% | 8.13% | 7.77% |  |  | 
| Total Non-Performing Assets/Total Assets | 5.95% | 7.25% | 7.76% |  |  | 
| Total Non-Performing Assets/Allowance for Loan  Losses | 118.5% | 122.3% | 169.2% |  |  | 
|  |  |  |  |  |  | 
| DELINQUENT LOANS (Accrual Status) | $ 21,457 | $ 23,896 | $ 41,218 |  |  | 
|  |  |  |  |  |  | 
| Delinquent Loans (Accrual Status)/Total Gross  Loans | 0.95% | 1.00% | 1.46% |  |  | 
|  |  |  |  |  |  | 
| LOAN PORTFOLIO: |  |  |  |  |  | 
| Real Estate Loans | $ 856,527 | $ 885,734 | $ 1,043,097 |  |  | 
| Commercial and Industrial Loans (2) | 1,360,865 | 1,456,163 | 1,714,212 |  |  | 
| Consumer Loans | 50,300 | 53,237 | 63,303 |  |  | 
| Total Gross Loans | 2,267,692 | 2,395,134 | 2,820,612 |  |  | 
| Deferred Loan Fees | (566) | (843) | (1,552) |  |  | 
| Gross Loans, Net of Deferred Loan Fees | 2,267,126 | 2,394,291 | 2,819,060 |  |  | 
| Allowance for Loan Losses | (146,059) | (176,063) | (144,996) |  |  | 
| Loans Receivable, Net | $ 2,121,067 | $ 2,218,228 | $ 2,674,064 |  |  | 
|  |  |  |  |  |  | 
| LOAN MIX: |  |  |  |  |  | 
| Real Estate Loans | 37.8% | 37.0% | 37.0% |  |  | 
| Commercial and Industrial Loans | 60.0% | 60.8% | 60.8% |  |  | 
| Consumer Loans | 2.2% | 2.2% | 2.2% |  |  | 
| Total Gross Loans | 100.0% | 100.0% | 100.0% |  |  | 
|  |  |  |  |  |  | 
| DEPOSIT PORTFOLIO: |  |  |  |  |  | 
| Demand – Noninterest-Bearing | $ 546,815 | $ 559,764 | $ 556,306 |  |  | 
| Savings | 113,968 | 119,824 | 111,172 |  |  | 
| Money Market Checking and NOW Accounts | 402,481 | 422,564 | 685,858 |  |  | 
| Time Deposits of $100,000 or More | 1,118,621 | 1,126,760 | 815,190 |  |  | 
| Other Time Deposits | 284,836 | 298,474 | 580,801 |  |  | 
| Total Deposits | $ 2,466,721 | $ 2,527,386 | $ 2,749,327 |  |  | 
|  |  |  |  |  |  | 
| DEPOSIT MIX: |  |  |  |  |  | 
| Demand – Noninterest-Bearing | 22.2% | 22.1% | 20.2% |  |  | 
| Savings | 4.6% | 4.7% | 4.0% |  |  | 
| Money Market Checking and NOW Accounts | 16.3% | 16.7% | 24.9% |  |  | 
| Time Deposits of $100,000 or More | 45.3% | 44.6% | 29.7% |  |  | 
| Other Time Deposits | 11.6% | 11.9% | 21.2% |  |  | 
| Total Deposits | 100.0% | 100.0% | 100.0% |  |  | 
|  |  |  |  |  |  | 
| CAPITAL RATIOS (Bank Only): |  |  |  |  |  | 
| Total Risk-Based | 12.23% | 11.61% | 9.07% |  |  | 
| Tier 1 Risk-Based | 10.91% | 10.28% | 7.77% |  |  | 
| Tier 1 Leverage | 8.55% | 8.26% | 6.69% |  |  | 
| Tangible equity ratio | 8.60% | 8.37% | 7.13% |  |  | 
|  | 
| (2) Commercial and industrial loans  include owner-occupied property loans of $894.8 million, $967.9 million  and $1.12 billion as of December 31, 2010, September 30, 2010, and December 31,  2009, respectively. | 
|  | 
|  | 
| HANMI FINANCIAL CORPORATION AND  SUBSIDIARIES | 
| AVERAGE BALANCES, AVERAGE YIELDS EARNED  AND AVERAGE RATES PAID (UNAUDITED) | 
| (Dollars in Thousands) | 
|  | Three Months  Ended | 
|  | December 31, 2010 | September 30, 2010 | December 31,  2009 | 
|  | Average Balance | Interest Income/  Expense  | Average Yield/ Rate  | Average Balance | Interest Income/  Expense  | Average Yield/ Rate  | Average Balance | Interest Income/  Expense  | Average  Yield/ Rate  | 
|  |  |  |  |  |  |  |  |  |  | 
| INTEREST-EARNING ASSETS |  |  |  |  |  |  |  |  |  | 
| Loans: |  |  |  |  |  |  |  |  |  | 
| Real Estate Loans: |  |  |  |  |  |  |  |  |  | 
| Commercial Property | $ 746,868 | $ 10,144 | 5.39% | $ 773,589 | $ 10,638 | 5.46% | $ 861,831 | $ 11,872 | 5.47% | 
| Construction | 66,221 | 416 | 2.49% | 71,545 | 862 | 4.78% | 130,400 | 1,342 | 4.08% | 
| Residential Property | 63,716 | 747 | 4.65% | 67,291 | 805 | 4.75% | 80,257 | 997 | 4.93% | 
| Total Real Estate Loans | 876,805 | 11,307 | 5.12% | 912,425 | 12,305 | 5.35% | 1,072,488 | 14,211 | 5.26% | 
| Commercial and Industrial Loans  (1) | 1,421,369 | 20,435 | 5.70% | 1,490,811 | 20,611 | 5.49% | 1,787,795 | 25,472 | 5.65% | 
| Consumer Loans | 52,251 | 660 | 5.01% | 54,469 | 690 | 5.03% | 66,074 | 965 | 5.79% | 
| Total Gross Loans | 2,350,425 | 32,402 | 5.47% | 2,457,705 | 33,606 | 5.42% | 2,926,357 | 40,648 | 5.51% | 
| Prepayment Penalty Income | — | 64 | — | — | 75 | — | — | 162 | — | 
| Unearned Income on Loans, Net of Costs | (765) | — | — | (823) | — | — | (1,635) | — | — | 
| Gross Loans, Net | 2,349,660 | 32,466 | 5.48% | 2,456,882 | 33,681 | 5.44% | 2,924,722 | 40,810 | 5.54% | 
|  |  |  |  |  |  |  |  |  |  | 
| Investment Securities: |  |  |  |  |  |  |  |  |  | 
| Municipal Bonds (2) | 21,182 | 203 | 3.83% | 6,301 | 95 | 6.03% | 41,653 | 665 | 6.39% | 
| U.S. Government Agency Securities | 84,904 | 389 | 1.83% | 92,690 | 620 | 2.68% | 36,500 | 437 | 4.79% | 
| Mortgage-Backed Securities | 107,764 | 467 | 1.73% | 63,439 | 537 | 3.39% | 77,354 | 738 | 3.82% | 
| Collateralized Mortgage Obligations | 108,491 | 550 | 2.03% | 45,747 | 300 | 2.62% | 14,312 | 143 | 4.00% | 
| Corporate Bonds | 16,151 | 135 | 3.34% | 3,130 | 30 | 3.83% | 286 | — | 0.00% | 
| Other Securities | 12,462 | 110 | 3.53% | 12,402 | 103 | 3.32% | 12,530 | 97 | 3.10% | 
| Total Investment  Securities (2) | 350,954 | 1,854 | 2.11% | 223,709 | 1,685 | 3.01% | 182,635 | 2,080 | 4.56% | 
|  |  |  |  |  |  |  |  |  |  | 
| Other Interest-Earning Assets: |  |  |  |  |  |  |  |  |  | 
| Equity Securities | 35,883 | 135 | 1.50% | 36,568 | 135 | 1.48% | 40,605 | 136 | 1.34% | 
| Federal Funds Sold and Securities Purchased |  |  |  |  |  |  |  |  |  | 
| Under Resale Agreements | 8,239 | 11 | 0.53% | 6,932 | 8 | 0.46% | 51,713 | 65 | 0.50% | 
| Term Federal Funds Sold | 3,043 | 4 | 0.53% | 22,880 | 32 | 0.56% | 8,500 | 30 | 1.41% | 
| Interest-Bearing Deposits in Other Banks | 213,518 | 149 | 0.28% | 242,790 | 165 | 0.27% | 82,867 | 70 | 0.34% | 
| Total Other Interest-Earning  Assets | 260,683 | 299 | 0.46% | 309,170 | 340 | 0.44% | 183,685 | 301 | 0.66% | 
|  |  |  |  |  |  |  |  |  |  | 
| TOTAL INTEREST-EARNING  ASSETS (2) | $ 2,961,297 | $ 34,619 | 4.64% | $ 2,989,761 | $ 35,706 | 4.74% | $ 3,291,042 | $ 43,191 | 5.21% | 
|  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  | 
| INTEREST-BEARING LIABILITIES |  |  |  |  |  |  |  |  |  | 
| Interest-Bearing Deposits: |  |  |  |  |  |  |  |  |  | 
| Savings | $ 116,220 | $ 804 | 2.74% | $ 122,122 | $ 889 | 2.89% | $ 104,068 | $ 711 | 2.71% | 
| Money Market Checking and NOW Accounts | 414,773 | 1,003 | 0.96% | 429,601 | 1,094 | 1.01% | 733,063 | 3,508 | 1.90% | 
| Time Deposits of $100,000 or More | 1,127,027 | 4,736 | 1.67% | 1,133,970 | 5,059 | 1.77% | 835,726 | 4,930 | 2.34% | 
| Other Time Deposits | 291,198 | 1,049 | 1.43% | 312,351 | 1,257 | 1.60% | 680,959 | 4,261 | 2.48% | 
| Total Interest-Bearing Deposits | 1,949,218 | 7,592 | 1.55% | 1,998,044 | 8,299 | 1.65% | 2,353,816 | 13,410 | 2.26% | 
|  |  |  |  |  |  |  |  |  |  | 
| Borrowings: |  |  |  |  |  |  |  |  |  | 
| FHLB Advances | 153,693 | 339 | 0.88% | 153,777 | 342 | 0.88% | 160,754 | 412 | 1.02% | 
| Other Borrowings | 1,603 | — | 0.00% | 3,809 | 22 | 2.29% | 1,544 | — | 0.00% | 
| Junior Subordinated Debentures | 82,406 | 711 | 3.42% | 82,406 | 739 | 3.56% | 82,406 | 690 | 3.32% | 
| Total Borrowings | 237,702 | 1,050 | 1.75% | 239,992 | 1,103 | 1.82% | 244,704 | 1,102 | 1.79% | 
|  |  |  |  |  |  |  |  |  |  | 
| TOTAL INTEREST-BEARING LIABILITIES | $ 2,186,920 | $ 8,642 | 1.57% | $ 2,238,036 | $ 9,402 | 1.67% | $ 2,598,520 | $ 14,512 | 2.22% | 
|  |  |  |  |  |  |  |  |  |  | 
| NET INTEREST  INCOME (2) |  | $ 25,977 |  |  | $ 26,304 |  |  | $ 28,679 |  | 
|  |  |  |  |  |  |  |  |  |  | 
| NET INTEREST  SPREAD (2) |  |  | 3.07% |  |  | 3.07% |  |  | 2.99% | 
|  |  |  |  |  |  |  |  |  |  | 
| NET INTEREST  MARGIN (2) |  |  | 3.48% |  |  | 3.49% |  |  | 3.46% | 
|  |  |  |  |  |  |  |  |  |  | 
| (1) Commercial and industrial  loans include owner-occupied commercial real estate loans | 
| (2) Amounts calculated on a fully  taxable equivalent basis using the current statutory federal tax  rate. | 
|  | 
|  | 
| HANMI FINANCIAL CORPORATION AND  SUBSIDIARIES | 
| AVERAGE BALANCES, AVERAGE YIELDS EARNED  AND AVERAGE RATES PAID (UNAUDITED) | 
| (Dollars in Thousands) | 
|  | Year Ended | 
|  | December 31, 2010 | December 31,  2009 | 
|  | Average Balance  | Interest Income/ Expense  | Average Yield/ Rate  | Average Balance  | Interest Income/ Expense  | Average Yield/ Rate  | 
|  |  |  |  |  |  |  | 
| INTEREST-EARNING ASSETS |  |  |  |  |  |  | 
| Loans: |  |  |  |  |  |  | 
| Real Estate Loans: |  |  |  |  |  |  | 
| Commercial Property | $ 791,622 | $ 42,507 | 5.37% | $ 894,408 | $ 49,901 | 5.58% | 
| Construction | 82,827 | 3,618 | 4.37% | 156,619 | 5,947 | 3.80% | 
| Residential Property | 68,723 | 3,267 | 4.75% | 85,228 | 4,329 | 5.08% | 
| Total Real Estate Loans | 943,172 | 49,392 | 5.24% | 1,136,255 | 60,177 | 5.30% | 
| Commercial and Industrial Loans  (1) | 1,546,115 | 84,765 | 5.48% | 1,947,669 | 108,346 | 5.56% | 
| Consumer Loans | 56,121 | 2,937 | 5.23% | 74,700 | 4,310 | 5.77% | 
| Total Gross Loans | 2,545,408 | 137,094 | 5.39% | 3,158,624 | 172,833 | 5.47% | 
| Prepayment Penalty Income | — | 234 | — | — | 485 | — | 
| Unearned Income on Loans, Net of Costs | (936) | — | — | (1,491) | — | — | 
| Gross Loans, Net | 2,544,472 | 137,328 | 5.40% | 3,157,133 | 173,318 | 5.49% | 
|  |  |  |  |  |  |  | 
| Investment Securities: |  |  |  |  |  |  | 
| Municipal Bonds (2) | 10,655 | 535 | 5.02% | 54,448 | 3,543 | 6.51% | 
| U.S. Government Agency Securities | 69,112 | 1,952 | 2.82% | 24,417 | 1,108 | 4.54% | 
| Mortgage-Backed Securities | 72,985 | 2,071 | 2.84% | 77,627 | 3,320 | 4.28% | 
| Collateralized Mortgage Obligations | 45,245 | 1,092 | 2.41% | 21,365 | 879 | 4.11% | 
| Corporate Bonds | 4,860 | 165 | 3.40% | 271 | — | 0.00% | 
| Other Securities | 12,423 | 405 | 3.26% | 10,197 | 369 | 3.62% | 
| Total Investment  Securities (2) | 215,280 | 6,220 | 2.89% | 188,325 | 9,219 | 4.90% | 
|  |  |  |  |  |  |  | 
| Other Interest-Earning Assets: |  |  |  |  |  |  | 
| Equity Securities | 37,437 | 532 | 1.42% | 41,399 | 656 | 1.58% | 
| Federal Funds Sold and Securities Purchased |  |  |  |  |  |  | 
| Under Resale Agreements | 10,346 | 52 | 0.50% | 84,363 | 326 | 0.39% | 
| Term Federal Funds Sold | 8,342 | 33 | 0.40% | 95,822 | 1,718 | 1.79% | 
| Interest-Bearing Deposits in Other Banks | 166,001 | 468 | 0.28% | 43,967 | 151 | 0.34% | 
| Total Other Interest-Earning  Assets | 222,126 | 1,085 | 0.49% | 265,551 | 2,851 | 1.07% | 
|  |  |  |  |  |  |  | 
| TOTAL INTEREST-EARNING  ASSETS (2) | $ 2,981,878 | $ 144,633 | 4.85% | $ 3,611,009 | $ 185,388 | 5.13% | 
|  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  | 
| INTEREST-BEARING LIABILITIES |  |  |  |  |  |  | 
| Interest-Bearing Deposits: |  |  |  |  |  |  | 
| Savings | $ 119,754 | $ 3,439 | 2.87% | $ 91,089 | $ 2,328 | 2.56% | 
| Money Market Checking and NOW Accounts | 464,864 | 4,936 | 1.06% | 507,619 | 9,786 | 1.93% | 
| Time Deposits of $100,000 or More | 1,069,600 | 19,529 | 1.83% | 1,051,994 | 34,807 | 3.31% | 
| Other Time Deposits | 371,046 | 6,504 | 1.75% | 916,798 | 29,325 | 3.20% | 
| Total Interest-Bearing Deposits | 2,025,264 | 34,408 | 1.70% | 2,567,500 | 76,246 | 2.97% | 
|  |  |  |  |  |  |  | 
| Borrowings: |  |  |  |  |  |  | 
| FHLB Advances | 158,531 | 1,366 | 0.86% | 257,529 | 3,399 | 1.32% | 
| Other Borrowings | 2,753 | 53 | 1.93% | 1,579 | 2 | 0.13% | 
| Junior Subordinated Debentures | 82,406 | 2,811 | 3.41% | 82,406 | 3,271 | 3.97% | 
| Total Borrowings | 243,690 | 4,230 | 1.74% | 341,514 | 6,672 | 1.95% | 
|  |  |  |  |  |  |  | 
| TOTAL INTEREST-BEARING LIABILITIES | $ 2,268,954 | $ 38,638 | 1.70% | $ 2,909,014 | $ 82,918 | 2.85% | 
|  |  |  |  |  |  |  | 
| NET INTEREST  INCOME (2) |  | $ 105,995 |  |  | $ 102,470 |  | 
|  |  |  |  |  |  |  | 
| NET INTEREST  SPREAD (2) |  |  | 3.15% |  |  | 2.28% | 
|  |  |  |  |  |  |  | 
| NET INTEREST  MARGIN (2) |  |  | 3.55% |  |  | 2.84% | 
|  |  |  |  |  |  |  | 
| (1) Commercial and industrial  loans include owner-occupied commercial real estate loans | 
| (2) Amounts calculated on a fully  taxable equivalent basis using the current statutory federal tax  rate. | 
CONTACT: BRIAN E. CHO
         Chief Financial Officer
         (213) 368-3200
         DAVID YANG
         Investor Relations Officer
         (213) 637-4798
				
								
								
				
			
			 
		
			
			
			
				
				
				BASSETT, Va., Jan. 27, 2011 (GLOBE NEWSWIRE) — Bassett Furniture Industries,  Inc. (Nasdaq:BSET) announced today its results of operations for its fiscal  quarter ended November 27, 2010.
Consolidated sales for the quarter ended November 27, 2010 were $66.0 million  as compared to $59.5 million for the quarter ended November 28, 2009, an  increase of 10.9%. This sales increase was primarily driven by a 10.1% increase  in total wholesale shipments and increased sales at retail due primarily to  additional Company-owned stores. Gross margins for the fourth quarter of 2010  and 2009 were 48.3% and 46.5%, respectively. The margin increase was primarily a  result of the retail segment’s increased share of the overall sales mix,  partially offset by lower margins in both the wholesale and retail segments.  Selling, general and administrative expenses, excluding bad debt and notes  receivable valuation charges, increased $4.8 million for the fourth quarter of  2010 as compared to the fourth quarter of 2009, primarily due to the net  addition of 11 Company-owned retail stores since the fourth quarter of 2009. The  Company also recorded $1.4 million of bad debt and notes receivable valuation  charges during the fourth quarter of 2010 as compared to $2.2 million for the  fourth quarter of 2009, a $0.8 million decrease. The Company reported net income  of $1.9 million, or $0.17 per share, for the quarter ended November 27, 2010, as  compared to net income of $2.6 million, or $0.22 per share, for the quarter  ended November 28, 2009.
In order to better understand profitability trends related to on-going  operations, the Company’s management considers the effects of certain items on  results for the quarter. Accordingly, the results for the quarter ended November  27, 2010 included $0.5 million of proceeds from the Continued Dumping &  Subsidy Offset Act (CDSOA), and $0.8 million of periodic costs associated with  carrying idle retail facilities. The results for the quarter ended November 28,  2009 included a $1.7 million tax benefit associated with a one-time carryback of  net operating losses due to a change in tax law, $1.6 million of proceeds from  the CDSOA, pretax charges of $1.1 million associated with the closure of the  Company’s fiberboard manufacturing facility in Bassett, Va., $0.5 million  associated with the impairment of goodwill, $0.4 million associated with updates  to certain assumptions concerning existing lease termination accruals, and $0.5  million of periodic costs associated with carrying idle retail facilities.  Excluding these items, the net income for the quarter ended November 27, 2010  would have been $2.3 million as compared to net income of $1.7 million for the  quarter ended November 28, 2009. See the attached Reconciliation of Net Income  (Loss) as Reported to Net Income (Loss) as Adjusted.
“We are pleased to report an 11% sales increase for the fourth quarter of  2010,” said Robert H. Spilman Jr., President and CEO. “While we do not  believe that the overall pace of sales has improved significantly on an  industry-wide basis, we are making progress on several fronts to grow our top  line. This includes slight improvements in sales in our Company-owned retail  fleet, the addition of new accounts outside our store network, and improved  service levels on our imported products by virtue of our strategy to carry  higher levels of inventory on our key items. The profit that we generated during  the quarter resulted from a higher level of sales enhanced by an expense  structure that has been aggressively trimmed for several quarters. We are very  focused on doing everything that we can to generate future growth while  continuing to monitor our operating expenses.”
Wholesale Segment
Net sales for the wholesale segment were $49.3 million for the fourth quarter  of 2010 as compared to $44.8 million for the fourth quarter of 2009, an increase  of 10.1%. This increase is due to a 5.6% improvement in wholesale orders as  compared to the fourth quarter of 2009. Furthermore, shipments were increased to  bring down existing backlogs that had built up in the second and third quarters  of 2010 due to delays in receiving imported product from certain of the  Company’s overseas vendors. In an effort to mitigate the stock outages caused by  these delays and improve service levels to customers, the Company has increased  inventory levels during the second half of 2010. Approximately 55% of wholesale  shipments during the fourth quarter of 2010 were imported products compared to  approximately 50% for the fourth quarter of 2009. Gross margins for the  wholesale segment were 31.0% for the fourth quarter of 2010 as compared to 32.5%  for the fourth quarter of 2009. This decrease is primarily due to higher freight  costs on imported product during the fourth quarter of 2010, while the fourth  quarter of 2009 included a favorable adjustment to the last in, first out (LIFO)  inventory valuation reserves due to inventory reductions in that year. Wholesale  SG&A, excluding bad debt and notes receivable valuation charges, increased  $1.3 million, or 12.1%, for the fourth quarter of 2010 as compared to 2009. As a  percentage of net sales, SG&A increased 0.5 percentage points to 25.0% for  the fourth quarter of 2010 as compared to 24.5% for the fourth quarter of 2009.  The Company recorded $1.4 million of bad debt and notes receivable valuation  charges for the fourth quarter of 2010, as compared with $2.2 million for the  fourth quarter of 2009.
The wholesale backlog, representing orders received but not yet shipped to  dealers and company stores, was $12.5 million at November 27, 2010 as compared  with $10.3 million at November 28, 2009. The $2.2 million increase is primarily  due to the improvement in order levels as compared to the fourth quarter of  2009.
“As noted, we were able to reduce our backlog on imported wood items during  the quarter, which had a positive effect on our wholesale revenue,” continued  Mr. Spilman. “We were also able to generate a 5.6% increase in wholesale written  orders during the period. The introduction of our “Go To” program of  promotionally priced wood products at the High Point market was well received  and will be promoted aggressively in 2011. Those products will be stocked at our  three U.S. distribution centers and in our Asia warehouse. The domestic  upholstery product that we introduced last spring and are manufacturing at our  recently re-opened facility in Newton, NC is performing very well at retail and  already comprises approximately 15% of our total upholstery volume. We will  expand this assortment at the next High Point show as we seek to leverage our  superior U.S. value and service propositions to take market share.”
Retail Segment
At November 27, 2010, the total store network included 54 licensee-owned  stores and 47 Company-owned and operated stores. During the three months ended  November 27, 2010, the Company acquired certain assets of, and now operates one  additional licensee store, while another store acquired during the first quarter  of 2010 was closed at the end of the fourth quarter. The following table  summarizes the changes in store count during the year ended November 27,  2010:
|  | November 28, | New | Stores | Stores | November 27, | 
|  | 2009 | Stores | Acquired | Closed | 2010 | 
|  |  |  |  |  |  | 
| Company-owned stores | 36 | 2 | 11 | (2) | 47 | 
| Licensee-owned stores | 68 | – | (11) | (3) | 54 | 
|  |  |  |  |  |  | 
| Total | 104 | 2 | – | (5) | 101 | 
|  |  |  |  |  |  | 
The Company-owned stores had sales of $34.8 million in the fourth quarter of  2010 as compared to $27.5 million in the fourth quarter of 2009, an increase of  26.6%. The increase was comprised of a $7.1 million increase from the net  addition of 11 stores since the end of the fourth quarter of 2009, and a $0.2  million, or 0.7% increase in comparable store sales (“comparable” stores include  those locations that have been open and operated by the Company for all of each  comparable reporting period).
While the Company does not recognize sales until goods are delivered to the  customer, the Company’s management tracks written sales (the dollar value of  sales orders taken, rather than delivered) as a key store performance indicator.  Written sales for comparable stores decreased by 1.4% for the fourth quarter of  2010 as compared to the fourth quarter of 2009.
Gross margins for the quarter decreased 0.7 percentage points to 48.1% as  compared to the fourth quarter of 2009 primarily due to lower margins in the  recently acquired stores. SG&A increased $3.4 million from the fourth  quarter of 2009, primarily due to increased store count. On a comparable store  basis, gross margins decreased 0.1 percentage points to 48.8% and SG&A  decreased 1.3 percentage points to 50.1% for the fourth quarter of 2010 as  compared to the comparable 2009 period. Operating losses for the comparable  stores were reduced by 48.7% to $0.3 million. In all other stores (consisting of  the 14 stores which have been acquired, opened or closed during the twelve  months ended November 27, 2010), the operating loss was $0.5 million or 6.5% of  sales. This higher level of operating losses reflects the fact that several of  the acquired stores were struggling or failing at the time of acquisition. It  has generally taken six to 12 months of operations by corporate retail  management to either implement the changes necessary to improve performance in  the acquired stores or to make a final determination regarding the on-going  viability. Refer to the accompanying schedule of Supplemental Retail Information  for results of operations for the Company’s retail segment by comparable and all  other stores. The dollar value of retail backlog, representing orders received  but not yet shipped to customers, was $13.7 million, or an average of $291  thousand per open store, at November 27, 2010 as compared with $8.7 million, or  an average of $241 thousand per open store, at November 28, 2009.
“2010 was an extremely busy year in our corporate retail network,” added Mr.  Spilman. “The fact that we acquired 11 licensee stores, closed two existing  locations, and opened two new facilities while operating our existing stores  presented a tremendous challenge for our team. We were pleased with the 49% loss  reduction in our comparable stores during the quarter. Performance at this level  for the entire fleet is our goal and the fact that our 35 comparable stores  achieved it during the quarter is encouraging and significant. 2011 will also be  a challenge as we are currently closing four existing corporate stores and will  certainly acquire additional stores over the course of the year. We are also  seeking to expand our network with new stores in certain markets where we  currently operate. Despite the upheaval that store acquisitions and closings  have produced, our comp store operating performance improved again in 2010,  giving us the confidence that our corporate store network will continue to  contribute to the Company’s improving operating performance.”
Balance Sheet and Cash Flow
The Company generated $6.1 million of cash from operating activities during  the fourth quarter of 2010, primarily due to improved collections from wholesale  customers as order backlogs were reduced, tighter working capital management,  and the receipt of a $1.7 million Federal income tax refund associated with a  one-time carryback of net operating losses due to a change in tax law; the  benefit from which was recognized in earnings during the fourth quarter of 2009.  In addition to the $11.1 million of cash on-hand, the Company has investments of  $15.1 million, primarily consisting of $14.3 million in cash, money market  accounts, bond funds, and individual treasuries, and $0.8 million in a hedge  fund. Although the $14.3 million is primarily cash and other liquid assets, the  Company presents these as long-term assets as they are pledged as collateral for  the revolving debt agreement.
The Company has four mortgages totaling approximately $9.4 million that will  mature during the 12 month period following November 27, 2010. The Company  expects to satisfy these obligations through a variety of means, which may  include refinancing, drawing from its revolving credit facility, or paying from  cash on hand or future operating cash flow. However, there can be no assurance  that any of these strategies will be successful.
After having voluntarily repaid the outstanding balance of $15.0 million on  its revolving credit facility during the second quarter of 2010, the Company  ended the fourth quarter with no amounts outstanding. The facility, which  matured on November 30, 2010, has been extended until February 28, 2011. The  Company is continuing discussions with its bank regarding the amendment and  extension of the facility beyond its current maturity. While there can be no  assurance that these discussions will result in a favorable outcome, the Company  expects to have an amended and extended facility in place prior to February 28,  2011.
Potential Sale of the International Home Furnishings  Center
The Company also announced today that it is engaged in negotiations for the  sale of its 46.9% interest in International Home Furnishings Center, Inc.  (“IHFC”).  No definitive agreement for the sale has been reached. Any such sale  would be made only as part of the simultaneous sale of 100% of the ownership  interests in IHFC to the prospective purchaser. The Company is one of four  shareholders of IHFC.
“The proposed sale of IHFC offers us the opportunity to unlock value in a key  non-core asset that we believe is not currently fully recognized in the  Company’s stock price as well as to significantly strengthen our already strong  balance sheet,” said Mr. Spilman. “Although there can be no assurance that an  agreement among all of the required parties will be reached, we hope to complete  the sale by the end of February.”
About Bassett Furniture Industries, Inc.
Bassett Furniture Industries, Inc. (Nasdaq:BSET), is a leading manufacturer  and marketer of high quality, mid-priced home furnishings. With 101 licensee-  and company- owned stores, Bassett has leveraged its strong brand name in  furniture into a network of corporate and licensed stores that focus on  providing consumers with a friendly environment for buying furniture and  accessories. The most significant growth opportunity for Bassett continues to be  the Company’s dedicated retail store program. Bassett’s retail strategy includes  affordable custom-built furniture that is ready for delivery in the home within  30 days. The stores also feature the latest on-trend furniture styles, more than  750 upholstery fabrics, free in-home design visits, and coordinated decorating  accessories. For more information, visit the Company’s website at  bassettfurniture.com. (BSET-E)
Certain of the statements in this release, particularly those  preceded by, followed by or including the words “believes,” “expects,”  “anticipates,” “intends,” “should,” “estimates,” or similar expressions, or  those relating to or anticipating financial results for periods beyond the end  of the fourth quarter of fiscal 2010, constitute “forward looking statements”  within the meaning of Section 27A of the Securities Act of 1933, as amended. For  those statements, Bassett claims the protection of the safe harbor for forward  looking statements contained in the Private Securities Litigation Reform Act of  1995. In many cases, Bassett cannot predict what factors would cause actual  results to differ materially from those indicated in the forward looking  statements. Expectations included in the forward-looking statements are based on  preliminary information as well as certain assumptions which management believes  to be reasonable at this time. The following important factors affect Bassett  and could cause actual results to differ materially from those indicated in the  forward looking statements: the effects of national and global economic or other  conditions and future events on the retail demand for home furnishings and the  ability of Bassett’s customers and consumers to obtain credit; and the economic,  competitive, governmental and other factors identified in Bassett’s filings with  the Securities and Exchange Commission. Any forward-looking statement that  Bassett makes speaks only as of the date of such statement, and Bassett  undertakes no obligation to update any forward-looking statements, whether as a  result of new information, future events or otherwise. Comparisons of results  for current and any prior periods are not intended to express any future trends  or indication of future performance, unless expressed as such, and should only  be viewed as historical data.
| BASSETT FURNITURE INDUSTRIES, INC. AND  SUBSIDIARIES | 
| Condensed Consolidated Statements of Operations  – Unaudited | 
| (In thousands, except for per share  data) | 
|  |  |  |  |  |  |  |  |  | 
|  | Quarter Ended | Quarter Ended | Year Ended | Year Ended | 
|  | November 27, 2010 | November 28, 2009 | November 27, 2010 | November 28, 2009 | 
|  |  | Percent of |  | Percent of |  | Percent of |  | Percent of | 
|  | Amount | Net Sales | Amount | Net Sales | Amount | Net Sales | Amount | Net Sales | 
| Net sales | $ 65,991 | 100.0% | $ 59,523 | 100.0% | $ 235,254 | 100.0% | $ 232,722 | 100.0% | 
|  |  |  |  |  |  |  |  |  | 
| Cost of sales | 34,097 | 51.7% | 31,845 | 53.5% | 122,566 | 52.1% | 129,882 | 55.8% | 
|  |  |  |  |  |  |  |  |  | 
| Gross profit | 31,894 | 48.3% | 27,678 | 46.5% | 112,688 | 47.9% | 102,840 | 44.2% | 
|  |  |  |  |  |  |  |  |  | 
| Selling, general and administrative  expense excluding bad debt and notes receivable valuation charges | 29,660 | 44.9% | 24,850 | 41.7% | 110,808 | 47.1% | 103,789 | 44.6% | 
| Bad debt and notes receivable valuation charges | 1,431 | 2.2% | 2,241 | 3.8% | 6,567 | 2.8% | 15,205 | 6.5% | 
| Income from Continued Dumping & Subsidy Offset Act | (488) | -0.7% | (1,627) | -2.7% | (488) | -0.2% | (1,627) | -0.7% | 
| Restructuring and asset impairment charges | – | – | 1,599 | 2.7% | – | – | 2,987 | 1.3% | 
| Lease exit costs | – | – | 372 | 0.6% | – | – | 2,434 | 1.0% | 
|  |  |  |  |  |  |  |  |  | 
| Income (loss) from operations | 1,291 | 2.0% | 243 | 0.4% | (4,199) | -1.8% | (19,948) | -8.6% | 
|  |  |  |  |  |  |  |  |  | 
| Other income (loss), net | 556 | 0.8% | 825 | 1.4% | 1,991 | 0.8% | (4,505) | -1.9% | 
|  |  |  |  |  |  |  |  |  | 
| Income (loss) before income taxes | 1,847 | 2.8% | 1,068 | 1.8% | (2,208) | -0.9% | (24,453) | -10.5% | 
|  |  |  |  |  |  |  |  |  | 
| Income tax benefit | 94 | 0.1% | 1,498 | 2.5% | 206 | 0.1% | 1,754 | 0.8% | 
| Net income (loss) | $ 1,941 | 2.9% | $ 2,566 | 4.3% | $ (2,002) | -0.9% | $ (22,699) | -9.8% | 
|  |  |  |  |  |  |  |  |  | 
| Basic income (loss) per share | $ 0.17 |  | $ 0.22 |  | $ (0.17) |  | $ (1.99) |  | 
|  |  |  |  |  |  |  |  |  | 
| Diluted income (loss) per share | $ 0.17 |  | $ 0.22 |  | $ (0.17) |  | $ (1.99) |  | 
|  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  | 
| BASSETT FURNITURE INDUSTRIES, INC. AND  SUBSIDIARIES |  | 
| Condensed Consolidated Balance Sheets |  | 
| (In thousands) |  | 
|  |  | 
|  | (Unaudited) |  | 
| Assets | November 27, 2010 | November 28, 2009 | 
| Current assets |  |  | 
| Cash and cash equivalents | $ 11,071 | $ 23,221 | 
| Accounts receivable, net | 31,621 | 34,605 | 
| Inventories | 41,810 | 33,388 | 
| Other current assets | 6,969 | 13,312 | 
| Total current assets | 91,471 | 104,526 | 
|  |  |  | 
| Property and equipment |  |  | 
| Cost | 142,362 | 152,153 | 
| Less accumulated depreciation | 96,112 | 101,517 | 
| Property and equipment, net | 46,250 | 50,636 | 
|  |  |  | 
| Investments | 15,111 | 14,931 | 
| Retail real estate | 27,513 | 28,793 | 
| Notes receivable, net | 7,508 | 8,309 | 
| Other | 9,464 | 9,034 | 
|  | 59,596 | 61,067 | 
| Total assets | $ 197,317 | $ 216,229 | 
|  |  |  | 
| Liabilities and Stockholders’  Equity |  |  | 
| Current liabilities |  |  | 
| Accounts payable | $ 24,893 | $ 14,711 | 
| Accrued compensation and benefits | 6,652 | 6,490 | 
| Customer deposits | 9,171 | 5,946 | 
| Other accrued liabilities | 11,594 | 11,730 | 
| Current portion of real estate notes  payable | 9,521 | 4,393 | 
| Total current liabilities | 61,831 | 43,270 | 
|  |  |  | 
| Long-term liabilities |  |  | 
| Post employment benefit obligations | 11,004 | 10,841 | 
| Bank debt | – | 15,000 | 
| Real estate notes payable | 4,295 | 16,953 | 
| Distributions in excess of affiliate  earnings | 7,356 | 10,954 | 
| Other long-term liabilities | 6,526 | 8,877 | 
|  | 29,181 | 62,625 | 
|  |  |  | 
| Commitments and Contingencies |  |  | 
|  |  |  | 
| Stockholders’ equity |  |  | 
| Common stock | 57,795 | 57,274 | 
| Retained earnings | 48,459 | 50,461 | 
| Additional paid-in-capital | 478 | 481 | 
| Accumulated other comprehensive income | (427) | 2,118 | 
| Total stockholders’ equity | 106,305 | 110,334 | 
| Total liabilities and stockholders’  equity | $ 197,317 | $ 216,229 | 
|  |  |  | 
|  |  |  | 
| BASSETT FURNITURE INDUSTRIES, INC. AND  SUBSIDIARIES |  | 
| Consolidated Statements of Cash Flows –  Unaudited |  | 
| (In thousands) |  | 
|  | Year Ended | Year Ended | 
|  | November 27, 2010 | November 28, 2009 | 
| Operating activities: |  |  | 
| Net loss | $ (2,002) | $ (22,699) | 
| Adjustments to reconcile net loss to net cash provided by  operating activities: |  |  | 
| Depreciation and amortization | 5,966 | 6,604 | 
| Equity in undistributed income of investments and  unconsolidated affiliated companies | (4,737) | (2,319) | 
| Provision for restructuring and asset impairment  charges | – | 2,987 | 
| Lease exit costs | – | 2,434 | 
| Provision for lease and loan guarantees | 1,407 | 2,834 | 
| Provision for losses on accounts and notes  receivable | 6,567 | 15,205 | 
| Other than temporary impairment of investments | – | 1,255 | 
| Realized income from investments | (2,272) | (764) | 
| Payment to terminate lease | – | (400) | 
| Other, net | 504 | (2,364) | 
| Changes in operating assets and liabilities |  |  | 
| Accounts receivable | (4,467) | (6,744) | 
| Inventories | (5,443) | 11,704 | 
| Other current assets | 5,262 | 3,451 | 
| Accounts payable and accrued liabilities | 7,003 | (7,064) | 
| Net cash provided by operating  activities | 7,788 | 4,120 | 
|  |  |  | 
| Investing activities: |  |  | 
| Purchases of property and equipment | (2,013) | (1,096) | 
| Proceeds from sales of property and equipment | 4,247 | 129 | 
| Acquisition of retail licensee stores, net of cash  acquired | (378) | (481) | 
| Proceeds from sales of investments | 9,101 | 26,234 | 
| Purchases of investments | (8,851) | (6,939) | 
| Dividends from affiliates | 937 | 3,847 | 
| Net cash received on licensee notes | 494 | 645 | 
| Net cash provided by investing  activities | 3,537 | 22,339 | 
|  |  |  | 
| Financing activities: |  |  | 
| Net repayments under revolving credit facility | (15,000) | (4,000) | 
| Repayments of real estate notes payable | (7,530) | (812) | 
| Issuance of common stock | 142 | 95 | 
| Repurchases of common stock | – | (75) | 
| Cash dividends | – | (1,142) | 
| Payments on other notes | (1,087) | (1,081) | 
| Net cash used in financing  activities | (23,475) | (7,015) | 
| Change in cash and cash equivalents | (12,150) | 19,444 | 
| Cash and cash equivalents – beginning of  period | 23,221 | 3,777 | 
|  |  |  | 
| Cash and cash equivalents – end of  period | $ 11,071 | $ 23,221 | 
|  |  |  | 
|  |  |  | 
| BASSETT FURNITURE INDUSTRIES, INC. AND  SUBSIDIARIES | 
| Segment Information – Unaudited | 
| (In thousands) | 
|  |  |  |  |  |  |  |  |  | 
|  | Quarter ended |  | Quarter ended |  | Year Ended |  | Year Ended |  | 
|  | November 27, 2010 |  | November 28, 2009 |  | November 27, 2010 |  | November 28, 2009 |  | 
| Net Sales |  |  |  |  |  |  |  |  | 
| Wholesale | $ 49,322 | (a) | $ 44,803 | (a) | $ 176,255 | (a) | $ 179,534 | (a) | 
| Retail | 34,842 |  | 27,501 |  | 122,241 |  | 105,378 |  | 
| Inter-company elimination | (18,173) |  | (12,781) |  | (63,242) |  | (52,190) |  | 
| Consolidated | $ 65,991 |  | $ 59,523 |  | $ 235,254 |  | $ 232,722 |  | 
|  |  |  |  |  |  |  |  |  | 
| Operating Income (Loss) |  |  |  |  |  |  |  |  | 
| Wholesale | $ 1,561 | (b) | $ 1,340 | (b) | $ 2,431 | (b) | $ (9,100) | (b) | 
| Retail | (863) |  | (799) |  | (7,387) |  | (8,131) |  | 
| Inter-company elimination | 105 |  | 46 |  | 269 |  | 1,077 |  | 
| Income from CDSOA | 488 |  | 1,627 |  | 488 |  | 1,627 |  | 
| Restructuring and asset impairment charges | – |  | (1,599) |  | – |  | (2,987) |  | 
| Lease exit costs | – |  | (372) |  | – |  | (2,434) |  | 
| Consolidated | $ 1,291 |  | $ 243 |  | $ (4,199) |  | $ (19,948) |  | 
|  |  |  |  |  |  |  |  |  | 
| (a) Excludes wholesale shipments for dealers where  collectibility is not reasonably assured at time of shipment as follows: |  |  |  | 
|  | November 27, 2010 |  | November 28, 2009 |  |  |  |  |  | 
| Quarter ended | $ 85 |  | $ 174 |  |  |  |  |  | 
| Year ended | 947 |  | 7,149 |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  | 
| (b) Includes bad debt and notes receivable  valuation charges as follows: |  |  |  |  |  |  | 
|  | November 27, 2010 |  | November 28, 2009 |  |  |  |  |  | 
| Quarter ended | $ 1,431 |  | $ 2,241 |  |  |  |  |  | 
| Year Ended | 6,567 |  | 15,205 |  |  |  |  |  | 
|  | 
|  | 
| BASSETT FURNITURE INDUSTRIES, INC. AND  SUBSIDIARIES | 
| Reconciliation of Net Income (Loss) as Reported  to Net Income (Loss) as Adjusted (Unaudited) | 
| (In thousands, except for per share  data) | 
|  |  |  |  |  |  |  |  |  | 
|  | Quarter ended | Per | Quarter ended | Per | Year Ended | Per | Year Ended | Per | 
|  | November 27, 2010 | Share | November 28, 2009 | Share | November 27, 2010 | Share | November 28, 2009 | Share | 
|  |  |  |  |  |  |  |  |  | 
| Net income (loss) as reported | $ 1,941 | $ 0.17 | $ 2,566 | $ 0.22 | $ (2,002) | $ (0.17) | $ (22,699) | $ (1.99) | 
|  |  |  |  |  |  |  |  |  | 
| One-time tax benefit (1) | – | – | (1,672) | (0.15) | – | – | (1,672) | (0.15) | 
| Income from CDSOA | (488) | (0.04) | (1,627) | (0.14) | (488) | (0.04) | (1,627) | (0.14) | 
| Restructuring and asset impairment charges | – | – | 1,599 | 0.14 | – | – | 2,987 | 0.26 | 
| Lease exit costs | – | – | 372 | 0.03 | – | – | 2,434 | 0.21 | 
| Other than temporary impairment of securities | – | – | – | – | – | – | 1,255 | 0.11 | 
| Closed stores and idle retail facility charges | 804 | 0.07 | 450 | 0.04 | 2,256 | 0.20 | 2,062 | 0.18 | 
| Net income (loss) as adjusted | $ 2,257 | $ 0.20 | $ 1,688 | $ 0.14 | $ (234) | $ (0.01) | $ (17,260) | $ (1.51) | 
|  |  |  |  |  |  |  |  |  | 
| (1) $1.7 million tax benefit in 2009 associated  with the one-time carryback of net operating losses resulting from a change in  tax law. |  |  | 
The Company has included the “as adjusted” information because it  uses, and believes that others may use, such information in comparing the  Company’s operating results from period to period. The “as adjusted” information  is not presented in conformity with generally accepted accounting principals in  the United States. However, the items excluded in determining the “as adjusted”  information are significant components in understanding and assessing the  Company’s overall financial performance for the periods covered. 
|  | 
| BASSETT FURNITURE INDUSTRIES, INC. AND  SUBSIDIARIES | 
| Supplemental Retail Information –  Unaudited | 
| (In thousands) | 
|  |  |  |  |  |  |  |  |  | 
|  | 35 Comparable Stores | 27 Comparable Stores | 
|  | Quarter Ended | Quarter Ended | Year Ended | Year Ended | 
|  | November 27, 2010 | November 28, 2009 | November 27, 2010 | November 28, 2009 | 
|  |  | Percent of |  | Percent of |  | Percent of |  | Percent of | 
|  | Amount | Net Sales | Amount | Net Sales | Amount | Net Sales | Amount | Net Sales | 
|  |  |  |  |  |  |  |  |  | 
| Net sales | $ 26,928 | 100.0% | $ 26,734 | 100.0% | $ 82,063 | 100.0% | $ 86,131 | 100.0% | 
|  |  |  |  |  |  |  |  |  | 
| Cost of sales | 13,782 | 51.2% | 13,661 | 51.1% | 41,982 | 51.2% | 45,293 | 52.6% | 
|  |  |  |  |  |  |  |  |  | 
| Gross profit | 13,146 | 48.8% | 13,073 | 48.9% | 40,081 | 48.8% | 40,838 | 47.4% | 
|  |  |  |  |  |  |  |  |  | 
| Selling, general and administrative expense* | 13,492 | 50.1% | 13,747 | 51.4% | 43,288 | 52.8% | 46,279 | 53.7% | 
|  |  |  |  |  |  |  |  |  | 
| Loss from operations | $ (346) | -1.3% | $ (674) | -2.5% | $ (3,207) | -3.9% | $ (5,441) | -6.3% | 
|  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  | 
|  | All Other Stores | All Other Stores | 
|  | Quarter Ended | Quarter Ended | Year Ended | Year Ended | 
|  | November 27, 2010 | November 28, 2009 | November 27, 2010 | November 28, 2009 | 
|  |  | Percent of |  | Percent of |  | Percent of |  | Percent of | 
|  | Amount | Net Sales | Amount | Net Sales | Amount | Net Sales | Amount | Net Sales | 
|  |  |  |  |  |  |  |  |  | 
| Net sales | $ 7,914 | 100.0% | $ 767 | 100.0% | $ 40,178 | 100.0% | $ 19,247 | 100.0% | 
|  |  |  |  |  |  |  |  |  | 
| Cost of sales | 4,318 | 54.6% | 431 | 56.2% | 21,631 | 53.8% | 10,535 | 54.7% | 
|  |  |  |  |  |  |  |  |  | 
| Gross profit | 3,596 | 45.4% | 336 | 43.8% | 18,547 | 46.2% | 8,712 | 45.3% | 
|  |  |  |  |  |  |  |  |  | 
| Selling, general and administrative expense | 4,113 | 52.0% | 461 | 60.0% | 22,727 | 56.6% | 11,402 | 59.2% | 
|  |  |  |  |  |  |  |  |  | 
| Loss from operations | $ (517) | -6.5% | $ (125) | -16.3% | $ (4,180) | -10.4% | $ (2,690) | -14.0% | 
|  |  |  |  |  |  |  |  |  | 
| *Comparable store SG&A includes retail  corporate overhead and administrative costs. |  |  |  |  |  | 
CONTACT:  J. Michael Daniel, Vice-President
          and Chief Accounting Officer
          (276) 629-6614 - Investors
          Jay S. Moore, Director of
          Communications
          (276) 629-6450 - Media
				
								
								
				
			
			 
		
			
			
			
				
				
				DAQING, China, Jan. 24, 2011 /PRNewswire-Asia-FirstCall/ — China  Nutrifruit Group Limited (NYSE Amex: CNGL) (“China Nutrifruit” or “the  Company”), a leading producer of premium specialty fruit based products in China  (“PRC”), today announced that the Company entered into a supply contract (the  “Contract”) with Doehler Food and Beverage Ingredients (Rizhao) Co., Ltd.  (“Doehler Rizhao”) to supply 1,500 tons of its fruit concentrate products.
Doehler Rizhao, a subsidiary of DoehlerGroup, is a global consumer brand  which offers a variety of fruit concentrate juices, including apple, pear,  strawberry and kiwi juice concentrates. . Pursuant to the Contract, China  Nutrifruit will supply 1,500 tons of fruit concentrate products to Doehler  Rizhao in January 2011 at the prevailing market price.
“Our new supply contract with Doehler Rizhao marks an important milestone for  China Nutrifruit as we diversify our customer base with the addition of a global  consumer brand,” commented Mr. Changjun Yu, Chairman of China Nutrifruit. “Our  products passed stringent testing criteria and we are currently performing the  contract. We believe this demonstrates the high-quality and market acceptance of  our premium specialty fruit products. We are encouraged by our co-operation with  Doehler Rizhao and will continue to step up our marketing efforts to further  expand our customer base. We anticipate increased sales contribution from  international customers in fiscal year 2011 and are confident that our  nutritious specialty products will be well received in both the domestic and  international markets.”
About China Nutrifruit Group Limited 
Through its subsidiary Daqing Longheda Food Company Limited, China  Nutrifruit, is engaged in developing, processing, marketing and distributing a  variety of food products processed primarily from premium specialty fruits grown  in Northeast China, including golden berry, crab apple, blueberry, seabuckthorn,  blackcurrant and raspberry. The Company’s processing facility possesses ISO9001  and HACCP series qualifications. Currently, the Company has established an  extensive sales and distribution network throughout 17 provinces in China. For  more information, please visit http://www.chinanutrifruit.com
Forward-Looking Statements
This press release contains forward-looking statements within the meaning  of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the  Securities Exchange Act of 1934, as amended (the “Exchange  Act“”). Such statements include, among others, those concerning our supply contract with Doehler Rizhao, our ability to expand our  international customer base, our expectation regarding market  reception of our products, our expected financial performance in  FY2011 and strategic and operational plans,  as well as all assumptions,  expectations, predictions, intentions or beliefs about future events. You are  cautioned that any such forward-looking statements are not guarantees of future  performance and that a number of risks and uncertainties could cause actual  results of the Company to differ materially from those anticipated, expressed or  implied in the forward-looking statements. The words “believe,“ “expect,“ “anticipate,“ “project,“ “targets,“ “optimistic,“ “intend,“ “aim,“ “will“ or similar expressions are intended to  identify forward-looking statements. All statements other than statements of  historical fact are statements that could be deemed forward-looking statements.  Risks and uncertainties that could cause actual results to differ materially  from those anticipated include risks related to new and existing products; any  projections of sales, earnings, revenue, margins or other financial items; any  statements of the plans, strategies and objectives of management for future  operations; any statements regarding future economic conditions or performance;  uncertainties related to conducting business in China; any statements of belief  or intention; any of the factors mentioned in the “Risk  Factors“ section of our Annual Report on Form 10-K for the year  ended March 31, 2010, and other risks and uncertainties mentioned in our other  reports filed with the Securities and Exchange Commission. The Company assumes  no obligation and does not intend to update any forward-looking statements,  except as required by law.
| Company Contact: | Investor Relations Contact: |  | 
| Mr. Colman Cheng, Chief Financial Officer | Mr. Crocker Coulson, President |  | 
| China Nutrifruit Group Limited | CCG Investor Relations |  | 
| Tel:+ 852 9039 8111 | Tel: +1-646-213-1915 (NY office) |  | 
| Email: zsj@chinanutrifruit.com | Email: crocker.coulson@ccgir.com |  | 
| Website: www.chinanutrifruit.com | Website: www.ccgirasia.com |  | 
|  |  |  | 
|  | Elaine Ketchmere, Partner |  | 
|  | Tel: +1-310-954-1345 (LA office) |  | 
|  | Email: elaine.ketchmere@ccgir.com |  | 
|  |  | 
 
				
								
								
				
			
			 
		
			
			
			
				
				
				
SAN DIEGO, Jan. 24, 2011 /PRNewswire/ — Genoptix, Inc. (Nasdaq: GXDX)  announced today that it has entered into a definitive merger agreement to be  acquired by Novartis.  Under the terms of the merger agreement, Novartis will  commence an all cash tender offer for all outstanding shares of common stock of  Genoptix at USD$25.00 per share.  The transaction implies, on a fully-diluted  basis, a total equity value of approximately USD$470 million and an enterprise  value of USD$330 million.
The $25.00 per share cash offer price represents a premium of 39% over  Genoptix’ unaffected closing share price of $17.98 on December 13, 2010 and a  27% premium over the closing price of USD$19.76 on January 21, 2011.
Genoptix’ Chief Executive Officer, Tina S. Nova, Ph.D., stated, “We believe  this transaction provides substantial value and liquidity to our stockholders.  We are excited about becoming part of the Novartis Molecular Diagnostics (MDx)  unit and continuing to enhance the value that we bring to our core community  oncologist customers. We share Novartis’ strong commitment to transforming  patient care, improving health outcomes for patients and enhancing the suite of  diagnostic tools for our physician customers.”
Genoptix’ board of directors unanimously determined that the merger agreement  and the transactions contemplated thereby are fair to and in the best interests  of Genoptix and its stockholders, and recommends that Genoptix’ stockholders  tender their shares and adopt the merger agreement.
Each of Genoptix’ directors and executive officers has agreed to tender their  shares in the offer.
The transaction is conditioned upon the tender of at least a majority of the  shares of Genoptix in the tender offer, receipt of regulatory approvals and  other customary closing conditions.  The transaction is expected to close within  the first half of 2011.
The terms and conditions of the tender offer will be described in the tender  offer documents, which will be filed with the U.S. Securities and Exchange  Commission (“SEC”).
Barclays Capital is serving as financial advisor to Genoptix and Cooley LLP  is serving as Genoptix’ legal advisor.
About Genoptix, Inc.
Genoptix is a specialized laboratory service provider focused on delivering  personalized and comprehensive diagnostic services to community-based  hematologists and oncologists.  Genoptix is headquartered in Carlsbad,  California.
This press release is neither an offer to purchase nor a solicitation of  an offer to sell shares of Genoptix.  The tender offer for shares of Genoptix  described in this press release has not yet been commenced.  The offer to buy  shares of Genoptix common stock will be made only pursuant to the offer to  purchase and related materials that Novartis will file on Schedule TO with the  SEC. At the same time, Genoptix will file its recommendation of the tender offer  on Schedule 14D-9 with the SEC.  Genoptix stockholders and other investors  should read these materials carefully because they contain important  information, including the terms and conditions of the offer.   These materials  and any other documents filed by Novartis or Genoptix with the SEC may be  obtained free of charge at the SEC’s website at www.sec.gov and by contacting  Genoptix Investor Relations at 800-881-3100. In addition, investors and security  holders will be able to obtain free copies of the documents filed with the SEC  on Genoptix’ website at www.Genoptix.com. Investors and security holders are  urged to read the Schedule TO, as amended from time to time, and the  Schedule 14D-9, as amended from time to time, and the other relevant materials  before making any investment decision with respect to the tender offer.
Statements in this press release that relate to future results and events  are forward-looking statements based on Genoptix’ current expectations regarding  the tender offer and transactions contemplated by the merger agreement. Actual  results and events in future periods may differ materially from those expressed  or implied by these forward-looking statements because of a number of risks,  uncertainties and other factors. There can be no assurances that a transaction  will be consummated. Other risks, uncertainties and assumptions include the  possibility that expected benefits may not materialize as expected; that the  transaction may not be timely completed, if at all; that, prior to the  completion of the transaction, if at all, Genoptix may not satisfy one or more  closing conditions; that the merger agreement may be terminated; and the impact  of the current economic environment, fluctuations in operating results, market  acceptance of Genoptix’ services, and other risks that are described in  Genoptix’ Annual Report on Form 10-K for the year ended December 31, 2009, in  its most recent Quarterly Report of Form 10-Q and in its subsequently filed SEC  reports. Genoptix undertakes no obligation to update these forward-looking  statements except to the extent otherwise required by law.
SOURCE Genoptix, Inc.
 
 
				
								
								
				
			
			 
		
			
			
			
				
				
				ROANOKE, Va., Jan. 24, 2011 /PRNewswire/ — Optical Cable Corporation (Nasdaq  GM: OCCF) (“OCC®” or the “Company”) today announced financial results for its  fourth quarter and fiscal year ended October 31, 2010.
OCC’s consolidated net sales for fiscal year 2010 were the highest in the  Company’s history.
Fourth Quarter 2010 Financial Results
Consolidated net sales for the fourth quarter of fiscal year 2010 increased  31.1% to $18.5 million compared to net sales of $14.1 million for the comparable  period in fiscal year 2009.  Net sales in both the Company’s commercial market  and its specialty markets increased during the fourth quarter of fiscal year  2010 compared to the same period last year.  The acquisition of Applied Optical  Systems, Inc. (“AOS”) by OCC on October 31, 2009 also contributed to the net  sales growth achieved by the Company in the fourth quarter of fiscal year  2010.
Gross profit increased 47.9% to $7.2 million in the fourth quarter of fiscal  year 2010, compared to $4.8 million for the fourth quarter of fiscal year 2009.   Gross profit margin, or gross profit as a percentage of net sales, increased to  38.8% in the fourth quarter compared to 34.4% in the same period last year.
OCC recorded net income attributable to the Company of $1.5 million, or $0.23  per basic and diluted share, for the fourth quarter of fiscal year 2010,  compared to a net loss of $90,000, or $0.01 per basic and diluted share, for the  fourth quarter of fiscal year 2009.
During the fourth quarter of fiscal year 2010, OCC reversed a $666,000, or  $0.10 per share, goodwill impairment charge associated with a purchase  accounting adjustment in connection with the AOS acquisition.  Excluding the  positive impact that this goodwill impairment charge reversal had on income from  operations, the Company’s proforma net income attributable to OCC was $808,000,  or $0.13 per share, during the fourth quarter of fiscal year 2010.(1)
Fiscal Year 2010 Financial Results
Consolidated net sales increased 15.2% to $67.5 million in fiscal year 2010,  compared to $58.6 million in fiscal year 2009.  Net sales growth during the  fiscal year was achieved over a broad customer base and product mix, with  notable increases in both commercial and specialty markets, despite the  difficult economic environment.  The AOS acquisition also contributed to the net  sales growth achieved by the Company in fiscal year 2010.
Geographically, OCC achieved consolidated net sales growth both in  international markets and within the United States.  Net sales to customers  located outside of the United States increased 14.3% in fiscal year 2010  compared to the prior year, and net sales to customers located in the United  States increased 15.6%.
Gross profit increased 19.8% to $23.8 million for fiscal year 2010, compared  to $19.8 million for fiscal year 2009.  Gross profit margin, or gross profit as  a percentage of net sales, increased to 35.2% for fiscal year 2010 from 33.9%  for fiscal year 2009.
For fiscal year 2010, OCC recorded a net loss attributable to the Company of  $5.7 million, or $0.95 per basic and diluted share, compared to a net loss of  $1.9 million, or $0.34 per basic and diluted share, for fiscal year 2009.   Significantly contributing to the net loss for fiscal year 2010 was a  non-recurring, non-cash net impairment charge of $5.6 million recorded to  write-off the carrying value of the goodwill associated with the acquisition of  AOS.
Excluding the non-recurring, non-cash net goodwill impairment charge of $5.6  million, the Company would have reported a net loss attributable to OCC of  $153,000, or $0.03 per share, for fiscal year 2010.(2)
At the end of fiscal year 2010, OCC’s net book value attributable to OCC was  $27.9 million, or $4.44 per share.   In addition, OCC had a retained earnings  balance of $21.9 million, or $3.48 per share as of the end of the fiscal year.   OCC’s share price closed at $3.70 per share on Friday, January 21, 2011.
Management’s Comments
Neil Wilkin, President and Chief Executive Officer of OCC, said,  “During the fiscal fourth quarter, we built on OCC’s strong momentum to finish  the year with the highest net sales in our company’s history.  Importantly, we  generated record revenue by meeting the needs of our diverse, global customer  base, which is increasingly taking advantage of OCC’s comprehensive suite of  products and integrated solutions.  With our strategic acquisitions now  positively contributing to our bottom line results, we are focused on  maintaining our operational discipline and executing on our plan to grow sales  and earnings in order to create meaningful value for shareholders.”
Mr. Wilkin added, “In addition to achieving record sales, we are pleased to  have further strengthened our balance sheet and initiated a quarterly dividend  to provide a regular return of capital to our shareholders.  Despite challenging  economic and market conditions, we demonstrated OCC’s strength in 2010 and we  are confident in OCC’s strategy, market position and prospects for continued  growth and value creation in the future.”
Company Information
Optical Cable Corporation (“OCC”) is a leading manufacturer of a broad range  of fiber optic and copper data communications cabling and connectivity solutions  primarily for the enterprise market, offering an integrated suite of high  quality, warranted products which operate as a system solution or seamlessly  integrate with other providers’ offerings.  OCC’s product offerings include  designs for uses ranging from commercial, enterprise network, datacenter,  residential and campus installations to customized products for specialty  applications and harsh environments, including military, industrial, mining and  broadcast applications.  OCC products include fiber optic and copper cabling,  fiber optic and copper connectors, specialty fiber optic and copper connectors,  fiber optic and copper patch cords, pre-terminated fiber optic and copper cable  assemblies, racks, cabinets, datacom enclosures, patch panels, face plates,  multi-media boxes and other cable and connectivity management accessories, and  are designed to meet the most demanding needs of end-users, delivering a high  degree of reliability and outstanding performance characteristics.
OCC® is internationally recognized for pioneering the design and production  of fiber optic cables for the most demanding military field applications, as  well as of fiber optic cables suitable for both indoor and outdoor use, and  creating a broad product offering built on the evolution of these fundamental  technologies.  OCC also is internationally recognized for its role in  establishing copper connectivity data communications standards, through its  innovative and patented technologies.
Founded in 1983, OCC is headquartered in Roanoke, Virginia with offices,  manufacturing and warehouse facilities located in each of Roanoke, Virginia,  near Asheville, North Carolina and near Dallas, Texas.  OCC primarily  manufactures its fiber optic cables at its Roanoke facility which is ISO  9001:2008 registered and MIL-STD-790F certified, its enterprise connectivity  products at its Asheville facility which is ISO 9001:2008 registered, and its  military and harsh environment connectivity products and systems at its Dallas  facility which is ISO 9001:2008 registered and MIL-STD-790F certified.
Optical Cable Corporation, OCC®, Superior Modular Products, SMP Data  Communications, Applied Optical Systems, and associated logos are trademarks of  Optical Cable Corporation.
Further information about OCC is available on the Internet at  www.occfiber.com.
FORWARD-LOOKING INFORMATION
This news release by Optical Cable Corporation and its subsidiaries  (collectively, the “Company” or “OCC”) may contain certain forward-looking  information within the meaning of the federal securities laws. The  forward-looking information may include, among other information, (i) statements  concerning our outlook for the future, (ii) statements of belief, anticipation  or expectation, (iii) future plans, strategies or anticipated events, and (iv)  similar information and statements concerning matters that are not historical  facts. Such forward-looking information is subject to variables, uncertainties,  contingencies and risks that may cause actual events to differ materially from  our expectations, and furthermore, such variables, uncertainties, contingencies  and risks may also adversely affect Optical Cable Corporation and its  subsidiaries, the Company’s future results of operations and future financial  condition, and/or the future equity value of the Company.  Factors that could  cause or contribute to such differences from our expectations or could adversely  affect the Company include, but are not limited to:  the level of sales to key  customers, including distributors; timing of certain projects and purchases by  key customers; the economic conditions affecting network service providers;  corporate and/or government spending on information technology; actions by  competitors; fluctuations in the price of raw materials (including optical  fiber, copper, gold and other precious metals, and plastics and other materials  affected by petroleum product pricing); fluctuations in transportation costs;  our dependence on customized equipment for the manufacture of our products and a  limited number of production facilities; our ability to protect our proprietary  manufacturing technology; our ability to replace royalty income as existing  patented and licensed products expire by developing and licensing new products;  market conditions influencing prices or pricing; our dependence on a limited  number of suppliers; the loss of, or conflict with, one or more key suppliers or  customers; an adverse outcome in litigation, claims and other actions, and  potential litigation, claims and other actions against us; an adverse outcome in  regulatory reviews and audits and potential regulatory reviews and audits;  adverse changes in state tax laws and/or positions taken by state taxing  authorities affecting us; technological changes and introductions of new  competing products; changes in end-user preferences for competing technologies,  relative to our product offering; economic conditions that affect the  telecommunications sector, certain technology sectors or the economy as a whole;  changes in demand of our products from certain competitors for which we provide  private label connectivity products; terrorist attacks or acts of war, and any  current or potential future military conflicts; changes in the level of military  spending by the United States government; ability to retain key personnel;  inability to recruit needed personnel; poor labor relations; the inability to  successfully complete the integration of the operations of our new subsidiaries;  the impact of changes in accounting policies and related costs of compliance,  including changes by the Securities and Exchange Commission (SEC), the Public  Company Accounting Oversight Board (PCAOB), the Financial Accounting Standards  Board (FASB), and/or the International Accounting Standards Board (IASB); our  ability to continue to successfully comply with, and the cost of compliance  with, the provisions of Section 404 of the Sarbanes-Oxley Act of 2002 or any  revisions to that act which apply to us; the impact of changes and potential  changes in federal laws and regulations adversely affecting our business and/or  which result in increases in our direct and indirect costs, including our direct  and indirect costs of compliance with such laws and regulations; the impact of  the Patient Protection and Affordable Care Act of 2010, the Health Care and  Education Reconciliation Act of 2010, and any revisions to those acts that apply  to us and the related legislation and regulation associated with those acts,  which directly or indirectly results in increases to our costs; the impact of  changes in state or federal tax laws and regulations increasing our costs;  impact of future consolidation among competitors and/or among customers  adversely affecting our position with our customers and/or our market position;  actions by customers adversely affecting us in reaction to the expansion of our  product offering in any manner, including, but not limited to, by offering  products that compete with our customers, and/or by entering into alliances  with, making investments in or with, and/or acquiring parties that compete with  and/or have conflicts with customers of ours; voluntary or involuntary delisting  of the Company’s capital stock from any exchange on which it is traded; the  deregistration by the Company from SEC reporting requirements, as a result of  the small number of holders of the Company’s capital stock; adverse reactions by  customers, vendors or other service providers to unsolicited proposals regarding  the ownership or management of the Company; the additional costs of considering  and possibly defending our position on such unsolicited proposals; impact of  weather or natural disasters in the areas of the world in which we operate and  market our products; an increase in the number of the Company’s capital stock  issued and outstanding; economic downturns and/or changes in market demand,  exchange rates, productivity, or market and economic conditions in the areas of  the world in which we operate and market our products; and our success in  managing the risks involved in the foregoing.  The foregoing is not intended to  be complete and the Company is subject to other variables, uncertainties,  contingencies and risks than those set forth above.
(1)  This reversal of a goodwill impairment charge partially reduces the $6.2  million non-cash, non-recurring goodwill impairment charge recorded by the  Company during the second quarter of fiscal year 2010.  The purchase accounting  adjustment made during the fourth quarter was primarily the result of the  Company’s adjustment to the valuation of certain deferred tax assets acquired in  the purchase of AOS, and is not a result of a re-evaluation of the goodwill  impairment recorded during the second quarter of fiscal year 2010.  There is no  tax benefit associated with the reversal of the goodwill impairment charge in  the fourth quarter, as it is considered a non-deductible permanent item for tax  purposes.  Accordingly, there is no change to the tax expense as reported for  fourth quarter of fiscal year 2010 in determining the proforma net loss and net  loss per share.
(2)  This proforma net loss attributable to OCC and proforma net loss per  share attributable to OCC are calculated by excluding the non-cash,  non-recurring net impairment of goodwill charge of $5.6 million that was  recorded during fiscal year 2010 from the Company’s net loss attributable to OCC  as reported for the fiscal year ended October 31, 2010.  The net goodwill  impairment charge of $5.6 million during fiscal year 2010 consists of (i) a $6.2  million goodwill impairment charge recognized during the second quarter of  fiscal year 2010 and (ii) a $666,000 reversal of the goodwill charge associated  with a purchase accounting adjustment recognized during the fourth quarter of  fiscal year 2010.  There is no tax benefit associated with the goodwill  impairment charge, as it is considered a non-deductible permanent item for tax  purposes.  Accordingly, there is no change to the tax expense as reported for  fiscal year 2010 in determining the proforma net loss and net loss per  share.
(Financial Tables Follow)
| OPTICAL CABLE CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF  OPERATIONS (thousands, except per share  data) (unaudited) |  | 
|  | Three Months Ended October 31, | Fiscal Year Ended October 31, |  | 
|  | 2010 |  | 2009 |  | 2010 |  | 2009 |  | 
|  |  |  |  |  |  |  |  |  | 
| Net sales | $        18,464 |  | $       14,080 |  | $      67,506 |  | $      58,589 |  | 
| Cost of goods sold | 11,298 |  | 9,233 |  | 43,746 |  | 38,748 |  | 
|  |  |  |  |  |  |  |  |  | 
| Gross profit | 7,166 |  | 4,847 |  | 23,760 |  | 19,841 |  | 
| SG&A expenses | 6,028 |  | 5,336 |  | 24,268 |  | 22,345 |  | 
| Royalty income, net | (309) |  | (198) |  | (1,233) |  | (878) |  | 
| Amortization of intangible  assets | 146 |  | 199 |  | 587 |  | 825 |  | 
| Impairment of goodwill | (666) |  | – |  | 5,580 |  | – |  | 
| Impairment of intangible assets (other  than goodwill) | – |  | 153 |  | – |  | 344 |  | 
|  |  |  |  |  |  |  |  |  | 
| Income (loss) from  operations | 1,967 |  | (643) |  | (5,442) |  | (2,795) |  | 
|  |  |  |  |  |  |  |  |  | 
| Interest income (expense), net | (157) |  | 653 |  | (542) |  | 149 |  | 
| Other, net | (3) |  | (9) |  | 65 |  | 16 |  | 
| Other income (expense), net | (160) |  | 644 |  | (477) |  | 165 |  | 
|  |  |  |  |  |  |  |  |  | 
| Income (loss) before income  taxes | 1,807 |  | 1 |  | (5,919) |  | (2,630) |  | 
|  |  |  |  |  |  |  |  |  | 
| Income tax expense (benefit) | 455 |  | 91 |  | 91 |  | (706) |  | 
|  |  |  |  |  |  |  |  |  | 
| Net income (loss) | $         1,352 |  | $           (90) |  | $      (6,010) |  | $      (1,924) |  | 
|  |  |  |  |  |  |  |  |  | 
| Net loss attributable to noncontrolling |  |  |  |  |  |  |  |  | 
| interest (2) | (122) |  | – |  | (277) |  | – |  | 
|  |  |  |  |  |  |  |  |  | 
| Net income (loss) attributable to  OCC | $         1,474 |  | $           (90) |  | $       (5,733) |  | $       (1,924) |  | 
|  |  |  |  |  |  |  |  |  | 
| Net income (loss) per share attributable  to |  |  |  |  |  |  |  |  | 
| OCC:  Basic and diluted | $             0.23 |  | $        (0.01) |  | $          (0.95) |  | $        (0.34) |  | 
|  |  |  |  |  |  |  |  |  | 
| PROFORMA net income (loss) attributable  to OCC, EXCLUDING impairment of goodwill (1) | $              808 |  |  |  | $         (153) |  |  |  | 
| PROFORMA net income (loss) per share  attributable to OCC, EXCLUDING impairment of goodwill: Basic and diluted  (1) | $            0.13 |  |  |  | $         (0.03) |  |  |  | 
|  |  | 
|  |  |  |  |  |  |  |  | 
 
| OPTICAL CABLE CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF  OPERATIONS (continued) (thousands, except per share  data) (unaudited) |  | 
|  | Three Months Ended October 31, | Fiscal Year Ended October 31, |  | 
|  | 2010 |  | 2009 |  | 2010 |  | 2009 |  | 
|  |  |  |  |  |  |  |  |  | 
| Weighted average shares  outstanding: |  |  |  |  |  |  |  |  | 
| Basic and diluted | 6,388 |  | 6,543 |  | 6,015 |  | 5,656 |  | 
|  |  |  |  |  |  |  |  |  | 
| (1) Proforma net income (loss) attributable to  OCC and proforma net income (loss) per share attributable to OCC are calculated  by excluding the non-cash, non-recurring net impairment of goodwill charge of  $5.6 million associated with the acquisition of Applied Optical Systems, Inc.  (“AOS”) that was recorded during fiscal year 2010 from the Company’s net loss  attributable to OCC as reported for the fiscal year ended October 31, 2010.  The  goodwill impairment charge of $5.6 million consists of (i) a $6.2 million  goodwill impairment charge recognized during the second quarter of fiscal year  2010 and (ii) a $666,000 reversal of the goodwill charge associated with a  purchase accounting adjustment recognized during the fourth quarter of fiscal  year 2010.   The purchase accounting adjustment made during the fourth quarter  was primarily the result of the Company’s adjustment to the valuation of certain  deferred tax assets acquired in the purchase of AOS, and is not a result of a  re-evaluation of the goodwill impairment recorded during the second quarter of  fiscal year 2010.  There is no tax benefit associated with the goodwill  impairment charge, as it is considered a non-deductible permanent item for tax  purposes.  Accordingly, there is no change to the tax expense as reported for  fiscal year 2010 in determining the proforma net loss and net loss per  share. (2) Accounting Standards Codification 810-10,  Consolidation (“ASC 810-10“), was adopted by OCC effective for  fiscal year 2010 as it relates to noncontrolling interests.  There are no  noncontrolling interest amounts presented for fiscal year 2009 since the  minority interest’s share of losses attributable to Centric Solutions LLC was  charged against the Company’s majority interest in accordance with the previous  accounting literature. |  | 
|  |  |  |  |  |  |  |  | 
 
| OPTICAL CABLE CORPORATION CONDENSED CONSOLIDATED BALANCE SHEET  DATA (thousands) (unaudited) |  | 
|  | October 31, 2010 | October 31, 2009 |  | 
| Cash and cash equivalents | $            2,522 |  | $          1,948 |  | 
| Trade accounts receivable, net | 10,660 |  | 9,533 |  | 
| Inventories | 14,423 |  | 12,306 |  | 
| Other current assets | 3,062 |  | 3,915 |  | 
| Total current assets | 30,667 |  | 27,702 |  | 
| Non-current assets | 14,624 |  | 22,625 |  | 
| Total assets | $          45,291 |  | $        50,327 |  | 
|  |  |  |  |  | 
| Current liabilities | $            7,762 |  | $          7,632 |  | 
| Non-current liabilities | 9,949 |  | 9,438 |  | 
| Total liabilities | 17,711 |  | 17,070 |  | 
| Total shareholders’ equity attributable to OCC | 27,857 |  | 33,257 |  | 
| Noncontrolling interest (a) | (277) |  | – |  | 
| Total shareholders’ equity | 27,580 |  | 33,257 |  | 
| Total liabilities and shareholders’ equity | $          45,291 |  | $        50,327 |  | 
| (a)  ASC 810-10, Consolidation, was adopted by OCC  effective for fiscal year 2010 as it relates to noncontrolling interests.  There  are no noncontrolling interest amounts presented for fiscal year 2009 since the  minority interest’s share of losses attributable to Centric Solutions LLC was  charged against the Company’s majority interest in accordance with the previous  accounting literature. |  | 
|  |  |  |  |  |  | 
 
|  |  |  | 
| AT THE COMPANY: |  |  | 
|  |  |  | 
| Neil Wilkin | Tracy Smith |  | 
| Chairman, President & CEO | Senior Vice President & CFO |  | 
| (540) 265-0690 | (540) 265-0690 |  | 
| investorrelations@occfiber.com | investorrelations@occfiber.com |  | 
|  |  |  | 
| AT JOELE FRANK, WILKINSON BRIMMER  KATCHER: |  |  | 
|  |  |  | 
| Andrew Siegel | Aaron Palash |  | 
| (212) 355-4449 ext. 127 | (212) 355-4449 ext. 103 |  | 
| occf-jfwbk@joelefrank.com | occf-jfwbk@joelefrank.com | 
 
				
								
								
				
			
			 
		
			
			
			
				
				
				Jan. 24, 2011 (Business Wire) — Clinical Data, Inc. (NASDAQ: CLDA), today  announced that the U.S. Food and Drug Administration (FDA) has approved  vilazodone HCl tablets, to be marketed under the brand name Viibryd™, for the  treatment of adults with major depressive disorder (MDD).1 Viibryd is  a new molecular entity and the first and only selective serotonin reuptake  inhibitor and 5HT1A receptor partial agonist.1 Clinical  Data plans to make Viibryd available in U.S. pharmacies in the second quarter of  this year.
U.S. Food and Drug Administration Approves Viibryd(TM)  (vilazodone HCl tablets) for Major Depressive Disorder (see accompanying press  release for details)(Photo: Business Wire)
 
“When treating MDD, our goal is to offer treatment options that meet the  individual needs of each patient,” said Stephen M. Stahl, M.D., Ph.D., Professor  of Psychiatry, University of California, San Diego. “Viibryd is an important new  treatment option with proven efficacy and a demonstrated safety profile.”
The mechanism of the antidepressant effect of Viibryd is not fully understood  but is thought to be related to its enhancement of serotonergic activity in the  central nervous system (CNS) through selective inhibition of serotonin reuptake.  Viibryd is also a partial agonist at serotonergic 5HT1A receptors;  however, the net result of this action on serotonergic transmission and its role  in Viibryd’s antidepressant effect are unknown.1
The efficacy of Viibryd as a treatment for MDD was established in two 8-week,  multicenter, randomized, double-blind, placebo-controlled studies in adults who  met the criteria for MDD. In these studies, patients were titrated over two  weeks to a dose of 40 mg of Viibryd once daily. Viibryd was superior to placebo  in the improvement of depressive symptoms as measured by the mean change from  baseline to week 8 in the Montgomery-Asberg Depression Rating Scale (MADRS)  total score.
Viibryd was demonstrated to be safe in clinical studies. In the  placebo-controlled, Phase III studies, the most commonly observed adverse  reactions in Viibryd-treated patients were diarrhea, nausea, vomiting and  insomnia. No single adverse event led to discontinuation of treatment in greater  than 1% of patients. Overall, 7.1% of the patients who received Viibryd  discontinued treatment due to an adverse reaction, compared to 3.2% of  placebo-treated patients. Viibryd has not been associated with any clinically  important changes in laboratory test parameters including liver function tests,  ECG including QT interval, or vital signs. In addition, Viibryd had no effect on  body weight as measured by mean change from baseline in the 8-week studies.  Among the common adverse reactions (≥2%) related to sexual function with Viibryd  compared to placebo were decreased libido (4% vs. <1%), abnormal orgasm (3%  vs. 0%), delayed ejaculation (2% vs. 0%, males only), and erectile dysfunction  (2% vs. 1%, males only).1
“While there are currently available treatments for MDD, no one therapy works  for every patient and side effect profiles vary, which may impact both  compliance and treatment success,” said Carol R. Reed M.D., Executive Vice  President and Chief Medical Officer of Clinical Data. “Viibryd will be a new  choice for healthcare providers and their patients who are suffering from  depression.”
“Viibryd is the only antidepressant that is a selective serotonin reuptake  inhibitor and 5HT1A receptor partial agonist,” said Drew Fromkin,  President and CEO of Clinical Data. “It is also the first drug that the Company  has developed, and to have received marketing approval from the FDA on its first  review is a significant milestone for Clinical Data.”
About Depression
Major depressive disorder (MDD), also called major depression, is a mental  disorder characterized by an imbalance of chemicals in the brain, also called  neurotransmitters, and is one of the most common mental disorders in the U.S. A  person diagnosed with MDD exhibits a combination of symptoms that interfere with  one’s ability to work, sleep, study, eat, and enjoy once–pleasurable activities.  Though an episode of depression may occur only once in a person’s life, it more  commonly recurs throughout a person’s lifetime.2
The World Health Organization estimates that MDD affects approximately 18  million people in the U.S.3 More than 212 million prescriptions were  written for antidepressants in 2009.4
About Viibryd (vilazodone HCl tablets)
Viibryd was approved for marketing by the FDA on January 21, 2011 for the  treatment of MDD in adults. Clinical Data holds exclusive worldwide rights to  Viibryd from Merck KGaA, Darmstadt, Germany. The safety of Viibryd was evaluated  in 2,177 patients diagnosed with MDD.
Important Information About Viibryd
Indication
VIIBRYD (vilazodone) is indicated for the treatment of major depressive  disorder (MDD) in adults.1
Important Safety Information
WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS
Antidepressants increased the risk compared to placebo of suicidal  thinking and behavior (suicidality) in children, adolescents, and young adults  in short-term studies of Major Depressive Disorder (MDD) and other psychiatric  disorders. Anyone considering the use of VIIBRYD or any other  antidepressant in a child, adolescent, or young adult must balance this risk  with the clinical need. Short-term studies did not show an increase in  the risk of suicidality with antidepressants compared to placebo in adults  beyond age 24; there was a reduction in risk with antidepressants compared to  placebo in adults aged 65 and older. Depression and certain other  psychiatric disorders are themselves associated with increases in the risk of  suicide. Patients of all ages who are started on antidepressant therapy  should be monitored appropriately and observed closely for clinical worsening,  suicidality, or unusual changes in behavior. Families and caregivers  should be advised of the need for close observation and communication with the  prescriber. VIIBRYD is not approved for use in pediatric  patients.1
Contraindications
VIIBRYD must not be used concomitantly in patients taking MAOIs or in  patients who have taken MAOIs within the preceding 14 days due to the risk of  serious, sometimes fatal, drug interactions with serotonergic drugs. Allow at  least 14 days after stopping VIIBRYD before starting an MAOI.1
Warnings and Precautions
- All patients treated with antidepressants should be  monitored appropriately and observed closely for clinical worsening,  suicidality, and unusual changes in behavior, especially during the first few  months of treatment and when changing the dose. Consider changing the  therapeutic regimen, including possibly discontinuing the medication, in  patients whose depression is persistently worse or includes symptoms of anxiety,  agitation, panic attacks, insomnia, irritability, hostility, aggressiveness,  impulsivity, akathisia, hypomania, mania, or suicidality that are severe, abrupt  in onset, or were not part of the patient’s presenting symptoms.1 Families and caregivers of patients being treated with antidepressants should  be alerted about the need to monitor patients.1
- The development of potentially life-threatening  serotonin syndrome or Neuroleptic Malignant Syndrome (NMS)-like reactions has  been reported with antidepressants alone, but particularly with concomitant use  of serotonergic drugs (including triptans) with drugs which impair metabolism of  serotonin (including MAOIs), or with antipsychotics or other dopamine  antagonists. Symptoms of serotonin syndrome were noted in 0.1% of patients  treated with VIIBRYD. Serotonin syndrome symptoms may include mental status  changes (e.g., agitation, hallucinations, coma), autonomic instability (e.g.,  tachycardia, labile blood pressure, hyperthermia), neuromuscular aberrations  (e.g., hyperreflexia, incoordination) and/or gastrointestinal symptoms (e.g.,  nausea, vomiting, diarrhea). Patients should be monitored for the emergence of  serotonin syndrome or NMS-like signs and symptoms while treated with  VIIBRYD.1
- Symptoms of mania/hypomania were noted in 0.1% of  patients treated with VIIBRYD in clinical studies. As with all antidepressants,  VIIBRYD should be used cautiously in patients with a history or family history  of mania or hypomania.1
- Prior to initiating treatment with an antidepressant,  patients with depressive symptoms should be adequately screened to determine if  they are at risk for bipolar disorder. VIIBRYD is not approved for use in  treating bipolar depression.1
- Discontinuation symptoms have been reported with  discontinuation of serotonergic drugs such as VIIBRYD. Gradual dose reduction is  recommended, instead of abrupt discontinuation, whenever possible. Monitor  patients for these symptoms when discontinuing VIIBRYD. If intolerable symptoms  occur following a dose decrease or upon discontinuation of treatment, consider  resuming the previously prescribed dose and decreasing the dose at a more  gradual rate.1
- Like other antidepressants, VIIBRYD should be  prescribed with caution in patients with a seizure disorder.1
- The use of drugs that interfere with serotonin  reuptake, including VIIBRYD, may increase the risk of bleeding events. Patients  should be cautioned about the risk of bleeding associated with the concomitant  use of VIIBRYD and NSAIDs, aspirin, or other drugs that affect coagulation or  bleeding.1
- Advise patients that if they are treated with  diuretics, or are otherwise volume depleted, or are elderly they may be at  greater risk of developing hyponatremia while taking VIIBRYD.1 Although no cases of hyponatremia resulting from VIIBRYD treatment were reported  in the clinical studies, hyponatremia has occurred as a result of treatment with  SSRIs and SNRIs. Discontinuation of VIIBRYD in patients with symptomatic  hyponatremia and appropriate medical intervention should be  instituted.1
Adverse Reactions
- The most commonly observed adverse reactions in MDD  patients treated with VIIBRYD in placebo-controlled studies (incidence ≥ 5% and  at least twice the rate of placebo) were: diarrhea (28% vs. 9%), nausea (23% vs.  5%), insomnia (6% vs. 2%), and vomiting (5% vs. 1%).1
Please see full prescribing information for VIIBRYD at www.viibryd.com. To report suspected adverse reactions, please  call Clinical Data, Inc. at 1-877-878-7200 or the FDA at 1-800-FDA-1088 / www.fda.gov/medwatch.
VIIBRYD™ is a trademark of Clinical Data, Inc. and its affiliates.
Conference Call Information
Date: Monday, January 24, 2011
Time: 8:30 a.m. ET
Internet: The live webcast can be accessed at www.clda.com, in the Investor  Relations section.
Telephone: Domestic dial (800) 535-7056; International dial (212) 729-5049  (access code: 39633801)
About Clinical Data, Inc.
Clinical Data’s mission is to develop first-in-class and best-in-category  therapeutics. The Company’s lead product, Viibryd, was approved for marketing by  the FDA for the treatment of major depressive disorder in adults. The Company is  also advancing its late-stage drug candidate, Stedivaze, a pharmacologic stress  agent in Phase III development for use during myocardial perfusion imaging.  Clinical Data has promising drug candidates entering the clinic in major  therapeutic areas including asthma, ophthalmology and diabetes. To learn more,  please visit the Company’s website at www.clda.com.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT  OF 1995
This press release contains certain forward-looking information and  statements that are intended to be covered by the safe harbor for forward  looking statements provided by the Private Securities Litigation Reform Act of  1995. Forward-looking statements are statements that are not historical facts.  Words such as “expect(s)”, “feel(s)”, “believe(s)”, “will”, “may”,  “anticipate(s)” and similar expressions are intended to identify forward-looking  statements. These statements include, but are not limited to, statements about  our ability to successfully introduce Viibryd; our ability to expand our  long-term business opportunities; and all other statements regarding future  performance. All such information and statements are subject to certain risks  and uncertainties, the effects of which are difficult to predict and generally  beyond the control of the Company, that could cause actual results to differ  materially from those expressed in, or implied or projected by, the  forward-looking information and statements contained in this press release.  These risks and uncertainties include, but are not limited to, whether Viibryd  will be successfully marketed; the strength of our intellectual property rights,  including, but not limited to, our patents for the various polymorphic versions  of Viibryd; competition from pharmaceutical and biotechnology companies; general  economic conditions; and those risks identified and discussed by Clinical Data  in its filings with the U.S. Securities and Exchange Commission. Readers are  cautioned not to place undue reliance on these forward looking statements that  speak only as of the date hereof. Clinical Data does not undertake any  obligation to publish revised forward-looking statements to reflect events or  circumstances after the date hereof or to reflect the occurrence of  unanticipated events. Readers are also urged to carefully review and consider  the various disclosures in Clinical Data’s SEC periodic and interim reports,  including but not limited to its Annual Report on Form 10-K for the fiscal year  ended March 31, 2010, Quarterly Report on Form 10-Q for the fiscal quarter ended  September 30, 2010, and Current Reports on Form 8-K filed from time to time by  the Company.
# # #
1 Viibryd Label.
2 http://www.nimh.nih.gov/health/publications/depression/what-are-the-different-forms-of-depression.shtml
3 Greden, John F. The Burden of Recurrent Depression: Causes,  Consequences, and Future Prospects, Journal of Clinical Psychiatry, 2001.
4 IMS Health’s National Prescription Audit, 2009.
Photos/Multimedia Gallery Available:  http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6582380&lang=en

Clinical Data, Inc.
Vice President
Corporate  Communications
Theresa McNeely, 617-467-6673
or
Media  inquiries:
Ruder Finn Public Relations
Trina Chiara, 860  673-4017
				
								
								
				
			
			 
		
			
			
			
				
				
				
NEW YORK, Jan. 21, 2011 /PRNewswire/ — CleanTech Innovations, Inc. (Nasdaq:  CTEK), a U.S. company and a market leader in China’s clean technology solutions  in the wind energy industry, announced today that CleanTech has signed two  initial wind tower supply contracts totaling US$11 million (RMB 72,732,000,  including VAT tax) with a subsidiary of China HuaNeng Group, the largest energy  company in China. CleanTech will supply these wind towers to HuaNeng in 2011.  HuaNeng has been a long-standing customer of CleanTech. China HuaNeng Group  posted US$35 billion in revenue for 2010 and had total assets of US$99  billion.
The completion of the $20 million in bridge financing with institutional  investors on December 13, 2010, made it possible for CleanTech to submit  contract bids to HuaNeng before the December 18, 2010 bidding deadline.
CleanTech has submitted other contract bids to HuaNeng and other large energy  companies in China. CleanTech anticipates winning additional wind tower supply  contracts throughout 2011.
Bei Lu, Chairman & CEO of CleanTech commented: “These two recent  contracts represent approximately 50% of our entire 2010 revenues.  The new  contracts are critical to meeting our 2011 revenue targets in a favorable market  environment. CleanTech’s management team is also the founders of our company. As  CleanTech has already disclosed publicly, our entire management and insider  holdings are locked up and prohibited from any share sales for at least 3 years  through December 2013. CleanTech management’s vested interest is completely  aligned with those of our public shareholders. We look forward to delivering  another year of record earnings growth in 2011.”
Large state-owned energy companies such as HuaNeng are the final customers  and integrators of the wind energy industry in China. Topping the five major  power producers in China, HuaNeng accounts for 11.9% of domestic power capacity,  and 17% of China’s clean energy capacity. In 2010, HuaNeng accounted for 12.8%  of China’s total power generation.
About CleanTech Innovations, Inc.
CleanTech Innovations, Inc. (Nasdaq: CTEK) is a U.S. public company with its  primary operations in China. CleanTech designs and manufactures high performance  clean technology products that promote renewable energy generation, energy  savings and pollution reduction. CleanTech’s products include wind turbine  towers, bellows expansion joints and pressure vessels, which are broadly used in  the wind power, steel, coking, petrochemical, high voltage electricity  transmission and thermoelectric industries. CleanTech’s longstanding customers  include China Guodian, HuaNeng Energy, Sinosteel and other industrial companies.
Safe Harbor Statement
All statements in this press release that are not historical are  forward-looking statements made pursuant to the “safe harbor” provisions of the  Private Securities Litigation Reform Act of 1995. There can be no assurance that  actual results will not differ from the company’s expectations. You are  cautioned not to place undue reliance on any forward-looking statements in this  press release as they reflect CleanTech’s current expectations with respect to  future events and are subject to risks and uncertainties that may cause actual  results to differ materially from those contemplated. Potential risks and  uncertainties include, but are not limited to, the risks described in  CleanTech’s filings with the Securities and Exchange Commission.
| Corporate Contact |  | 
| Mr. Jason Li |  | 
| Corporate Communications |  | 
| CleanTech Innovations, Inc. |  | 
| Tel: 011-86- 157-1403-7180 |  | 
| Email: investors@ctiproduct.com |  | 
| Website: www.ctiproduct.com |  | 
|  | 
 
SOURCE CleanTech Innovations, Inc.
 
 
				
								
								
				
			
			 
		
			
			
			
				
				
				Jan. 21, 2011 (Business Wire) — Online Resources Corporation (Nasdaq: ORCC),  a leading provider of online financial services, today announced that its Board  of Directors is evaluating unsolicited expressions of interest in potential  business combinations that it has received from third parties. The Board is  considering these alternatives against the long-term strategic growth plan that  it recently approved in order to determine whether there is now an option that  can deliver greater shareholder value. Under the strategic plan, the Company has  enhanced its management team and is currently investing in technology, products  and organizational structure to drive revenue growth and margin improvement.
“Since I arrived as CEO in June, we have worked diligently to develop a  long-term plan to put Online Resources back on the path to sustainable growth by  investing in new ways to provide exceptional value to our customers,” said  Joseph Cowan, President and Chief Executive Officer of Online Resources. “We  have a robust and unique set of core assets at Online Resources, and I believe  that with the strong team we have in place, we can deliver against the  objectives defined in the plan. However, because we have also been approached by  other parties, the Company has an obligation to examine other potential  value-creating alternatives that may now exist for our shareholders.”
Given this announcement, the Company is postponing its 2011 analyst and  investor day event, previously scheduled for Thursday, January 27, 2011. Online  Resources currently hopes to provide additional information or commentary in  conjunction with the release of its financial results for the fourth quarter of  fiscal 2010, planned for early March. However, no specific timetable has been  set for completion of this evaluation and there can be no assurance that any  transaction will result from the process. Online Resources does not intend to  make any further comment until its evaluation is complete.
The Company has retained Raymond James & Associates, Inc. as its  financial advisor and Kirkland & Ellis LLP as its legal counsel.
About Online Resources
Online Resources (Nasdaq: ORCC) powers financial interactions between  millions of consumers and the Company’s financial institution and biller  clients. Backed by its proprietary real-time payments gateway that links banks  directly with billers, the Company provides web and phone-based financial  services, electronic payments and marketing services to drive consumer adoption.  Founded in 1989, Online Resources is the largest financial technology provider  dedicated to the online channel. For more information, visit www.orcc.com.
This news release contains statements about future events and  expectations, which are “forward-looking statements.” Any statement in this  release that is not a statement of historical fact may be deemed to be a  forward-looking statement. Such forward-looking statements involve known and  unknown risks, uncertainties and other factors which may cause the company’s  actual results, performance or achievements to be materially different from any  future results, performance or achievements expressed or implied by such  forward-looking statements. Specifically factors that might cause such a  difference include, but are not limited to: the company’s history of losses and  anticipation of future losses; the company’s dependence on the marketing efforts  of third parties; the potential fluctuations in the company’s operating results;  the company’s potential need for additional capital; the company’s potential  inability to expand the company’s services and related products in the event of  substantial increases in demand for these services and related products; the  company’s competition; the company’s ability to attract and retain skilled  personnel; the company’s reliance on the company’s patents and other  intellectual property; the early stage of market adoption of the services it  offers; consolidation of the banking and financial services industry; and those  risks and uncertainties discussed in filings made by the company with the  Securities and Exchange Commission, including those risks and uncertainties  contained under the heading “Risk Factors” in the company’s Form 10-K, latest  10-Q, and S-3 as filed with the Securities and Exchange Commission. These  factors should be considered in evaluating the forward-looking statements, and  undue reliance should not be placed on such statements.

Online Resources Corporation
Media Contact:
Beth  Halloran
Sr. Dir., Corp. Communications
703-653-2248
bhalloran@orcc.com
or
Investor  Contact:
Catherine Graham
EVP & Chief Financial  Officer
703-653-3155
cgraham@orcc.com
 
				
								
								
				
			
			 
		
			
			
			
				
				
				GOLETA, Calif., Jan. 20, 2011 (GLOBE NEWSWIRE) — Community West Bancshares  (“Community West”), (Nasdaq:CWBC – News), parent company of  Community West Bank, today reported net income of $1.1 million in the fourth  quarter of 2010 (4Q10), compared to net income of $97,000 in the fourth quarter  a year ago (4Q09). The loan loss provision in 4Q10 was $1.3 million compared to  $2.8 million in 4Q09. For the full year, Community West reported net income of  $2.1 million, compared to a net loss of $5.8 million for 2009. The loan loss  provision for all of 2010 was $8.7 million compared to $18.7 million in  2009.
“We are extremely pleased by our positive operating results in 2010,” stated  Lynda J. Nahra, President and Chief Executive Officer. “We have improved across  all areas of the Bank and continue to benefit from strong core earnings, net  interest margin expansion and stabilizing asset quality. Our net interest income  and noninterest income both increased during the fourth quarter compared to the  fourth quarter a year ago, while our provision for loan losses has decreased.  Additionally, our nonperforming loans declined during the quarter and remain at  workable levels.”
2010 Financial Highlights
- Net income applicable to common stockholders was $795,000, or $0.11 per  diluted common share in 4Q10.
- For the year, net income applicable to common stockholders was $1.0 million,  or $0.18 per diluted common share.
- Net interest margin was 4.57% in 4Q10, a 39 basis point improvement compared  to 4Q09.
- For the year, net interest margin was 4.50%, a 59 basis point improvement  compared to 2009.
- Core deposits increased by 29.5% compared to a year ago.
- Nonperforming loans were $12.7 million, or 2.13% of total loans at 12/31/10,  compared to $15.1 million, or 2.51% of total loans, at 9/30/10.
- The total allowance for loan losses/total loans held for investment was  2.60% at 12/31/10 compared to 2.64% at 9/30/10.
- Community West Bank’s Total risk-based capital ratio was 12.87%, Tier 1  risk-based capital ratio was 11.61% and Tier 1 leverage ratio was 9.24% at  12/31/10.
In 4Q10, including the $262,000 preferred stock dividends, the net income  applicable to common stockholders was $795,000, or $0.11 per diluted share,  compared to a net loss applicable to common stockholders of $165,000, or $0.03  per diluted share, in 4Q09. For the full year, the net income applicable to  common stockholders was $1,044,000, or $0.18 per diluted share, compared to a  net loss applicable to common stockholders of $6.8 million, or $1.15 per diluted  share, a year ago.
Income Statement Review
“Improvement in our funding costs led to continued net interest margin  expansion,” said Charles G. Baltuskonis, EVP and Chief Financial Officer. In  4Q10, the net interest margin was 4.57% compared to 4.49% in 3Q10 and 4.18% in  4Q09. For the full year, the net interest margin increased 59 basis points to  4.50% from 3.91% in 2009.
Fourth quarter net interest income increased 5.6% to $7.4 million compared to  $7.1 million in 4Q09. For the year, net interest income increased 12.8% to $29.3  million compared to $26.0 million a year ago. Non-interest income increased  18.6% to $1.2 million in 4Q10, compared to $1.0 million in 4Q09. For the year,  there was a modest decline in loan servicing fees due to lower SBA sold loan  balances and lack of new loan sales.
Non-interest expenses were $5.6 million in 4Q10, compared to $5.1 million in  4Q09. The increase in operating costs was primarily attributable to higher costs  related to problem credits. For the year, non-interest expenses improved 2.3% to  $21.0 million compared to $21.5 million for 2009.
For 2010, the efficiency ratio improved by 11.2% to 63.5% compared to 71.0% a  year ago.
Credit Quality
Nonperforming loans totaled $12.7 million, or 2.13% of total loans at  December 31, 2010, compared to $15.1 million or 2.51% of total loans three  months earlier and $16.2 million, or 2.62% of total loans a year ago. Real  estate owned and repossessed assets totaled $8.5 million at December 31, 2010  compared to $5.5 million at September 30, 2010 and $1.8 million a year ago. Of  the $12.7 million in total nonperforming loans, $5.9 million or 46.7% were real  estate loans, $4.2 million or 33.0% were SBA loans, $1.9 million or 15.1% were  manufactured housing loans, $602,000 or 4.8% were commercial loans and $52,000  or 0.4% were other installment loans.
“The decrease in the provision for loan losses was the direct result of the  improving asset quality trends as well as real estate valuations stabilizing,”  said Nahra. The loan loss provision was $1.3 million in 4Q10 compared to $1.5  million in 3Q10 and $2.8 million in 4Q09. The allowance for loan losses totaled  $13.3 million at year-end, equal to 2.60% of total loans held for investment,  compared to 2.64% at September 30, 2010 and 2.67% a year ago.
Community West had net charge-offs of $1.4 million in 4Q10 compared to $2.0  million in 3Q10 and $2.3 million in 4Q09.
Balance Sheet
Total loans decreased from a year ago as loan demand has softened,  particularly in the commercial and SBA loan sectors. Total loans were $593.9  million at December 31, 2010 compared to $617.2 million a year ago.
Real estate loans outstanding decreased 4.9%, or $9.9 million, from year ago  levels to $192.5 million at December 31, 2010, and comprise 32.4% of the total  loan portfolio. Manufactured housing loans were down slightly from year ago  levels to $194.7 million and represent 32.8% of total loans. Commercial loans  were down 7.2% compared to a year ago and now represent 9.7% of the total loan  portfolio and SBA loans decreased 7.5% from a year ago and now represent 21.7%  of the total loan portfolio. Other installment loans increased 13.5% from year  ago levels and represent 3.5% of the total loan portfolio.
“Our deposit strategy is focused on the growth of core and business deposits  while reducing our reliance on wholesale funding,” said Baltuskonis. “As a  result, core deposits grew $14.0 million for the quarter and $72.6 million for  the year.”
Total deposits were $529.9 million at December 31, 2010 compared to $531.4  million a year earlier. Non-interest-bearing accounts were $35.8 million at  December 31, 2010 compared to $37.7 million a year ago. Interest-bearing  accounts increased 36.8% to $262.4 million compared to $191.9 million a year  ago. Core deposits, defined as non-interest-bearing, interest-bearing and  savings accounts, increased 29.5% to $318.6 million at year-end, compared to  $246.0 million a year earlier while certificates of deposit decreased 26.0% over  the same period to $211.3 million, compared to $285.4 million a year  earlier.
Total assets were $667.6 million at year-end, compared to $684.2 million a  year earlier. Stockholders’ equity was $61.6 million at year-end, compared to  $60.3 million a year earlier and book value per common share was $7.92 at  year-end compared to $7.74 a year earlier.
Capital Management
In August, Community West completed its public offering of $8,085,000 of 9%  convertible subordinated debentures. Proceeds from the offering further  strengthened the capital position of the Company and support its strategic  growth opportunities.
Company Overview
Community West Bancshares is a financial services company with headquarters  in Goleta, California. The Company is the holding company for Community West  Bank, which has five full-service California branch banking offices, in Goleta,  Santa Barbara, Santa Maria, Ventura and Westlake Village. The principal business  activities of the Company are Relationship banking, Mortgage lending and SBA  lending.
Safe Harbor Disclosure
This release contains forward-looking statements that reflect management’s  current views of future events and operations. These forward-looking statements  are based on information currently available to the Company as of the date of  this release. It is important to note that these forward-looking statements are  not guarantees of future performance and involve risks and uncertainties,  including, but not limited to, the ability of the Company to implement its  strategy and expand its lending operations.
| COMMUNITY WEST  BANCSHARES | 
| CONDENSED CONSOLIDATED INCOME  STATEMENTS | 
| (unaudited) | 
| (in 000’s, except per share data) | 
|  |  |  |  |  |  | 
|  | Three Months Ended | Twelve Months Ended | 
|  | December 31, 2010
 | September 30, 2010
 | December 31, 2009
 | December 31, 2010
 | December 31, 2009
 | 
|  |  |  |  |  |  | 
| Interest income | $ 9,862 | $ 9,727 | $ 10,108 | $ 39,234 | $ 40,903 | 
| Interest expense | 2,419 | 2,419 | 3,058 | 9,957 | 14,945 | 
| Net interest income | 7,443 | 7,308 | 7,050 | 29,277 | 25,958 | 
| Provision for loan losses | 1,279 | 1,518 | 2,788 | 8,743 | 18,678 | 
| Net interest income after provision for loan losses
 | 6,164 | 5,790 | 4,262 | 20,534 | 7,280 | 
| Non-interest income | 1,220 | 1,023 | 1,029 | 4,015 | 4,418 | 
| Non-interest expenses | 5,588 | 5,035 | 5,124 | 20,991 | 21,479 | 
|  |  |  |  |  |  | 
| Income (Loss) before income taxes | 1,796 | 1,778 | 167 | 3,558 | (9,781) | 
| Provision for income taxes | 739 | 733 | 70 | 1,467 | (4,018) | 
|  |  |  |  |  |  | 
| NET INCOME (LOSS) | $ 1,057 | $ 1,045 | $ 97 | $ 2,091 | $ (5,763) | 
|  |  |  |  |  |  | 
| Preferred stock dividends | 262 | 261 | 262 | 1,047 | 1,046 | 
|  |  |  |  |  |  | 
| NET INCOME (LOSS) APPLICABLE TO COMMON SHAREHOLDERS
 | $ 795 | $ 784 | $ (165) | $ 1,044 | $ (6,809) | 
|  |  |  |  |  |  | 
| Earnings (Loss) per common share: |  |  |  |  | 
| Basic | $ 0.13 | $ 0.13 | $ (0.03) | $ 0.18 | $ (1.15) | 
| Diluted | 0.11 | 0.12 | (0.03) | 0.18 | (1.15) | 
|  | 
| COMMUNITY WEST  BANCSHARES | 
| CONDENSED CONSOLIDATED BALANCE  SHEETS | 
| (unaudited) | 
| (in 000’s, except per share data) | 
|  |  |  |  | 
|  | December 31, 2010
 | September 30, 2010
 | December 31, 2009
 | 
|  |  |  |  | 
| Cash and cash equivalents | $ 6,226 | $ 12,332 | $ 5,511 | 
| Interest-earning deposits in other financial  institutions | 290 | 475 | 640 | 
| Investment securities | 40,235 | 39,186 | 40,348 | 
| Loans: |  |  |  | 
| Commercial | 57,369 | 55,120 | 61,810 | 
| Commercial real estate | 173,906 | 175,700 | 180,688 | 
| SBA | 128,721 | 131,366 | 139,113 | 
| Manufactured housing | 194,682 | 196,451 | 195,656 | 
| Single family real estate | 13,739 | 13,873 | 14,821 | 
| HELOC | 20,273 | 20,544 | 17,902 | 
| Consumer | 379 | 363 | 287 | 
| Mortgage loans held for sale | 4,865 | 7,223 | 6,896 | 
| Total loans | 593,934 | 600,640 | 617,173 | 
|  |  |  |  | 
| Loans, net |  |  |  | 
| Held for sale | 82,320 | 93,643 | 102,574 | 
| Held for investment | 511,614 | 506,997 | 514,599 | 
| Less: Allowance | (13,302) | (13,395) | (13,733) | 
| Net held for investment | 498,312 | 493,602 | 500,866 | 
| NET LOANS | 580,632 | 587,245 | 603,440 | 
|  |  |  |  | 
| Other assets | 40,221 | 37,232 | 34,277 | 
|  |  |  |  | 
| TOTAL ASSETS | $ 667,604 | $ 676,470 | $ 684,216 | 
|  |  |  |  | 
| Deposits |  |  |  | 
| Non-interest-bearing | $ 35,767 | $ 39,140 | $ 37,703 | 
| Interest-bearing | 262,431 | 246,576 | 191,905 | 
| Savings | 20,371 | 18,848 | 16,396 | 
| CDs over 100K | 163,118 | 170,130 | 173,594 | 
| CDs under 100K | 48,206 | 60,979 | 111,794 | 
| Total Deposits | 529,893 | 535,673 | 531,392 | 
| Other borrowings | 72,081 | 76,085 | 89,000 | 
| Other liabilities | 3,988 | 3,930 | 3,517 | 
| TOTAL LIABILITIES | 605,962 | 615,688 | 623,909 | 
|  |  |  |  | 
| Stockholders’ equity | 61,642 | 60,782 | 60,307 | 
|  |  |  |  | 
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 667,604 | $ 676,470 | $ 684,216 | 
|  |  |  |  | 
| Shares outstanding | 5,916 | 5,915 | 5,915 | 
|  |  |  |  | 
| Book value per common share | $ 7.92 | $ 7.78 | $ 7.74 | 
|  | 
| ADDITIONAL FINANCIAL  INFORMATION | 
| (Dollars in thousands except per share  amounts)(Unaudited) | 
|  | Quarter Ended | Quarter Ended | Quarter Ended | Twelve Months Ended | 
| PERFORMANCE MEASURES AND RATIOS | Dec. 31, 2010 | Sep. 30, 2010 | Dec. 31, 2009 | Dec. 31, 2010 | Dec. 31, 2009 | 
| Return on average common equity | 8.98% | 9.03% | 0.83% | 4.50% | -12.02% | 
| Return on average assets | 0.63% | 0.62% | 0.06% | 0.31% | -0.85% | 
| Efficiency ratio | 64.50% | 60.44% | 63.42% | 63.05% | 71.00% | 
| Net interest margin | 4.57% | 4.49% | 4.18% | 4.50% | 3.91% | 
|  |  |  |  |  |  | 
|  | Quarter Ended | Quarter Ended | Quarter Ended | Twelve Months Ended | 
| AVERAGE BALANCES | Dec. 31, 2010 | Sep. 30, 2010 | Dec. 31, 2009 | Dec. 31, 2010 | Dec. 31, 2009 | 
| Average assets | $ 676,475 | $ 673,932 | $ 681,201 | $ 676,776 | $ 675,672 | 
| Average earning assets | 646,180 | 645,765 | 669,248 | 650,448 | 663,151 | 
| Average total loans | 599,071 | 600,234 | 611,512 | 603,141 | 605,741 | 
| Average deposits | 535,258 | 536,616 | 531,453 | 537,454 | 502,173 | 
| Average equity (including preferred stock) | 61,837 | 60,975 | 61,187 | 61,132 | 62,353 | 
| Average common equity (excluding preferred stock) | 47,074 | 46,278 | 46,683 | 46,464 | 47,947 | 
|  |  |  |  |  |  | 
| EQUITY ANALYSIS | Dec. 31, 2010 | Sep. 30, 2010 | Dec. 31, 2009 |  |  | 
| Total equity | $ 61,642 | $ 60,782 | $ 60,307 |  |  | 
| Less: senior preferred stock | 14,807 | 14,740 | 14,540 |  |  | 
| Total common equity | $ 46,835 | $ 46,042 | $ 45,767 |  |  | 
|  |  |  |  |  |  | 
| Common stock outstanding | 5,916 | 5,915 | 5,915 |  |  | 
| Book value per common share | $ 7.92 | $ 7.78 | $ 7.74 |  |  | 
|  |  |  |  |  |  | 
| ASSET QUALITY | Dec. 31, 2010 | Sep. 30, 2010 | Dec. 31, 2009 |  |  | 
| Nonperforming loans (NPLs) | $ 12,671 | $ 15,104 | $ 16,177 |  |  | 
| Nonperforming loans/total loans | 2.13% | 2.51% | 2.62% |  |  | 
| REO and repossessed assets | $ 8,478 | $ 5,466 | $ 1,822 |  |  | 
| Less: SBA-guaranteed amounts | $ 1,725 | $ 1,435 | $ 181 |  |  | 
|  |  |  |  |  |  | 
| Net REO and repossessed assets | $ 6,753 | $ 4,031 | $ 1,641 |  |  | 
| Nonperforming assets (net) | $ 19,424 | $ 19,135 | $ 17,818 |  |  | 
| Nonperforming assets/total assets | 2.91% | 2.83% | 2.60% |  |  | 
| Net loan charge-offs in the quarter | $ 1,372 | $ 1,960 | $ 2,329 |  |  | 
| Net charge-offs in the quarter/total loans | 0.23% | 0.33% | 0.38% |  |  | 
|  |  |  |  |  |  | 
| Allowance for loan losses | $ 13,302 | $ 13,395 | $ 13,733 |  |  | 
| Plus: Allowance for undisbursed loan commitments | 194 | 208 | 501 |  |  | 
| Total allowance for credit losses | $ 13,496 | $ 13,603 | $ 14,234 |  |  | 
| Total allowance for loan losses/total loans held for  investment | 2.60% | 2.64% | 2.67% |  |  | 
| Total allowance for loan losses/nonperforming loans | 105% | 89% | 85% |  |  | 
|  |  |  |  |  |  | 
| Community West Bancshares |  |  |  |  |  | 
| Tier 1 leverage ratio | 9.08% | 8.98% | 8.81% |  |  | 
| Tier 1 risk-based capital ratio | 11.40% | 11.25% | 10.93% |  |  | 
| Total risk-based capital ratio | 14.16% | 14.02% | 12.20% |  |  | 
|  |  |  |  |  |  | 
| Community West Bank |  |  |  |  |  | 
| Tier 1 leverage ratio | 9.24% | 9.09% | 8.69% |  |  | 
| Tier 1 risk-based capital ratio | 11.61% | 11.38% | 10.78% |  |  | 
| Total risk-based capital ratio | 12.87% | 12.65% | 12.05% |  |  | 
|  |  |  |  |  |  | 
| INTEREST SPREAD ANALYSIS | Dec. 31, 2010 | Sep. 30, 2010 | Dec. 31, 2009 |  |  | 
| Yield on interest-bearing deposits | 1.42% | 1.44% | 1.92% |  |  | 
| Yield on total loans | 6.33% | 6.21% | 6.29% |  |  | 
| Yield on investments | 2.60% | 2.96% | 3.37% |  |  | 
| Yield on earning assets | 6.06% | 5.98% | 5.99% |  |  | 
|  |  |  |  |  |  | 
| Cost of deposits | 1.31% | 1.34% | 1.77% |  |  | 
| Cost of FHLB advances | 2.75% | 2.83% | 3.65% |  |  | 
| Cost of Federal Reserve borrowings | 0.00% | 0.00% | 0.50% |  |  | 
| Cost of interest-bearing liabilities | 1.68% | 1.67% | 2.10% |  |  | 

Contact:
Charles G. Baltuskonis, EVP & CFO
805.692.5821
 
 
				
								
								
				
			
			 
		
			
			
			
				
				
				IRVINE, CA–(Marketwire – 01/20/11) – BIOLASE Technology, Inc. (NASDAQ:BLTI – News), the world’s leading dental  laser manufacturer and distributor, today announced the launch of the Waterlase®  iPlus™ System dual-wavelength all-tissue laser, the first major breakthrough in  all-tissue laser technology since the Waterlase MD™ was introduced in 2005.
The iPlus’ Intuitive Power not only addresses the key needs for the next  generation of laser dentists, but it also delivers more power, control and  versatility for experienced laser dentists. Cutting of all tissue types with the  new iPlus can be performed twice as fast as current laser systems, with no pain  or discomfort, no risk of cross-contamination associated with conventional  drills, and resulting in surface quality much smoother than ever.
Chief Technology Officer Dmitri Boutoussov, PhD, said, “The iPlus represents  a major leap in the development of all-tissue dental lasers. Cutting teeth at  the speed of the mechanical drill without sacrificing patient comfort has always  been our goal at BIOLASE. It was a tremendous challenge for us which took  several years to develop. Now, our patent-pending technology (named ‘2R Powered’  technology) allows us to build an Er;Cr:YSGG laser with the highest pulse energy  at short pulses among all Erbium-based, 3-micron lasers in the industry, as well  as the highest pulse repetition rates. The result is very fast removal of hard  tooth tissue with no discomfort to the patient, in combination with a smooth  surface finish. Our new technology also opens a great opportunity to explore  non-dental applications in medicine, which require fast and smooth cutting of  both soft tissue and bone, coverage of larger surface areas (like skin or  wounds), and where the delivery of laser radiation to treatment site through a  flexible fiber is a must-have.”
After using the system, Southern California dentist Dr. Christina Do stated,  “It is amazingly fast, as fast or faster than my high-speed drill and the  patient never flinched.”
Unlike dental lasers of the last decade, the iPlus also features a  revolutionary and intuitive applications-based user interface with a large high  resolution touch screen programmed with over 50 factory-loaded procedure  presets. Dentists will simply choose which procedure to perform — from “bread  and butter” restorative cases to specialty cases like periodontal or endodontic  — and the iPlus will program everything for the dentist.
The iPlus is available in a system configuration and features the proprietary  2780 nm YSGG technology together with an integrated iLase 940 nm diode laser or  as a standalone unit. The YSGG technology has been the industry standard for all  tissue dental lasers since its introduction in 1997. The iLase will enhance the  capabilities of the YSGG by providing a diode laser that can be utilized for  unexpected soft-tissue cases in an adjacent treatment room, better control of  bleeding, and the potential for temporary pain relief and teeth whitening.
Chairman and CEO Federico Pignatelli said, “The iPlus is our new flagship  laser product and will have a substantial impact on our sales in 2011 and  beyond. It is the most advanced — yet most intuitive — dental laser ever  conceived. With the Intuitive Power of the iPlus, dentists will be able to  completely focus on dentistry, while the iPlus handles the technical laser  details. I’m extremely proud of the job done by our R&D team under the  leadership of Dr. Boutoussov, to deliver the perfect product for the rapidly  growing worldwide dental laser market. We have received full FDA clearance and  will begin taking orders next week for delivery this quarter.”
Other innovations include a new fiber delivery system with little to no  “pull-back” on the dentist’s hand and a new 3X brighter illumination source.  This allows for complete freedom of movement of the handpiece and greatly  reduces hand fatigue throughout the day in combination with excellent site  visibility.
“I have been using lasers from BIOLASE and other manufacturers for twenty  years in my practice, and also taught hundreds of other dentists how to use  lasers,” commented Dr. Phil Hudson from Spokane. “Whenever I have asked what  took them so long to buy a laser, two of the most common concerns were that it  would slow them down, and it would be too difficult to learn. The iPlus solves  all of that. It is blazingly fast in all classes of cavity preparation and is my  first choice when I am confronted by soft tissue surgical challenges. Any  dentist with a smart phone will feel right at home with the iPlus, as its  intuitive nature eliminates both the mystery and the fear factor of lasers.”
Pignatelli added, “With the iPlus, any dentist can quickly integrate an  all-tissue laser into his or her practice. The intuitive nature of the interface  is very much like the personal electronic devices we already use in our daily  lives, so dentists will easily learn how to operate the iPlus. With our higher  powered laser, dentists will be able to perform hard tissue procedures with as  much speed as conventional drills, but without the discomfort and risk of cross  contamination as often occurs with drills in conventional dental procedures as  per recent astonishing published research. Finally, the iLase diode laser  completes the set of services that dentists can provide for their patients. Our  new Waterlase iPlus makes all of this possible.”
The formal introduction of the iPlus, with a retail price depending on a  system configuration expected to be at a price point of $54,900, will be in  booth #1640 at the Yankee Dental Congress on January 27th in Boston. A preview  video of the iPlus can also be viewed at www.waterlaseiplus.com
About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the  World’s leading dental laser company, is a medical technology company that  develops, manufactures and markets lasers and related products focused on  technologies that advance the practice of dentistry and medicine. The Company’s  products incorporate patented and patent pending technologies designed to  provide clinically superior performance with less pain and faster recovery  times. BIOLASE’s principal products are dental laser systems that perform a  broad range of dental procedures, including cosmetic and complex surgical  applications. Other products under development address ophthalmology and other  medical and consumer markets.
For updates and information on laser and Waterlase dentistry, find BIOLASE at  http://www.biolase.com,  Twitter at http://twitter.com/GoWaterlase,  and YouTube at http://www.youtube.com/user/Rossca08.
This press release may contain forward-looking statements within the meaning  of safe harbor provided by the Securities Reform Act of 1995 that are based on  the current expectations and estimates by our management. These forward-looking  statements can be identified through the use of words such as “anticipates,”  “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,”  and variations of these words or similar expressions. Forward-looking statements  are based on management’s current, preliminary expectations and are subject to  risks, uncertainties and other factors which may cause the Company’s actual  results to differ materially from the statements contained herein, and are  described in the Company’s reports it files with the Securities and Exchange  Commission, including its annual and quarterly reports. No undue reliance should  be placed on forward-looking statements. Such information is subject to change,  and we undertake no obligation to update such statements.
				
								
								
				
			
			 
		
			
			
			
				
				
				XI’AN, China,  Jan. 20, 2011 /PRNewswire-Asia/ — Kingtone  Wirelessinfo Solution Holding Ltd (Nasdaq:KONE – News) (“Kingtone”, or the  “Company”), a leading China-based software and  solutions developer focused on wirelessly enabling businesses and government  agencies to more efficiently manage their operations, today announced financial  results for the fourth quarter and fiscal year 2010. The financial statements  and other financial information included in this press release are prepared in  conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Fourth Quarter Financial Highlights
- Revenues increased 36.1% to $5.33 million from  $3.92 million in the prior year period.
- Gross profit increased 104.7% to $4.64 million from $2.27 million in the prior year period.
- Gross margin increased to 87.0% from 57.9% in the prior year period.
- Net income increased 72.9% to $3.13 million from  $1.81 million in the prior year period.
- Basic and diluted earnings per share were $0.22 as compared to $0.18 in the prior year period with  weighted average shares outstanding of 14,000,000 as compared to 10,000,000 in  the prior year period.
Fiscal Year 2010 Financial Highlights
- Revenues increased 29.1% to $14.51 million from  $11.24 million in the prior year period.
- Gross profit increased 65.5% to $12.15 million from $7.35 million in the prior year period.
- Gross margin increased to 83.8% from 65.4% in the prior year period.
- Net income increased 55.5% to $8.24 million from  $5.3 million in the prior year period.
- Basic and diluted earnings per share were $0.71 as compared to $0.53 in the prior year period with  weighted average shares outstanding of 11,527,473 as compared to 10,000,000 in  the prior year period.
“We are pleased with our strong performance in 2010 which demonstrates our  ability to expand revenues and profits as we capitalize on our first mover  advantage, highly competitive suite of products and renowned customer service  quality. Our results also benefited from our strategic shift towards software  solutions which enjoy much higher margins than wireless systems solutions”  commented Mr. Peng Zhang, Chief Executive Officer  of Kingtone. “During the year, we reached several milestones in our corporate  history. We became publicly traded on Nasdaq and raised US$16 million in equity capital to strengthen our  financial position and support our growth strategy. Our geographic footprint  expanded, creating further opportunities to build a stronger business pipeline  and we continued to build our scalable infrastructure on the back of targeted  cost controls, selective investments and productivity improvements. All these  steps enabled us to conclude fiscal 2010 with the strongest growth prospects in  our company history.”
“As we move forward, we believe that we are ideally positioned to capture the  growing opportunities in front of us as our clients continue to strive for  greater efficiency in their business. We will continue to carefully evaluate  each new business opportunity on its own merits in the best interest of the  company and its shareholders,” concluded Mr. Peng.
Fourth Quarter Financial Performance
Results of Operations – Three months ended September 30, 2010 compared to three months ended September 30, 2009.
Revenues. For the fourth quarter of fiscal year 2010, revenues  increased by 36.1% to $5.33 million from $3.92 million in the comparable period of fiscal 2009.  Revenue from software solutions increased by 124.5% to $4.1 million in the fourth quarter of fiscal year 2010  compared to $1.82 million in the fourth quarter of  fiscal year 2009. Revenue from wireless system solutions decreased by 40.9% to  $1.24 million in the fourth quarter of fiscal year  2010 compared to $2.09 million in the prior year  period.
Gross Profit and Gross Margin. For the fourth quarter of fiscal  year 2010, gross profit increased by 104.7 % to $4.64 million from $2.27  million in the prior year period. Gross margin for the fourth quarter of  fiscal year 2010 was 87.0% compared to 57.9% in the fourth quarter of fiscal  year 2009.
Income from Operations. Income from operations  increased by 90.8% to $3.75 million in the fourth  quarter of fiscal year 2010 from $1.97 million in  the comparable period of fiscal 2009. Operating margins for the fourth quarter  of fiscal year 2010 and 2009 were 70.4% and 50.2%, respectively.
Net Income and EPS. Net income was $3.13  million in the fourth quarter of fiscal year 2010, compared to $1.81 million in the prior year’s fourth quarter, an  increase of 72.9%. Net income as a percentage of total net revenues was 58.6%  and 46.2% for the fourth quarter of fiscal year 2010 and 2009, respectively.  Basic and diluted earnings per share were $0.22 in  the fourth quarter of fiscal year 2010, compared to $0.18 in the prior year period. The number of weighted  average common shares outstanding for the three months ended September 30, 2010 was 14 million, compared to 10 million  a year ago.
Fiscal Year 2010 Financial Performance
Results of Operations – The year ended  September 30, 2010 compared to the year ended September 30, 2009.
Revenues. For the year ended September 30,  2010, total revenues increased by 29.1% to $14.51  million from $11.24 million in the comparable  period of fiscal 2009. Revenue from software solutions increased by 118% to  $11.27 million for the year ended September 30, 2010 compared to $5.17  million for the prior year, mainly driven by mobile enterprise  applications in police and emergency agencies in new geographic areas. Revenue  from wireless system solution decreased by 46.7% to $3.23  million for the year ended September 30, 2010 compared to $6.07 million in the prior year. This  decrease was due primarily to two factors: (1) we had smaller contract value and  less recognizable revenue with one major customer in the oil refinery industry  this year, even though the number of contracts with its different subsidiaries  had increased; and (2) we completed two related party transactions in the prior  year with Shaanxi TechTeam Jinong Humic Acid Product Co., Ltd.. As a result, the  third-party revenue from wireless system solution sales decreased 34.3% from a  year ago without the $1.1 million revenue from these  two related party transactions from the prior year.
Gross Profit and Gross Margin. For the year ended September 30, 2010, gross profit increased by 65.5 % to  $12.15 million from $7.35  million in the prior year period. Gross margin for the year ended September 30, 2010 was 83.8%, compared to 65.4% for the  same period in the prior year.
Income from Operations. Income from operations increased by  58.2% to $10 million for the year ended September 30, 2010 from $6.32  million in fiscal 2009, primarily due to the growth in revenues.  Operating margin for the year ended September 30,  2010 and 2009 were 68.9% and 56.2%, respectively.
Net Income and EPS. Net income increased by 55.5% to $8.2 million for the year ended September 30, 2010 from $5.3  million in the fiscal 2009. The growth of net income was mainly  attributed to the growth in our revenue. Basic and diluted earnings per share  were $0.71 in the fiscal year 2010, compared to  $0.53 in the prior year. The number of weighted  average common shares outstanding for the year ended September 30, 2010 was 11.5 million, compared to 10  million a year ago.
Liquidity and Capital Resources.
Cash and Cash Equivalents. As of September  30, 2010, the Company had cash and cash equivalents of $14.9 million, compared to $0.34million as of November 30,  2009, the Company’s last fiscal year end. Cash flows provided by  operating activities for the year ended September 30,  2010 were approximately$4.3 million, compared to approximately $4 million in the prior year period. Depreciation and  amortization expenses were $0.23 million and $0.13  million for the years ended September 30,  2010 and 2009, respectively. Cash flows provided by financing activities  were approximately $10.32 million and $8.55 million for the years ended September 30, 2010 and 2009, respectively.
Financial Outlook
For the fiscal year ending September 30, 2011,  management expects revenues of $18.8 million to $20.2  million and net income of $10.2 million to $11.6  million. This guidance reflects management’s anticipated increase in  sales resulting from the Company’s existing solution offerings and the  increasing demand driven by the on-going adoption of 3G in the PRC.
Conference Call 
The Company will host a conference call to discuss its fourth quarter and  fiscal year 2010 financial results at 9:00 a.m. ET on Thursday, January 20, 2011. Mr. Tao Li, Chairman,  Mr. Peng Zhang, Chief Executive Officer, Ms. Ying Yang, Chief Financial Officer, will be on the  call.
To participate in the conference call, please dial any of the following  numbers:
|  USA Toll Free: (877) 407-9205 |  | 
|  International: (201) 689-8054 |  | 
|  Conference ID #: 364788 |  | 
|  | 
 
A replay of the call will be available until 11:59 PM  ET on January 20, 2011.
To access the replay, please dial any of the following numbers:
|  USA Toll Free: (877)-660-6853 |  | 
|  International: (201) 612-7415 |  | 
|  | 
 
Replay Passcodes (both required for playback):
|  Account #: 286 |  | 
|  Conference ID #: 364788 |  | 
|  | 
 
The conference call will be webcast live by Vcall and can be accessed at http://www.InvestorCalendar.com.
About Kingtone Wirelessinfo Solution Holding Ltd
Kingtone Wirelessinfo Solution Holding Ltd (Nasdaq:KONE – News) is a leading China-based software and solutions developer focused on  wirelessly enabling businesses and government agencies to more efficiently  manage their operations. The Company’s products, known as mobile enterprise  solutions, extend a company’s or enterprise’s information technology systems to  include mobile participants. The Company develops and implements mobile  enterprise solutions for customers in a broad variety of sectors and industries,  to improve efficiencies by enabling information management in wireless  environments. At the core of its many diverse packaged solutions is proprietary  middleware that enables wireless interactivity across many protocols, devices  and platforms.
For more information, please visit Kingtone’s website at www.kingtoneinfo.com.  The Company routinely posts important information on its website.
Safe Harbor Statements
This press release contains “forward-looking statements” within the meaning  of the Private Securities Litigation Reform Act of 1995, including certain  plans, expectations, goals, and projections, which are subject to numerous  assumptions, risks, and uncertainties. These forward-looking statements may  include, but are not limited to, statements containing words such as “may,”  “could,” “would,” “plan,” “anticipate,” “believe,” “estimate,” “predict,”  “potential,” “expects,” “intends”, “future” and “guidance” or similar  expressions. These forward-looking statements speak only as of the date of this  press release and are subject to change at any time. These forward-looking  statements are based upon management’s current expectations and are subject to a  number of risks, uncertainties and contingencies, many of which are beyond the  Company’s control that may cause actual results, levels of activity, performance  or achievements to differ materially from any future results, levels of  activity, performance or achievements expressed or implied by such  forward-looking statements. The Company’s actual results could differ materially  from those contained in the forward-looking statements due to a number of  factors, including those described under the heading “Risk Factors” in the  Company’s prospectus, dated May 14, 2010 filed with  the Securities and Exchange Commission (the “SEC”), and in documents  subsequently filed by the Company from time to time with the SEC including the  Company’s Transition Report for the transition period from December 1, 2009 to September 30,  2010 to be filed with the SEC. The Company undertakes no obligation to  update or revise any forward-looking statements, whether as a result of new  information, future events or otherwise, except as required under applicable  law.
|  | KINGTONE  WIRELESSINFO SOLUTION HOLDING LTD AND SUBSIDIARIES |  | 
|  | CONSOLIDATED AND  COMBINED BALANCE SHEETS |  | 
|  | (Express in  thousands of U.S. Dollars, except shares and per share data) |  | 
|  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  | 
|  |  |  |  | As of  September  30, |  | As of  November  30, |  | 
|  |  |  |  | 2010 |  | 2009 |  | 
|  |  |  |  | (see note  below) |  |  |  | 
|  |  |  |  |  |  |  |  | 
|  | ASSETS |  |  |  |  |  | 
| Current assets |  |  |  |  |  | 
|  | Cash and cash equivalents |  | $14,909 |  | $344 |  | 
|  | Accounts receivable, net of allowance  |  | 6,650 |  | 2,353 |  | 
|  | Unbilled revenue |  | 973 |  | 178 |  | 
|  | Due from related companies |  | 120 |  | – |  | 
|  | Inventories, net |  | 383 |  | 127 |  | 
|  | Other receivables and prepayments |  | 771 |  | 1,012 |  | 
|  | Total Current Assets |  | 23,806 |  | 4,014 |  | 
| Non-current assets |  |  |  |  |  | 
|  | Property and Equipment, net |  | 13,637 |  | 1,693 |  | 
|  | Deposit to purchase building |  | – |  | 12,200 |  | 
|  | Intangible assets |  | 630 |  | – |  | 
|  | Total Assets |  | $38,073 |  | $17,907 |  | 
|  |  |  |  |  |  |  |  | 
|  | LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  | 
|  |  |  |  |  |  |  |  | 
| Current liabilities |  |  |  |  |  | 
|  | Accounts payable  |  | $  575 |  | $  1,409 |  | 
|  | Advances from customers |  | 371 |  | 1,398 |  | 
|  | Other payables and accruals |  | 167 |  | 559 |  | 
|  | Taxes payable |  | 3,421 |  | 601 |  | 
|  | Short-term loan |  | – |  | 3,437 |  | 
|  | Amounts due to shareholder |  | – |  | 200 |  | 
|  | Deferred government grant |  | – |  | – |  | 
|  | Dividend payable |  | 772 |  | 1,177 |  | 
|  | Total Current Liabilities |  | 5,306 |  | 8,781 |  | 
|  |  |  |  |  |  |  |  | 
|  | Commitments and contingencies |  |  |  |  |  | 
|  |  |  |  |  |  |  |  | 
| Stockholders’ equity |  |  |  |  |  | 
|  | Ordinary share ($.001 par value, 100,000,000 shares  authorized, and 10,000,000 shares and 14,000,000 shares issued and  outstanding) | $  14 |  | $10 |  | 
|  |  |  |  |  | 
|  | Paid in capital |  | – |  | 6,897 |  | 
|  | Additional paid in capital |  | 21,915 |  | 216 |  | 
|  | Appropriated retained earnings |  | 844 |  | 231 |  | 
|  | Unappropriated retained earnings |  | 8,281 |  | 657 |  | 
|  | Accumulated other comprehensive income |  | 1,713 |  | 1,115 |  | 
|  | Total Stockholders’ Equity |  | 32,767 |  | 9,126 |  | 
|  |  |  |  |  |  |  |  | 
|  | Total Liabilities and Stockholders’ Equity |  | $38,073 |  | $17,907 |  | 
|  |  |  |  |  |  |  | 
 
Note: In March 2010, the Company changed its  fiscal year-end from November 30th to September  30th, so that it would have the same fiscal year end as its variable  interest entity (“VIE”), Xi’an Kingtone Information Technology Co., Ltd.  (“Kingtone Information”).
| KINGTONG  WIRELESSINFO SOLUTION HOLDING LTD AND SUBSIDIARIES |  | 
| CONSOLIDATED AND  COMBINED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME |  | 
| (Express in  thousands of U.S. Dollars, except shares and per share data) |  | 
|  |  |  |  |  |  |  |  |  |  | 
|  |  | For the quarter  ended September 30, |  | For the year ended  September 30, |  | 
|  |  | 2010 |  | 2009 |  | 2010 |  | 2009 |  | 
|  |  | (Unaudited) |  | (Unaudited) |  |  |  |  |  | 
|  |  |  |  |  |  |  |  | (see note  below) |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Revenues |  |  |  |  |  |  |  |  | 
|  | Software | $  4,095 |  | $  1,824 |  | $  11,272 |  | $  5,170 |  | 
|  | Wireless system solution | 1,236 |  | 2,092 |  | 3,234 |  | 6,070 |  | 
|  | Total revenues | 5,331 |  | 3,916 |  | 14,506 |  | 11,240 |  | 
| Cost of sales |  |  |  |  |  |  |  |  | 
|  | Software | 413 |  | 126 |  | 903 |  | 476 |  | 
|  | Wireless system solution | 280 |  | 1,524 |  | 1,449 |  | 3,418 |  | 
|  | Total cost of sales | 693 |  | 1,650 |  | 2,352 |  | 3,894 |  | 
| Gross profit | 4,638 |  | 2,266 |  | 12,154 |  | 7,346 |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Operating expenses |  |  |  |  |  |  |  |  | 
|  | Selling and marketing expenses | 85 |  | 92 |  | 341 |  | 350 |  | 
|  | General and administrative expenses | 752 |  | 172 |  | 1,635 |  | 537 |  | 
|  | Research and development expenses | 48 |  | 35 |  | 179 |  | 139 |  | 
|  | Total Operating expenses | 885 |  | 299 |  | 2,155 |  | 1,026 |  | 
| Income from operations | 3,753 |  | 1,967 |  | 9,999 |  | 6,320 |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Other income(expense) |  |  |  |  |  |  |  |  | 
|  | Subsidy income | – |  | 278 |  | 44 |  | 307 |  | 
|  | Interest expense | (9) |  | (11) |  | (218) |  | (340) |  | 
|  | Other income (expense) | 14 |  | (121) |  | 20 |  | (55) |  | 
|  | Total other income (expense) | 5 |  | 146 |  | (154) |  | (88) |  | 
| Income before income tax expenses | 3,758 |  | 2,113 |  | 9,845 |  | 6,232 |  | 
|  | Income tax expenses | 633 |  | 305 |  | 1,608 |  | 935 |  | 
| Net income  | $  3,125 |  | $  1,808 |  | $  8,237 |  | $  5,297 |  | 
| Other comprehensive income  |  |  |  |  |  |  |  |  | 
|  | Foreign currency translation gain  | 517 |  | (4) |  | 598 |  | 22 |  | 
| Comprehensive income  | $  3,642 |  | $  1,804 |  | $  8,835 |  | $  5,319 |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Earnings per ordinary share: |  |  |  |  |  |  |  |  | 
|  | Basic and Diluted | $  0.22 |  | $  0.18 |  | $  0.71 |  | $  0.53 |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Weighted average number of ordinary shares  outstanding |  |  |  |  |  |  |  |  | 
|  | Basic and Diluted  | 14,000,000 |  | 10,000,000 |  | 11,527,473 |  | 10,000,000 |  | 
|  |  |  |  |  |  |  |  |  | 
 
Note: In March 2010, the Company changed its  fiscal year-end from November 30th to September  30th, so that it would have the same fiscal year end as its VIE, Xi’an  Kingtone Information Technology Co., Ltd. (“Kingtone Information”). There were  no operations in the Company other than in its VIE, Kingtone Information from  October 1, 2009 to November 30,  2009. In addition, the consolidated and combined statements of income and  comprehensive income for the year ended November 30,  2009 included Kingtone Information for the year ended September 30, 2009. Therefore the Company is presenting  its consolidated and combined statements of income and comprehensive income for  the years ended September 30, 2010 and 2009 instead  of for the ten months ended September 30, 2010 and  the year ended November 30, 2009.
| KINGTONE  WIRELESSINFO SOLUTION HOLDING LTD AND SUBSIDIARIES |  | 
| CONSOLIDATED AND  COMBINED STATEMENTS OF CASH FLOWS |  | 
| (Express in  thousands of U.S. Dollars, except shares and per share data) |  | 
|  |  |  |  |  |  |  |  |  |  | 
|  | For the year ended  September 30, |  |  |  |  |  | 
|  | 2010 |  | 2009 |  |  |  |  |  |  | 
| Cash flows from operating activities |  |  | (see note  below) |  |  |  |  |  |  | 
| Net income | $8,237 |  | $5,297 |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  | 
|  Depreciation and amortization | 225 |  | 129 |  |  |  |  |  |  | 
|  Disposal of fixed assets | – |  | – |  |  |  |  |  |  | 
|  Subsidiary income recognized from deferred government  grant | – |  | (50) |  |  |  |  |  |  | 
|  Share-based compensation expense | 302 |  | – |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Changes in operating assets and liabilities |  |  |  |  |  |  |  |  |  | 
| Accounts receivable | (4,170) |  | (1,851) |  |  |  |  |  |  | 
| Unbilled revenue | (778) |  | (177) |  |  |  |  |  |  | 
| Other receivables and prepayments | 257 |  | (234) |  |  |  |  |  |  | 
| Inventories | (249) |  | 150 |  |  |  |  |  |  | 
| Tax payable | 2,756 |  | 601 |  |  |  |  |  |  | 
| Accounts payable | (848) |  | 1,092 |  |  |  |  |  |  | 
| Advance from customers | (1,037) |  | (1,424) |  |  |  |  |  |  | 
| Other payables and accruals | (394) |  | 467 |  |  |  |  |  |  | 
| Deferred government grant | – |  | – |  |  |  |  |  |  | 
| Net cash provided by operating activities | 4,301 |  | 4,000 |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Cash flows from investing activities |  |  |  |  |  |  |  |  |  | 
| Purchases of vehicles and office equipment | (308) |  | (24) |  |  |  |  |  |  | 
| Prepayment to purchase building  | – |  | (12,186) |  |  |  |  |  |  | 
| Net cash used in investing activities | (308) |  | (12,210) |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Cash flows from financing activities |  |  |  |  |  |  |  |  |  | 
| Proceeds in short-term bank loan | – |  | 3,432 |  |  |  |  |  |  | 
| Repayment of short-term bank loan | (3,445) |  | (3,681) |  |  |  |  |  |  | 
| (Payment)/Collection in amounts due from related-party  companies | (118) |  | 11,335 |  |  |  |  |  |  | 
| Repayment of loan from non-related companies |  |  |  |  |  |  |  |  |  | 
| Collection from loan to non-related companies |  |  |  |  |  |  |  |  |  | 
|  Receipt/(Repayment) in amounts due to  shareholders | (200) |  | 200 |  |  |  |  |  |  | 
| Proceeds from issuance of shares | 14,503 |  | 10 |  |  |  |  |  |  | 
| Dividend paid to shareholders | (422) |  | (2,751) |  |  |  |  |  |  | 
| Net cash provided by financing activities | 10,318 |  | 8,545 |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Effect of exchange rate changes on cash and cash  equivalents | 254 |  | – |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Net increase in cash and cash equivalents | 14,565 |  | 335 |  |  |  |  |  |  | 
|  Cash and cash equivalents at beginning of  year | 344 |  | 9 |  |  |  |  |  |  | 
|  Cash and cash equivalents at end of year | $14,909 |  | $  344 |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  | 
| Supplemental disclosure of cash flow  information |  |  |  |  |  |  |  |  |  | 
|  Interest paid | $  218 |  | $  340 |  |  |  |  |  |  | 
|  Income taxes paid | $92 |  | $  215 |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  | 
 
Note: In March 2010, the Company changed its  fiscal year-end from November 30th to September  30th, so that it would have the same fiscal year end as its VIE, Xi’an  Kingtone Information Technology Co., Ltd. (“Kingtone Information”). There were  no operations in the Company other than in its VIE, Kingtone Information from  October 1, 2009 to November 30,  2009. In addition, the consolidated and combined statements of income and  comprehensive income for the year ended November 30,  2009 included Kingtone Information for the year ended September 30, 2009. Therefore the Company is presenting  its consolidated and combined statements of income and comprehensive income for  the years ended September 30, 2010 and 2009 instead  of for the ten months ended September 30, 2010 and  the year ended November 30, 2009.
| KINGTONE  WIRELESSINFO SOLUTION HOLDING LTD AND SUBSIDIARIES |  | 
| CONSOLIDATED AND  COMBINED STATEMENTS OF SHAREHOLDERS’ EQUITY |  | 
| (Express in  thousands of U.S. Dollars, except shares and per share data) |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  | Ordinary  shares |  | Paid-in capital  |  | Additional paid-in  capital  |  | Appropriated  Retained earnings |  | Unappropriated  Retained earnings |  | Comprehensive  income |  | Total stockholders’  equity |  | 
|  | No. of  share | Amount |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Balance at November 30, 2007 | – | $- |  | $  6,034 |  | $- |  | $  30 |  | $(1,527) |  | $  549 |  | $  5,086 |  | 
| Net income for the year | – | – |  | – |  | – |  | – |  | 1,015 |  | – |  | 1,015 |  | 
| Share contribution  | – | – |  | 863 |  | 216 |  | – |  | – |  | – |  | 1,079 |  | 
| Transfer to statutory reserves | – | – |  | – |  | – |  | 32 |  | (32) |  | – |  | – |  | 
| Foreign currency translation gain | – | – |  | – |  | – |  | – |  | – |  | 544 |  | 544 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Balance as of November 30, 2008 | – | $- |  | $  6,897 |  | $  216 |  | $  62 |  | $(544) |  | $  1,093 |  | $  7,724 |  | 
| Share contribution | 10,000,000 | 10 |  | – |  |  |  |  |  |  |  |  |  | 10 |  | 
| Net income for the year | – | – |  | – |  | – |  | – |  | 5,297 |  | – |  | 5,297 |  | 
| Payment of dividends | – | – |  | – |  | – |  | – |  | (4,096) |  | – |  | (4,096) |  | 
| Transfer to statutory reserves | – | – |  | – |  | – |  | 169 |  | – |  | – |  | 169 |  | 
| Foreign currency translation gain | – | – |  | – |  | – |  | – |  | – |  | 22 |  | 22 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Balance as of November 30, 2009 | 10,000,000 | 10 |  | 6,897 |  | 216 |  | 231 |  | 657 |  | 1,115 |  | 9,126 |  | 
| Issuance of ordinary shares in form of American Depositary  Shares | 4,000,000 | 4 |  | – |  | 14,500 |  | – |  | – |  | – |  | 14,504 |  | 
| Share-based compensation | – | – |  | – |  | 302 |  | – |  | – |  | – |  | 302 |  | 
| Net income for the year | – | – |  | – |  | – |  | – |  | 8,237 |  | – |  | 8,237 |  | 
| Effect of reorganization | – | – |  | (6,897) |  | 6,897 |  | – |  |  |  | – |  | – |  | 
| Transfer to statutory reserves | – | – |  | – |  | – |  | 613 |  | (613) |  | – |  | – |  | 
| Foreign currency translation gain | – | – |  | – |  | – |  | – |  | – |  | 598 |  | 598 |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Balance as of September 30, 2010 | 14,000,000 | $  14 |  | $- |  | $  21,915 |  | $  844 |  | $8,281 |  | $  1,713 |  | $ 32,767 | 
 
				
								
								
				
			
			 
		
			
			
			
				
				
				STILLWATER, Okla., Dec. 20, 2010 (GLOBE NEWSWIRE) — Southwest Bancorp, Inc.  (Nasdaq:OKSB), (“Southwest”), today reported that on December 16, 2010 its board  of directors elected Laura Robertson as Southwest’s new Executive Vice  President and Chief Financial Officer and Priscilla Barnes, Executive  Vice President/Regulatory Risk Management, to the additional office of  Southwest’s Secretary.
Laura Robertson (age 37) previously served as Senior Vice President/Finance  Division Manager of Southwest and its principal subsidiary, Stillwater National  Bank and Trust Company. Ms. Robertson joined Stillwater National in 2006. She  has also served as the Public Company Reporting and Tax Manager and Assistant  Secretary of Southwest and Stillwater National. Prior to joining Southwest, Ms.  Robertson practiced public accounting in the Dallas, Texas metro area. She is a  Certified Public Accountant and a member of both the Oklahoma and Texas Society  of CPAs as well as the American Institute of Certified Public Accountants. She  reported to Kerby Crowell, the former Executive Vice President and Chief  Financial Officer, since joining Southwest. Ms. Robertson currently serves on  the Board of Directors for Payne County Court Appointed Special Advocates.
Priscilla Barnes (age 54) served as Executive Vice President, Director of  Human Resources and Compliance prior to becoming Executive Vice President/  Regulatory Risk Management in 2010. Ms. Barnes joined Southwest in 2005 as Vice  President, Compliance of Stillwater National. Ms. Barnes has 30 years experience  in the banking industry. Prior to joining Stillwater National, Ms. Barnes was a  federal bank examiner, a senior consultant for a regional accounting firm, and  served as a banker in many similar capacities. She was named an Oklahoma State  University Regent’s Distinguished Scholar and attended the Graduate School of  Banking in Madison, Wisconsin.
Rick Green, Southwest Bancorp’s President and Chief Executive Officer,  stated, “We are fortunate to have these experienced and talented individuals to  serve in these offices, and are confident that they will continue their track  records of excellence in these new roles.  Southwest maintains succession plans  for all executive officers, which has served us well during this  transition.”
These elections follow the death of Kerby Crowell, who served with  distinction as Executive Vice President, Chief Financial Officer, and Secretary  for many years before his death in November 2010.
Southwest Bancorp and  Subsidiaries
Southwest is the bank holding company for Stillwater National and Bank of  Kansas. Through its subsidiaries, Southwest offers commercial and consumer  lending, deposit and investment services, and specialized cash management, and  other financial services from offices in Oklahoma, Texas, and Kansas, and on the  Internet, through SNB DirectBanker®. We were organized in 1981 as  the holding company for Stillwater National, which was chartered in 1894. At  September 30, 2010 we had total assets of $2.9 billion, deposits of $2.3  billion, and shareholders’ equity of $376.6 million.
Our area of expertise focuses on the special financial needs of healthcare  and health professionals, businesses and their managers and owners, and  commercial and commercial real estate borrowers. We established a strategic  focus on healthcare lending in 1974. We provide credit and other services, such  as deposits, cash management, and document imaging for physicians and other  healthcare practitioners to start or develop their practices and finance the  development and purchase of medical offices, clinics, surgical care centers,  hospitals, and similar facilities. As of September 30, 2010, approximately  $706.1 million, or 29%, of our noncovered loans were loans to individuals and  businesses in the healthcare industry.
We also focus on commercial real estate mortgage and construction credits. We  do not focus on one-to-four family residential development loans or “spec”  residential property credits. Additionally, subprime lending has never been a  part of our business strategy, and our exposure to subprime loans and subprime  lenders is minimal. One-to-four family mortgages account for less than 5% of  total noncovered loans. As of September 30, 2010 approximately $1.8 billion, or  74%, of our noncovered loans was commercial real estate mortgage and  construction loans, including $404.7 million of loans to individuals and  businesses in the healthcare industry. Our commercial real estate mortgage and  construction and commercial loans are concentrated in states that have  experienced less adverse effects from the recession than many others.
We operate six offices in Texas, eleven offices in Oklahoma, and eight  offices in Kansas. At September 30, 2010 our Texas segment accounted for $1.0  billion, or 41% of total portfolio loans, followed by $890.6 million, or 36%,  from our Oklahoma segment, $309.2 million, or 13%, from our Kansas segment, and  $248.9 million, or 10%, from our other states segment.
Southwest’s common stock is traded on the NASDAQ Global Select Market under  the symbol OKSB. Southwest’s public trust preferred securities are traded on the  NASDAQ Global Select Market under the symbol OKSBP.
The Southwest Bancorp, Inc. logo is available at  http://www.globenewswire.com/newsroom/prs/?pkgid=8074
CONTACT:  Southwest Bancorp, Inc.
          Rick Green, President & CEO
          (405) 372-2230
				
								
								
				
			
			 
		
			
			
			
				
				
				Jan. 19, 2011 (Business Wire) — Pernix™ Therapeutics Holdings, Inc.  (NYSE Amex: PTX) and ParaPRO, LLC announced today that the U.S. Food and Drug  Administration (FDA) has approved Natroba™ (spinosad) Topical Suspension, 0.9%  to eliminate head lice (pediculosis capitis). Natroba™ received approval as a  prescription medication and is indicated for the topical treatment of head lice  infestations in patients four (4) years of age and older.
Natroba™ is an effective, easy-to-use product, which has been shown to  resolve most head lice problems in about 10 minutes with just one application  and no nit combing. Pernix and ParaPRO expect to launch the product in the first  half of 2011.
“We believe Natroba™ gives physicians and parents a game-changing solution to  the problem of head lice,” said Bill Culpepper III, president of ParaPRO, LLC.  “Natroba™ is the only head lice treatment whose approval is supported by  superiority studies versus permethrin 1%. FDA approval of Natroba™ is a  significant step forward in the longstanding struggle to treat head lice  infestations and we look forward to making the product available in pharmacies  nationwide in the first half of 2011. Unlike many other currently available  treatments, most children will only require one application and do not need to  sit through extensive, time-consuming nit combing sessions when Natroba™ is  used. This means that parents trying to rid their children of head lice will  soon have an important new treatment option given the ease of use and  effectiveness of Natroba™.”
Natroba™ (pronounced na-ˈtrōb- ə) treats head lice using spinosad, a compound  derived from a soil microbe. Until Natroba™ was approved, the most common  pediatrician-recommended head lice treatments available either over-the-counter  or by prescription required nit combing, which can be painstaking and time  consuming. Further, in the clinical studies, patients treated with permethrin  1%, (marketed under the brand name Nix®i) more often required an  additional round of treatment than patients who were treated with Natroba™.
“We are pleased by the FDA’s decision to approve Natroba™,” said Cooper  Collins, President and Chief Executive Officer of Pernix. “This product provides  Pernix with a unique opportunity to promote a treatment that has been proven in  multiple clinical trials to be more effective than currently available  treatments. We look forward to launching this innovative new prescription  product to the pediatrics market via our established sales force in the first  half of 2011.”
Head lice are the second most communicable disease among schoolchildren,  after the common cold.ii The U.S. Centers for Disease Control and  Prevention estimate that there are between 6 to 12 million cases of head lice  infestations each year, mostly in children 3 to 12 years old. Head lice are  tiny, wingless insects that live on the human scalp and spread between people by  head-to-head contact or the sharing of hats, combs, brushes or  towels.iii
Costs associated with head lice infestations are estimated to be as high as  $1 billion per year in the United States alone.iv Direct costs  include treatments and clinic visits, while indirect costs range from school  nurse time to school absenteeism to lost wages.
“Head lice are a common problem that can affect anyone regardless of where  they live. Historically, it has been a time-consuming, frustrating problem for  families. Multiple treatments may be required and due to a variety of factors,  the initial treatment is often ineffective,” said Dow Stough, M.D., Burke  Pharmaceutical Research and an investigator in the Natroba™ Phase III clinical  studies. “When available, Natroba™ will offer a safe and effective option. The  Phase III studies showed that a single treatment of Natroba™ worked for most  patients and with Natroba™ combing is not required. This product will represent  a real advance in the treatment of head lice.”
Natroba™ is the only head lice treatment whose approval is supported by  superiority studies versus permethrin 1%, the most commonly prescribed head lice  treatment to date.v In two Phase III clinical studies, Natroba™ was  significantly more effective in eliminating head lice than permethrin 1%  (marketed under the brand name Nix®) – the head lice treatment recommended by  the American Academy of Pediatrics at the time the study protocol was approved  by the FDA.vi The studies, published online in the journal  Pediatrics (Pediatrics 2009; 124:e389-e395), also confirmed the  safety and effectiveness of Natroba™. The 1,038 participants with active head  lice infestations were provided either Natroba™ or Nix® to  be used at home. A total of 84.6% (study 1) and 86.7% (study 2) of  Natroba™-treated participants were assessed to be lice-free 14 days after the  last treatment, compared with 44.9% and 42.9% treated with permethrin (P <  0.001 for both studies). Most participants in the Natroba™ groups (63.8% and  86.2%) needed only one application, whereas most participants in the permethrin  groups (60.3% and 64.5%) required two applications.
There were few adverse events reported in the Phase III clinical studies. The  most commonly occurring adverse events included application-site erythema  (redness of the skin) which occurred in 3% of the Natroba™ patients (vs. 7% of  permethrin), ocular hyperemia (redness and irritation of the eyes) which  occurred in 2% of the Natroba™ patients (vs. 3% of permethrin) and  application-site irritation which occurred in 1% of Natroba™ patients (vs. 2%  permethrin). Although adverse event rates were low for both products,  application site redness occurred significantly less frequently in patients  treated with Natroba™ than in patients treated with permethrin (P = 0.007).
Indication
Natroba™ Topical Suspension is a pediculicide indicated for the topical  treatment of head lice infestations in patients four (4) years of age and older.
Important Safety Information
Natroba™ contains benzyl alcohol and is not recommended for use in neonates  and infants below the age of 6 months. Systemic exposure to benzyl alcohol has  been associated with serious adverse reactions and death in neonates and low  birth-weight infants.
The most common adverse events were: application site redness (3%), redness  and irritation of the eyes (2%) and application site irritation (1%).
For additional safety information, see the patient and full prescribing  information at www.Natroba.com.
About ParaPRO
ParaPRO, LLC (www.parapro.com), based in the Indianapolis, Indiana  metropolitan area, is a specialty pharmaceutical company focused on  commercializing proprietary products for the pediatric market. ParaPRO is a  wholly owned subsidiary of SePRO Corporation (www.sepro.com).
Natroba™ is a trademark of ParaPRO, LLC. Other trademarks are the property of  their respective owners.
About Pernix Therapeutics
Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company  primarily focused on serving the needs of the pediatric marketplace.  Commercially-proven branded product families include CEDAX®, Brovex®, Aldex®,  Pediatex®, ReZyst®, QuinZyme® and Z-Cof®. The Company was originally founded in  1999 and is based in the Houston, TX metropolitan area. Additional information  about Pernix is available on the Company’s website located at www.pernixtx.com.
Pernix™ is a registered trademark of Pernix Therapeutics, LLC.
Cautionary Notice Regarding Forward-Looking Statements
The Company wishes to caution readers not to place undue reliance on any  forward-looking statements, which speak only as of the date made. No  assurances can be given regarding the future performance of the Company. The Company wishes to advise readers that factors could affect the Company’s  financial performance and could cause the Company’s actual results for future  periods to differ materially from any opinions or statements expressed with  respect to future periods in any current statements.
The Company does not undertake, and specifically declines any obligation,  to publicly release the result of any revisions which may be made to any  forward-looking statements to reflect events or circumstances after the date of  such statements or to reflect the occurrence of anticipated or unanticipated  events.
i Nix is a registered trademark and the property of its owner.
ii Mayo Clinic website, available at  http://www.mayoclinic.com/health/head-lice/DS00953. Accessed Dec. 13.2010
iii Centers for Disease Control and Prevention, available at  http://www.cdc.gov/lice/head/factsheet.html. Accessed Sept. 28, 2010.
iv Lebwohl M, Clark L, Levitt J. Therapy for head lice based on  life cycle, resistance and safety considerations. Pediatrics 2007; 119(5):  965-974
v Wolters Kluwer Health, Source® Pharmaceutical Audit Suite  prescription pediculicide/head lice market audit current 12 months, November  2010.
vi Frankowski BL, Weiner LB; American Academy of Pediatrics,  Committee on School Health, Committee on Infectious Diseases, Head Lice,  Pediatrics 2002; 110(3):648-643.

Pernix Therapeutics Holdings, Inc.
Tracy Clifford,  843-720-1501
Chief Financial Officer
or
The IGB  Group
Investor Relations Contacts:
Nick Rust,  212-477-8439
nrust@igbir.com
or
Lev Janashvilli,  212-227-7098
ljanashvili@igbir.com
				
								
								
				
			
			 
		
			
			
			
				
				
				NEW YORK, NY — (Marketwire) — 01/19/11 — China Metro-Rural Holdings  Limited (NYSE Amex: CNR) (the “Company”) today announced that it has released  two new 6K forms which can be found on the Company’s website at  http://www.chinametrorural.com/ as well as on the SEC website at  http://secfilings.com/searchresultswide.aspx?link=1&filingid=7660386 and  http://secfilings.com/searchresultswide.aspx?link=1&filingid=7660588  respectively.
The First 6-K was issued as an update to the Form 20-F previously filed on  July 9, to reflect a) the distribution of Man Sang International Limited which  resulted the discontinued operations; b) adoption of amendments to an existing  International Accounting Standard; and c) a change in the accounting policy of  the Company.
The second 6K filing was issued to reflect a full set of condensed  consolidated interim financial information for the six months ended September  30, 2010 and related management discussion and analysis of results of  operations.
ABOUT CHINA METRO-RURAL HOLDINGS LIMITED
China Metro-Rural Holdings  Limited, through Man Sang International Limited engages in pearl and jewelry  business and in selling and leasing of properties in the PRC related to the  pearl and jewelry business and, through Mega Dragon is one of the leading  developers and operators of large scale, integrated agricultural logistics and  trade centers in Northeast China that facilitate a relationship between sellers  and buyers of agricultural commodities and small appliances, provide relevant  physical platform and timely marketing information and intelligence, provide a  transparent and competitive market price discovery mechanism and provide  infrastructure to enhance the living standards of those from the rural area.
CONTACT:
China Metro-Rural Holdings Limited
Investor Relations  Department
Phone: (852) 2317 9888
E-mail: Email Contact
				
								
								
				
			
			 
		
			
			
			
				
				
				NEW YORK and HANGZHOU, China, Jan. 18, 2011 /PRNewswire/ — Ener1, Inc.  (Nasdaq: HEV), a leader in lithium-ion battery technology, and Wanxiang Electric  Vehicle Co., Ltd., a division of the Chinese conglomerate Wanxiang Group  Corporation, today signed a joint venture agreement to co-manufacture Li-ion  cells and battery packs for the rapidly growing Chinese market.  The new company  will harness cutting-edge American technology and advanced Chinese manufacturing  capability to produce battery systems for Wanxiang’s several existing light- and  heavy-duty automotive and power grid customers for delivery this year.
(Logo:  http://photos.prnewswire.com/prnh/20080312/CLW018LOGO )
(Logo:  http://photos.prnewswire.com/prnh/20110118/CL31242LOGO )
“Wanxiang and Ener1 share a vision to help fulfill our country’s strong  commitment to electrifying transportation on a mass scale and to deploy  lithium-ion technology to improve the effectiveness of the power grid,” said Lu  Guanqiu, founder and chairman of Wanxiang Group.  “We believe our manufacturing  expertise and deep customer relationships throughout China and in the region  will help ensure the success of this timely technology venture.”
The signing takes place against the background of a state visit by Chinese  President Hu Jintao and expanding U.S.-China bilateral initiatives to spur  cooperation in transportation electrification and grid energy storage, a  hallmark of the Obama administration’s policy toward China.  The Chinese  government, anticipating the environmental and oil demand impact of potentially  hundreds of millions of new vehicle purchases by a burgeoning middle class, has  set an annual production goal of 500,000 hybrid or all-electric cars and buses  by 2012.
The new venture – Zhejiang Wanxiang Ener1 Power System Co., Ltd – will use  Wanxiang Electric Vehicle’s existing 553,000-square-foot facility in Hangzhou.   The joint enterprise is expected to achieve annual cell manufacturing capacity  of 300 million Ampere hours (approximately 40,000 electric vehicle battery  packs) annually by 2014.
“We are honored and excited to enter into this important new venture with one  of China’s most respected industrial leaders,” commented Ener1 Chairman and CEO  Charles Gassenheimer, referring to Wanxiang’s emergence from a small business to  the second-largest private company in China and the country’s largest tier-one  auto parts supplier with $10 billion in annual revenue.  “This joint venture  gives us scalability by leveraging an existing manufacturing facility and an  established broad customer base.  Applying our advanced battery technology will  enable us to hit the ground running in serving what is potentially the largest  advanced battery market in the world.”
Wanxiang Electric Vehicle will have a 60-percent equity stake in the joint  venture.  The company will contribute property, plant, equipment, and customer  relationships, including State Grid, SAIC Motor, Dongfeng Motor, Guangzhou Auto  and Yutong.
As part of its 40-percent stake, Ener1 will provide intellectual property,  engineering, manufacturing and technical expertise.  The joint venture will help  further expand Ener1’s global footprint, and increase the company’s head count  through the addition of R&D and engineering staff in the U.S.
“We are very fortunate to be able to work in partnership with a manufacturing  giant in one of the fastest-growing markets in the world for Li-ion technology,”  Gassenheimer commented.  “A combination of industrial policy, explosive growth  potential and vision make this a winning proposition for both sides.”
About Ener1, Inc.
Ener1, Inc. is a publicly traded (Nasdaq: HEV) energy technology company that  develops compact, lithium-ion-powered battery solutions for the transportation,  utility grid storage and consumer markets.  Headquartered in New York City, the  company has more than 700 employees with manufacturing locations in the United  States and Korea.  Ener1 also develops commercial fuel cell products,  nanotechnology-based materials and manufacturing processes.  In collaboration  with strategic partner and electric vehicle manufacturer THINK, Ener1 also  manufactures electric vehicle drive train products.
About Wanxiang Group
Wanxiang Group was founded by Dr. Lu Guanqiu, who is regarded as a legendary  entrepreneur in China for taking $500 in start-up capital in 1969 to create a  farm tool repair shop and transforming it into one of the largest  non-government-owned companies in China. The company is the country’s largest  automotive components manufacturer, and a conglomerate with more than $10  billion (USD) in revenue covering businesses including financial services,  alternative energies, agricultural products, international trading, natural  resources, real estate, private equity and venture capital investment, and other  areas.  Wanxiang Group currently employs more than 30,000 employees worldwide,  with 19 companies in 9 countries and a sales and marketing network covering over  50 countries.  The Boston Consulting Group has listed Wanxiang Group as one of  the 100 most challenging and successful companies in China.
Safe Harbor Statement
Certain statements made in this press release constitute forward-looking  statements that are based on management’s expectations, estimates, projections  and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,”  “scheduled,” “estimates” and variations of these words and similar expressions  are intended to identify forward-looking statements. Forward-looking statements  are made pursuant to the safe harbor provisions of the Private Securities  Litigation Reform Act of 1995, as amended. These statements are not guarantees  of future performance and involve certain risks and uncertainties, which are  difficult to predict. Therefore, actual future results and trends may differ  materially from what is forecast in forward-looking statements due to a variety  of factors. All forward-looking statements speak only as of the date of this  press release and the company does not undertake any obligation to update or  publicly release any revisions to forward-looking statements to reflect events,  circumstances or changes in expectations after the date of this press  release.
| MEDIA CONTACT |  | 
| Brian Sinderson |  | 
| 212-920-3500 X117 |  | 
| brian.sinderson@ener1.com |  | 
|  | 
 
				
								
								
				
			
			 
		
			
			
			
				
				
				Jan. 18, 2011 (Business Wire) — Datalink (Nasdaq: DTLK), a leading provider  of data center infrastructure and services, today announced that it expects to  significantly exceed its previous revenue and earnings guidance for the fourth  quarter of 2010. The company now expects fourth quarter 2010 revenues to be  approximately $90 million. This is up over 70% from revenues of $51.8 million in  the fourth quarter of 2009, and up over 45% from revenues of $60.2 million in  the third quarter of 2010. At the end of the third quarter of 2010 the company  had provided revenue guidance of between $75.0 million and $80.0 million for the  fourth quarter of 2010.
On a GAAP basis the company expects earnings per share to be in the range of  $0.15 per share to $0.18 per share. On a non-GAAP basis the company expects  earnings per share in the range of $0.21 per share to $0.24 per share. The  company’s previous guidance was for GAAP earnings per share to be in the range  of $0.09 per share to $0.13 per share, and non-GAAP earnings to be in the range  of $0.12 per share to $0.16 per share.
The company ended the year with a record fourth quarter backlog of over $47  million. This compares to a $46 million backlog at the end of 2009, which was  previously a record for the fourth quarter.
Paul Lidsky, Datalink’s president and CEO, commented, “I am pleased with such  a strong finish to 2010 and the momentum it provides for 2011. We continued to  see strong demand for our data center solutions during the quarter as the result  of a steadily increasing trend in technology spending, coupled with the success  from our previous investments to expand Datalink’s market share around data  center solutions. Another key driver of the revenue growth was our success in  closing several multi-million dollar sales at Fortune 100 companies during the  quarter. We believe that this market share expansion is vital to our long-term  success. Although these transactions carry lower gross margins, they allow us  entry into new customer accounts with the potential for significant future  business. As a result, we expect to see our overall fourth quarter gross margins  decline to approximately 22.0%, compared to 24.1% in the third quarter of 2010.”
The company will report its fourth quarter financial results and hold an  investor conference call after the market closes on February 17, 2011.
About Datalink
A complete data center solutions and services provider for Fortune 500 and  mid-tier enterprises, Datalink transforms data centers so they become more  efficient, manageable and responsive to changing business needs. Datalink helps  leverage and protect storage, server, and network investments with a focus on  long-term value, offering a full lifecycle of services, from consulting and  design to implementation, management and support. Datalink solutions span  virtualization and consolidation, data storage and protection, advanced  networks, and business continuity. Each delivers measurable performance gains  and maximizes the business value of IT. For more information, call 800.448.6314  or visit www.datalink.com.
This press release contains forward-looking statements, including information  about management’s view of Datalink’s future expectations, plans and prospects,  including internal projections of anticipated 2010 results, within the safe  harbor provisions under The Private Securities Litigation Reform Act of 1995.  These statements involve known and unknown risks, uncertainties and other  factors which may cause the results of Datalink to be materially different than  those expressed or implied in such statements. Certain of these risk factors and  others are included in documents Datalink files with the Securities and Exchange  Commission, including but not limited to, its annual report on Form 10-K , as  well as subsequent reports filed with the Securities and Exchange Commission.  Additional risks include, but are not limited to: the level of continuing demand  for storage, including the effects of current economic and credit conditions;  competition and pricing pressures and timing of Datalink’s installations that  may adversely affect its revenues and profits; fixed employment costs that may  impact profitability if it suffers revenue shortfalls; revenue recognition  policies that may unpredictably defer reporting of Datalink’s revenues;  Datalink’s ability to hire and retain key technical and sales personnel;  Datalink’s dependence on key suppliers; Datalink’s ability to adapt to rapid  technological change; risks associated with integrating possible future  acquisitions; fluctuations in our quarterly operating results; future changes in  applicable accounting rules; and volatility in stock price. Further, Datalink’s  revenues for any particular quarter are not necessarily reflected by its backlog  of contracted orders, which also may fluctuate unpredictably.
Non-GAAP Details
Non-GAAP financial measures exclude the impact from acquisition accounting  adjustments to deferred revenue and costs, stock-based compensation expense,  amortization of intangible assets, integration and transaction costs related to  acquisitions and the related effects on income taxes. These non-GAAP measures  are not in accordance with, or an alternative for measures prepared in  accordance with, GAAP and may be different from non-GAAP measures used by other  companies. In addition, these non-GAAP measures are not based on any  comprehensive set of accounting rules or principles. Datalink believes that  non-GAAP measures have limitations in that they do not reflect all of the  amounts associated with Datalink’s results of operations as determined in  accordance with GAAP and that these measures should only be used to evaluate  Datalink’s results of operations in conjunction with the corresponding GAAP  measures.
These non-GAAP financial measures facilitate management’s internal  comparisons to the Datalink’s historical operating results and comparisons to  competitors’ operating results. We include these non-GAAP financial measures in  our earnings announcement because we believe they are useful to investors in  allowing for greater transparency with respect to supplemental information used  by management in its financial and operational decision making, such as employee  compensation planning. Datalink believes that the presentation of these non-GAAP  measures when shown in conjunction with the corresponding GAAP measures provides  useful information to investors and management regarding financial and business  trends relating to its financial condition and results of operations.

Datalink
Media &  Alliances:
Suzanne Gallagher, 720-566-5110
SVP of  Marketing
Email : sgallagher@datalink.com
or
Investors & Analysts:
Greg Barnum,  952-944-3462
Vice President and CFO
Email: gbarnum@datalink.com
				
								
								
				
			
			 
		
			
			
			
				
				
				CLEARWATER, Fla., Jan. 18, 2011 (GLOBE NEWSWIRE) — Technology Research  Corporation (Nasdaq:TRCI) today announced that its Board of Directors has  adopted a Shareholder Rights Plan and declared a dividend of one right on each  outstanding share of TRC’s common stock. The Rights Plan has a term of two  years.
The Company also announced that it had received an unsolicited indication of  interest from Coleman Cable, Inc. (Nasdaq:CCIX) in acquiring TRC at a price of  $5.50 per share in cash. The Board adopted the Rights Plan, consistent with its  responsibilities to shareholders, to better assure that the Company has time to  properly evaluate and respond to this indication of interest in relation to the  Company’s prospects and opportunities. The Board cautions shareholders that  there is no need to take any action at this time with respect to the indication  of interest from Coleman Cable. Rights plans are often adopted by boards of  directors under these and similar circumstances and are designed to protect the  interests of the company and all its shareholders.
Owen Farren, President and Chief Executive of TRC, stated, “The Board  unanimously believes the adoption of the short-term rights plan is appropriate  at this time. The Board will consider this expression of interest consistent  with its responsibilities to the Company and all its shareholders.”
Under the Rights Plan, the rights generally become exercisable only if a  person or group (i) acquires beneficial ownership of 15% or more of TRC’s common  stock or (ii) announces or commences a tender or exchange offer that would  result in that person or group acquiring 15% or more of TRC’s common  stock. Thereafter, all rights beneficially owned by the person or group that  acquired (or that would acquire as a result of a tender or exchange offer) 15%  or more of TRC’s common stock will become null and void. The exercise price of  the rights has been set at $15.00. If they become exercisable, the rights  entitle the holder of each right to purchase for the exercise price that number  of shares of common stock of the Company which has a market value of twice the  exercise price, subject to certain adjustments as provided under the Rights  Plan. The rights are redeemable by TRC for $0.001 per right, subject to  adjustment, any time before the rights become exercisable, including to permit  an offer to purchase all of TRC’s shares. Until the rights become exercisable,  they will not be evidenced by separate certificates and will trade automatically  with the Company’s common stock. The rights will expire on January 18, 2013,  unless earlier redeemed, exchanged, or amended by TRC.
Additional information regarding the Rights Plan is contained in a Form 8-K  being filed with the Securities and Exchange Commission. The above description  is only a summary; interested persons are urged to read the full Rights Plan  filed with the Securities and Exchange Commission.
Technology Research Corporation is a recognized leader in providing cost  effective engineered solutions for applications involving power management and  control, intelligent battery systems technology and electrical safety products  based on our proven ground fault sensing and Fire Shield®  technology.  These products are designed, manufactured and distributed to the  consumer, commercial and industrial markets worldwide.  The Company also  supplies power monitors and control equipment to the United States Military and  its prime contractors.  More information is available at www.trci.net.
The Technology Research Corporation logo is available at  http://www.globenewswire.com/newsroom/prs/?pkgid=6266
“Safe Harbor” Statement under the Private Securities Litigation Reform Act  of 1995:  Some of the statements in this press release constitute  “forward-looking statements” within the meaning of the Private Securities  Litigation Reform Act of 1995 and the Securities Exchange Act of 1934.  These  statements are related to future events, other future financial performance or  business strategies, and may be identified by terminology such as “may,” “will,”  “should,” “expects,” “scheduled,” “plans,” “intends,” “anticipates,” “believes,”  “estimates,” “potential,” or “continue,” or the negative of such terms, or other  comparable terminology.  These statements are only predictions and are  subject to risks and uncertainties that could cause actual results to differ  materially from those expressed in the forward-looking statements.  In  evaluating these statements, you should specifically consider the factors discussed in our filings with the Securities and Exchange Commission,  including our annual report on Form 10-K for the year ended March 31, 2010, our  quarterly reports on Form 10-Q, and periodic reports on Form 8-K. Do not  rely on any forward-looking statement, as we cannot predict or control many of  the factors that ultimately may affect our ability to achieve the results  estimated. We make no promise to update any forward-looking statement, whether  as a result of changes in underlying factors, new information, future events or  otherwise. 
CONTACT: Robert D. Woltil
         Chief Financial Officer
         Tel: (727) 812-0551
         Fax: (727) 535-9691
         Web Page: www.trci.net
				
								
								
				
			
			 
		
			
			
			
				
				
				Jan. 18, 2011 (Business Wire) — ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA),  today announced top-line data showing that ridaforolimus, an investigational  oral mTOR inhibitor, met the primary endpoint of improved progression-free  survival (PFS) compared to placebo in the Phase 3 SUCCEED trial conducted in  patients with metastatic soft-tissue or bone sarcomas who previously had a  favorable response to chemotherapy. Merck is currently developing ridaforolimus  in multiple cancer indications under an exclusive license and collaboration  agreement with ARIAD. Complete findings from the SUCCEED trial will be submitted  for presentation at an upcoming medical meeting this year.
Based on the full analysis of 552 PFS events in 711 patients, determined by  an independent review committee, the blinded prospective study achieved its  primary endpoint, with a statistically significant (p=0.0001) 28 percent  reduction by ridaforolimus in the risk of progression compared to placebo  (hazard ratio=0.72). Determination of median PFS for each arm of the trial  demonstrated that ridaforolimus treatment resulted in a statistically  significant 21 percent (3.1 week) improvement in median PFS (ridaforolimus, 17.7  weeks vs. placebo, 14.6 weeks).
Based on the full analysis of PFS determined by the investigative sites,  there also was a statistically significant (p<0.0001) 31 percent reduction by  ridaforolimus in the risk of progression compared to placebo (hazard  ratio=0.69). Ridaforolimus treatment resulted in a statistically significant 52  percent (7.7 week) improvement in median PFS (ridaforolimus, 22.4 weeks  vs. placebo, 14.7 weeks).
The most common side effects observed in the study to date were consistent  with the known safety profile of ridaforolimus and included stomatitis  (e.g., mouth sores), fatigue, diarrhea and thrombocytopenia.
This trial remains active, and study participants continue to be followed to  gather additional data on secondary endpoints, including overall survival and  the safety profile of ridaforolimus. Merck currently plans to file for marketing  approval of oral ridaforolimus in 2011, subject to final collection and analysis  of all available data from the trial.
“Patients with metastatic soft-tissue and bone sarcomas have extremely  limited treatment options available to them,” stated Harvey J. Berger, M.D.,  chairman and chief executive officer of ARIAD. “These top-line data illustrate  how devastating metastatic sarcomas can be, even in patients who have responded  favorably to conventional chemotherapy. We are very pleased with the positive  outcome of the SUCCEED trial and the statistically significant improvement in  progression-free survival in those patients treated with oral ridaforolimus.”
The SUCCEED trial is a randomized (1:1), placebo-controlled, double-blind  study of oral ridaforolimus administered at 40 mg/day (five of seven days/week)  in patients with metastatic soft-tissue or bone sarcomas who demonstrated a  favorable response to prior conventional chemotherapy. Oral ridaforolimus was  granted a Special Protocol Assessment (SPA) by the U.S. Food and Drug  Administration for the SUCCEED trial. The European Medicines Agency has also  provided protocol advice regarding the trial design as part of its Protocol  Assistance program. More information about this trial can be found at  http://clinicaltrials.gov/ct2/results?term=NCT00538239.
Investor Call Today at 9:00 a.m. ET
ARIAD will hold an investor webcast to discuss the top-line results of the  SUCCEED trial today, January 18, 2011 at 9:00 am ET. The live webcast can be  accessed by visiting the investor relations section of ARIAD’s website at  http://investor.ariad.com. Investors can access the call by dialing 866-804-6928  (domestic) or 857-350-1674 (international) five minutes prior to the start time  and providing the pass code 14844206. A replay of the call will be available on  the ARIAD website approximately two hours after completion of the call and will  be archived for three weeks.
About Sarcoma
Sarcomas are a group of cancers of connective tissue of the body for which  there are currently limited treatment options. Sarcomas can arise anywhere in  the body and are divided into two main groups – bone tumors and soft-tissue  sarcomas.
About Ridaforolimus
Ridaforolimus is an investigational targeted and potent small-molecule  inhibitor of the protein mTOR, a protein that acts as a central regulator of  protein synthesis, cell proliferation, cell cycle progression and cell survival,  integrating signals from proteins, such as PI3K, AKT and PTEN, known to be  important to malignancy.
About ARIAD
ARIAD’s vision is to transform the lives of cancer patients with breakthrough  medicines. The Company’s mission is to discover, develop and commercialize  small-molecule drugs to treat cancer in patients with the greatest and most  urgent unmet medical need – aggressive cancers where current therapies are  inadequate. ARIAD’s lead product candidate, ridaforolimus, is an investigational  mTOR inhibitor being developed by Merck that has successfully completed a Phase  3 clinical trial in patients with soft-tissue and bone sarcomas and is being  studied in multiple cancer indications. ARIAD’s second internally discovered  product candidate, ponatinib, is an investigational pan-BCR-ABL inhibitor in a  pivotal Phase 2 clinical trial in patients with chronic myeloid leukemia and Ph+  acute lymphoblastic leukemia. For additional information, please visit  www.ariad.com.
This press release contains “forward-looking statements” including, but not  limited to, statements relating to top-line clinical data for ridaforolimus in  the treatment of metastatic soft-tissue and bone sarcomas. Forward-looking  statements are based on management’s expectations and are subject to certain  factors, risks and uncertainties that may cause actual results, outcome of  events, timing and performance to differ materially from those expressed or  implied by such statements. These risks and uncertainties include, but are not  limited to, results of clinical studies of ARIAD’s product candidates, timing  and acceptance of regulatory filing for drug approval, and other factors  detailed in ARIAD’s public filings with the U.S. Securities and Exchange  Commission. The information contained in this press release is believed to be  current as of the date of original issue. ARIAD does not intend to update any of  the forward-looking statements after the date of this document to conform these  statements to actual results or to changes in ARIAD’s expectations, except as  required by law.
				
								
								
				
			
			 
		
			
			
			
				
				
				Universal Forest Products, Inc., through its subsidiaries, designs, manufactures and markets wood and wood-alternative products for DIY/retail home centers and other retailers, structural lumber products for the manufactured housing industry, engineered wood components for the site-built construction market, and specialty wood packaging and components for various industries.
Founded in 1955, Universal has approximately 7,500 employees who work in more than 80 facilities across North America. Despite the massive size, the Company has maintained its local relationships and a strong presence via a strategic network of plants throughout North America. The breadth and depth of these relationships are further reinforced by the fact that there is virtually zero employee turnover.
Even though the recent recession has been particularly hard on the construction industry, Universal Forest Products has been able to leverage its agility and diverse business model to navigate through the carnage and capitalize on new opportunities for growth. In the most recently reported quarter, Universal announced that sales grew in three of its four markets while maintaining a cash position of more than $58 million.
The Company also recently announced a semiannual dividend payment of $0.20 per share as well as a two million share expansion of its stock repurchase program. In addition to underscoring Universal’s firm footing and bright future, the initiatives also serve as a gesture of the appreciation the Company has for its shareholders. Having established an enviable position within its industry, both competitively and financially, Universal Forest Products is one to keep on radar.
Let us hear your thoughts below:
				
								
								
				
			
			 
		
			
			
			
				
				
				Yesterday, while the markets were closed for Martin Luther King Jr. Day, Steve Jobs announced that he is taking another medical leave, raising new concerns among investors about the company’s future. During his leave, Apple chief operating officer Tim Cook will be responsible for all of the company’s day to day operations.
“At my request, the board of directors has granted me a medical leave of absence so I can focus on my health,” Jobs said in an email to all Apple employees, which was published on the company’s website. The email did not disclose details about his health condition or when he is expected to resume full command.
This leave marks the third time in the past ten years that Jobs has stepped back from his role for medical reasons. He took medical leave in 2004 and then again in the first half of 2009, returning to the company in late June of that year.
Today when the stock market opened for trading, AAPL fell as far as $326.00 before recovering to the current PPS of $336.85, still down 3.34% from Friday’s close. Analysts say that Jobs’ leave shouldn’t derail the company’s current momentum, but could have longer-term implications.
Let us hear your thoughts below:
				
								
								
				
			
			 
		
			
			
			
				
				
				
NINGBO, China, Jan. 14, 2011 /PRNewswire-Asia-FirstCall/ — Keyuan  Petrochemicals, Inc. (Nasdaq: KEYP) (“Keyuan or the “Company”), a leading  merchant manufacturer of various petrochemical products in China, announced that  the Company received approval by NASDAQ’s Listing Qualifications Department to  list its common stock on the NASDAQ Global Market. The Company anticipates that  its common stock will commence trading on the NASDAQ Global Market on January  18, 2011 under the same ticker symbol “KEYP.” Until that time, the Company’s  common stock will continue to trade on the NASDAQ Capital Market.
“We are proud to have qualified for the NASDAQ Global Market,” said  Chunfeng Tao, Chairman and Chief Executive Officer of Keyuan. “This move  is a significant milestone of our progress and indicative of our commitment to  generating shareholder value. We believe inclusion in this higher tier of  companies reflects our commitment to accretive growth and our positive momentum  in 2011.”
About Keyuan Petrochemicals, Inc.
Keyuan Petrochemicals, Inc., established in 2007 and operating through its  wholly-owned subsidiary, Keyuan Plastics, Co. Ltd., is located in Ningbo, China  and is a leading independent manufacturer and supplier of various petrochemical  products. Having commenced production in October 2009, Keyuan’s operations  include an annual petrochemical manufacturing design capacity of 550,000 MT for  a variety of petrochemical products, with facilities for the storage and loading  of raw materials and finished goods, and a technology that supports the  manufacturing process with low raw material costs and high utilization and  yields. In order to meet increasing market demand, Keyuan plans to expand its  manufacturing capacity to include a SBS production facility, additional storage  capacity, a raw material pre-treatment facility, and an asphalt production  facility.
Safe Harbor Statement
This press release includes statements that may constitute forward-looking  statements made pursuant to the safe harbor provision of the Private Securities  Litigation Reform Act of 1995. These forward-looking statements can be  identified by terminology such as “will,” “expects,” “anticipates,” “future,”  “intends,” “plans,” “believes,” “estimates” and similar statements. For example,  statements about the future use of the proceeds are forward looking and subject  to risks. Keyuan Petrochemicals, Inc. may also make written or oral  forward-looking statements in its periodic reports to the U.S. Securities and  Exchange Commission on forms 10-K, 10-Q and 8-K, in its annual report to  shareholders, in press releases and other written materials and in oral  statements made by its officers, directors or employees to third parties.  Statements that are not historical facts, including statements about the  Company’s beliefs and expectations, are forward-looking statements.  Forward-looking statements involve inherent risks and uncertainties that could  cause actual results to differ materially from the forward-looking statements. A  number of important factors could cause actual results to differ materially from  those contained in any forward-looking statement. Potential risks and  uncertainties include, but are not limited to, risks outlined in the Company’s  filings with the U.S. Securities and Exchange Commission, including its  registration statement on Form S-1, as amended. The Company does not undertake  any obligation to update any forward-looking statement, except as required under  applicable law.
| For more information, please contact: |  | 
|  |  | 
| Investor Relations: |  | 
| HC International, Inc. |  | 
| Ted Haberfield, Executive VP |  | 
| Tel: +1-760-755-2716 |  | 
| Email: thaberfield@hcinternational.net |  | 
| Website: http://www.hcinternational.net |  | 
|  |  | 
| Mr. Andrew Haag |  | 
| Managing Partner, USA |  | 
| Hampton Growth, LLC |  | 
| Tel: +1-877-368-3566 |  | 
| E-mail: andrew@hamptongrowth.com |  | 
| Website: www.hamptongrowth.com |  | 
|  | 
 
SOURCE Keyuan Petrochemicals, Inc.
 
 
				
								
								
				
			
			 
		
			
			
			
				
				
				Jan. 14, 2011 (Business Wire) — Simulations Plus, Inc. (NASDAQ: SLP), a  leading provider of simulation and modeling software for pharmaceutical  discovery and development, today reported financial results for its first  quarter of fiscal year 2011 ended November 30, 2010 (1QFY11).
1QFY11 highlights compared with 1QFY10:
- Consolidated revenues up 15.4% to record $2.811  million from $2.437 million
- Pharmaceutical software and services revenues up 18.2%  to $2.050 million from $1.735 million
- Words+ subsidiary revenues up 8.3% to $761,000 from  $702,000
- Gross profit up 13.1% to $2.070 million from $1.830  million
- SG&A increased 5.8% to $1.062 million from $1.004  million
- R&D expenditures decreased 14.4% to $395,000 from  $462,000
- Income before income taxes up 24.7% to $0.825 million  from $0.661 million
- Net income up 32.0% to $568,000 from $430,000
- Diluted earnings per share up 34% to $0.0343 from  $0.0256
Ms. Momoko Beran, chief financial officer of Simulations Plus, said, “We’re  pleased to report these results that show continued strong performance in both  business units. Cash at the end of 1QFY11 was $8.873 million compared to $7.973  million at the end of 1QFY10, and compared to $9.63 million at the beginning of  the quarter. We used $1.190 million of our cash to repurchase 397,680 shares  during the first quarter. Although we incurred this expenditure, shareholders’  equity increased 15.4% to $12.482 million compared to $10.812 million in  1QFY10.”
Walt Woltosz, chairman and chief executive officer of Simulations Plus,  added, “This is yet another record first quarter for both revenues and earnings.  We’ve experienced steady growth and new record quarter-over-quarter performance  for a number of years, including through the recent global downturn for so many  other businesses. We believe our emphasis on providing the very best in our  product areas, an aggressive marketing and sales program, strong customer  support, and frugal expense management have been the keys to this success. We  continue to seek accretive acquisitions, and while we’ve investigated a number  of them in the past couple of years, after due diligence we discovered either  inadequate technology or unfavorable business terms for our shareholders. This  area remains a high priority and we will continue to seek favorable  acquisitions. We are also expanding staff and outsourcing some activities in  order to enhance and expand our product lines.”
The Company has announced an earnings conference call for Friday, January 14,  at 11:00 EST, which can be joined by going to:  https://www2.gotomeeting.com/register/911775626. For listen-only mode, dial  516-453-0014 and enter access code 481-048-688.
About Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of groundbreaking drug  discovery and development simulation software, which is licensed and used  worldwide by major pharmaceutical and biotechnology companies for drug research  and in the study of environmental toxicology. We also provide a productivity  tool called Abbreviate! for PCs and the Apple iPhone as well as an educational  software series for science students in middle and high schools known as  FutureLab™. Our wholly owned subsidiary, Words+, Inc.,  provides assistive technologies to persons with disabilities. Simulations Plus,  Inc. is headquartered in Southern California and trades on the NASDAQ Capital  Market under the symbol “SLP.” For more information, visit our Web sites at  www.simulations-plus.com and www.words-plus.com.
Safe Harbor Statement Under the Private Securities Litigation Reform Act  of 1995 – With the exception of historical information, the matters  discussed in this press release are forward-looking statements that involve a  number of risks and uncertainties. Words like “believe,” “expect” and  “anticipate” mean that these are our best estimates as of this writing, but that  there can be no assurances that expected or anticipated results or events will  actually take place, so our actual future results could differ significantly  from those statements. Factors that could cause or contribute to such  differences include, but are not limited to: our ability to maintain our  competitive advantages, acceptance of new software and improved versions of our  existing software by our customers, the general economics of the pharmaceutical  industry, our ability to finance growth, our ability to continue to attract and  retain highly qualified technical staff, our ability to identify and close  acquisitions on terms favorable to the Company, and a sustainable market.  Further information on our risk factors is contained in our quarterly and annual  reports as filed with the Securities and Exchange Commission.
| SIMULATIONS PLUS, INC. AND SUBSIDIARY | 
| Condensed Consolidated Balance Sheets | 
| at November  30, 2010 (Unaudited) and August 31, 2010 (Audited) | 
|  |  |  |  |  |  |  |  | 
| ASSETS | 
|  |  |  |  |  | November  30, |  | August  31, | 
|  |  |  |  |  | 2010 |  | 2010 | 
| Current assets |  |  |  |  |  |  |  | 
| Cash and cash equivalents |  |  |  |  | $ | 8,873,080 |  | $ | 9,631,762 | 
| Income tax refund receivable |  |  |  |  |  | 259,434 |  |  | 225,510 | 
| Accounts receivable,  net of allowance for doubtful accounts |  |  |  |  |  |  |  |  |  | 
| and estimated contractual discounts of  $395,358 and $421,118 |  |  |  |  |  | 1,537,713 |  |  | 1,291,350 | 
| Contracts receivable |  |  |  |  |  | 166,669 |  |  | 184,081 | 
| Inventory |  |  |  |  |  | 522,478 |  |  | 554,867 | 
| Prepaid expenses and other current  assets |  |  |  |  |  | 105,193 |  |  | 138,163 | 
| Deferred income taxes |  |  |  |  |  | 310,024 |  |  | 364,264 | 
| Total current assets |  |  |  |  |  | 11,774,591 |  |  | 12,389,997 | 
|  |  |  |  |  |  |  |  | 
| Capitalized  computer software development costs, |  |  |  |  |  |  |  |  |  | 
| net of accumulated amortization of $4,674,008 and  $4,487,757 |  |  |  |  |  | 2,187,458 |  |  | 2,186,419 | 
| Property and equipment, net |  |  |  |  |  | 75,364 |  |  | 55,984 | 
| Customer relationships, net of  accumulated amortization of $120,935 and $118,442 |  |  |  |  |  | 7,107 |  |  | 9,600 | 
| Other assets |  |  |  |  |  | 18,445 |  |  | 18,445 | 
|  |  |  |  |  |  |  |  | 
| Total assets |  |  |  |  | $ | 14,062,965 |  | $ | 14,660,445 | 
|  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  | 
| LIABILITIES AND  SHAREHOLDERS’ EQUITY | 
| Current liabilities |  |  |  |  |  |  |  | 
| Accounts payable |  |  |  |  | $ | 309,480 |  | $ | 239,424 | 
| Accrued payroll and other expenses |  |  |  |  |  | 506,632 |  |  | 511,106 | 
| Accrued bonuses to officer |  |  |  |  |  | 103,402 |  |  | 60,000 | 
| Accrued income taxes |  |  |  |  |  | 102,914 |  |  | 261,861 | 
| Accrued warranty and service costs |  |  |  |  |  | 39,605 |  |  | 35,586 | 
| Deferred revenue |  |  |  |  |  | 33,170 |  |  | 96,092 | 
| Total current liabilities |  |  |  |  |  | 1,095,203 |  |  | 1,204,069 | 
|  |  |  |  |  |  |  |  | 
| Long-term liabilities |  |  |  |  |  |  |  | 
| Deferred income taxes |  |  |  |  |  | 486,072 |  |  | 410,523 | 
|  |  |  |  |  |  |  |  | 
| Total liabilities |  |  |  |  |  | 1,581,275 |  |  | 1,614,592 | 
|  |  |  |  |  |  |  |  | 
| Commitments and contingencies |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  | 
| Shareholders’ equity |  |  |  |  |  |  |  | 
| Preferred stock, $0.001 par value |  |  |  |  |  |  |  | 
| 10,000,000 shares authorized |  |  |  |  |  |  |  | 
| no shares issued and outstanding |  |  |  |  |  | – |  |  | – | 
| Common stock, $0.001 par value |  |  |  |  |  |  |  | 
| 50,000,000 shares authorized |  |  |  |  |  |  |  | 
| 15,501,979 and  15,833,006 shares issued and outstanding |  |  |  |  |  | 3,973 |  |  | 4,304 | 
| Additional paid-in capital |  |  |  |  |  | 4,759,943 |  |  | 5,891,268 | 
| Retained earnings |  |  |  |  |  | 7,717,774 |  |  | 7,150,281 | 
|  |  |  |  |  |  |  |  | 
| Total shareholders’ equity |  |  |  |  |  | 12,481,690 |  |  | 13,045,853 | 
|  |  |  |  |  |  |  |  | 
| Total liabilities and  shareholders’ equity |  |  |  |  | $ | 14,062,965 |  | $ | 14,660,445 | 
|  |  |  |  |  |  |  |  | 
| SIMULATIONS PLUS, INC. AND SUBSIDIARY | 
| Condensed Consolidated Statements of Operations | 
| For the three months ended  November 30 | 
| (Unaudited) | 
|  |  |  |  |  | 
|  |  | 2010 |  | 2009 | 
|  |  |  |  |  | 
| Net sales |  | $ | 2,811,286 |  |  | $ | 2,437,052 |  | 
|  |  |  |  |  | 
| Cost of sales |  |  | 740,983 |  |  |  | 606,889 |  | 
|  |  |  |  |  | 
| Gross profit |  |  | 2,070,303 |  |  |  | 1,830,163 |  | 
|  |  |  |  |  | 
| Operating expenses |  |  |  |  | 
|  | Selling, general, and  administrative |  |  | 1,062,375 |  |  |  | 1,004,273 |  | 
|  | Research and  development |  |  | 208,039 |  |  |  | 261,325 |  | 
|  |  |  |  |  | 
|  |  | Total operating expenses |  |  | 1,270,414 |  |  |  | 1,265,598 |  | 
|  |  |  |  |  | 
| Income from  operations |  |  | 799,889 |  |  |  | 564,565 |  | 
|  |  |  |  |  | 
| Other income  (expense) |  |  |  |  | 
|  | Interest income |  |  | 24,641 |  |  |  | 22,486 |  | 
|  | Miscellaneous income |  |  | 231 |  |  |  | 231 |  | 
|  | Gain on currency exchange |  |  | – |  |  |  | 73,232 |  | 
|  | Gain on sale of assets |  |  | – |  |  |  | 1,024 |  | 
|  | Interest expense |  |  | (118 | ) |  |  | (302 | ) | 
|  |  |  |  |  | 
|  |  | Total other income (expense) |  |  | 24,754 |  |  |  | 96,671 |  | 
|  |  |  |  |  | 
| Income before income  taxes |  |  | 824,643 |  |  |  | 661,236 |  | 
|  |  |  |  |  | 
| Provision for  income taxes |  |  | (257,150 | ) |  |  | (231,433 | ) | 
|  |  |  |  |  | 
| Net income |  | $ | 567,493 |  |  | $ | 429,803 |  | 
|  |  |  |  |  | 
| Basic earnings  per share |  | $ | 0.04 |  |  | $ | 0.03 |  | 
|  |  |  |  |  | 
| Diluted earnings  per share |  | $ | 0.03 |  |  | $ | 0.03 |  | 
|  |  |  |  |  | 
| Weighted-average common shares outstanding |  |  |  |  | 
|  |  |  |  |  | 
|  | Basic |  |  | 15,691,345 |  |  |  | 15,648,630 |  | 
|  |  |  |  |  | 
|  | Diluted |  |  | 16,525,142 |  |  |  | 16,775,287 |  | 

Simulations Plus Investor Relations
Ms.  Renée Bouché
661-723-7723
renee@simulations-plus.com
or
Hayden IR
Mr. Cameron  Donahue
651-653-1854
cameron@haydenir.com